


<!DOCTYPE html>
<html lang="en-CA">
  <head>
    <title>
    Anxiety and Depression |     Centre for Effective Practice - Digital Tools        </title>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width" />
  <meta name="theme-color" content="#999999" />
  <link href="https://fonts.googleapis.com/css?family=Montserrat:500,500i,700,700i|Open+Sans:400,400i,700,700i&display=swap" rel="stylesheet">
  <meta name='robots' content='noindex, nofollow' />
	<style>img:is([sizes="auto" i], [sizes^="auto," i]) { contain-intrinsic-size: 3000px 1500px }</style>
	<link rel='dns-prefetch' href='//a.omappapi.com' />
<link rel='dns-prefetch' href='//www.googletagmanager.com' />
		<!-- This site uses the Google Analytics by MonsterInsights plugin v9.5.3 - Using Analytics tracking - https://www.monsterinsights.com/ -->
							<script src="//www.googletagmanager.com/gtag/js?id=G-G1F4BDXK7E"  data-cfasync="false" data-wpfc-render="false" type="text/javascript" async></script>
			<script data-cfasync="false" data-wpfc-render="false" type="text/javascript">
				var mi_version = '9.5.3';
				var mi_track_user = true;
				var mi_no_track_reason = '';
								var MonsterInsightsDefaultLocations = {"page_location":"https:\/\/tools.cep.health\/tool\/anxiety-and-depression\/"};
				if ( typeof MonsterInsightsPrivacyGuardFilter === 'function' ) {
					var MonsterInsightsLocations = (typeof MonsterInsightsExcludeQuery === 'object') ? MonsterInsightsPrivacyGuardFilter( MonsterInsightsExcludeQuery ) : MonsterInsightsPrivacyGuardFilter( MonsterInsightsDefaultLocations );
				} else {
					var MonsterInsightsLocations = (typeof MonsterInsightsExcludeQuery === 'object') ? MonsterInsightsExcludeQuery : MonsterInsightsDefaultLocations;
				}

								var disableStrs = [
										'ga-disable-G-G1F4BDXK7E',
									];

				/* Function to detect opted out users */
				function __gtagTrackerIsOptedOut() {
					for (var index = 0; index < disableStrs.length; index++) {
						if (document.cookie.indexOf(disableStrs[index] + '=true') > -1) {
							return true;
						}
					}

					return false;
				}

				/* Disable tracking if the opt-out cookie exists. */
				if (__gtagTrackerIsOptedOut()) {
					for (var index = 0; index < disableStrs.length; index++) {
						window[disableStrs[index]] = true;
					}
				}

				/* Opt-out function */
				function __gtagTrackerOptout() {
					for (var index = 0; index < disableStrs.length; index++) {
						document.cookie = disableStrs[index] + '=true; expires=Thu, 31 Dec 2099 23:59:59 UTC; path=/';
						window[disableStrs[index]] = true;
					}
				}

				if ('undefined' === typeof gaOptout) {
					function gaOptout() {
						__gtagTrackerOptout();
					}
				}
								window.dataLayer = window.dataLayer || [];

				window.MonsterInsightsDualTracker = {
					helpers: {},
					trackers: {},
				};
				if (mi_track_user) {
					function __gtagDataLayer() {
						dataLayer.push(arguments);
					}

					function __gtagTracker(type, name, parameters) {
						if (!parameters) {
							parameters = {};
						}

						if (parameters.send_to) {
							__gtagDataLayer.apply(null, arguments);
							return;
						}

						if (type === 'event') {
														parameters.send_to = monsterinsights_frontend.v4_id;
							var hookName = name;
							if (typeof parameters['event_category'] !== 'undefined') {
								hookName = parameters['event_category'] + ':' + name;
							}

							if (typeof MonsterInsightsDualTracker.trackers[hookName] !== 'undefined') {
								MonsterInsightsDualTracker.trackers[hookName](parameters);
							} else {
								__gtagDataLayer('event', name, parameters);
							}
							
						} else {
							__gtagDataLayer.apply(null, arguments);
						}
					}

					__gtagTracker('js', new Date());
					__gtagTracker('set', {
						'developer_id.dZGIzZG': true,
											});
					if ( MonsterInsightsLocations.page_location ) {
						__gtagTracker('set', MonsterInsightsLocations);
					}
										__gtagTracker('config', 'G-G1F4BDXK7E', {"forceSSL":"true","link_attribution":"true","page_path":location.pathname + location.search + location.hash} );
															window.gtag = __gtagTracker;										(function () {
						/* https://developers.google.com/analytics/devguides/collection/analyticsjs/ */
						/* ga and __gaTracker compatibility shim. */
						var noopfn = function () {
							return null;
						};
						var newtracker = function () {
							return new Tracker();
						};
						var Tracker = function () {
							return null;
						};
						var p = Tracker.prototype;
						p.get = noopfn;
						p.set = noopfn;
						p.send = function () {
							var args = Array.prototype.slice.call(arguments);
							args.unshift('send');
							__gaTracker.apply(null, args);
						};
						var __gaTracker = function () {
							var len = arguments.length;
							if (len === 0) {
								return;
							}
							var f = arguments[len - 1];
							if (typeof f !== 'object' || f === null || typeof f.hitCallback !== 'function') {
								if ('send' === arguments[0]) {
									var hitConverted, hitObject = false, action;
									if ('event' === arguments[1]) {
										if ('undefined' !== typeof arguments[3]) {
											hitObject = {
												'eventAction': arguments[3],
												'eventCategory': arguments[2],
												'eventLabel': arguments[4],
												'value': arguments[5] ? arguments[5] : 1,
											}
										}
									}
									if ('pageview' === arguments[1]) {
										if ('undefined' !== typeof arguments[2]) {
											hitObject = {
												'eventAction': 'page_view',
												'page_path': arguments[2],
											}
										}
									}
									if (typeof arguments[2] === 'object') {
										hitObject = arguments[2];
									}
									if (typeof arguments[5] === 'object') {
										Object.assign(hitObject, arguments[5]);
									}
									if ('undefined' !== typeof arguments[1].hitType) {
										hitObject = arguments[1];
										if ('pageview' === hitObject.hitType) {
											hitObject.eventAction = 'page_view';
										}
									}
									if (hitObject) {
										action = 'timing' === arguments[1].hitType ? 'timing_complete' : hitObject.eventAction;
										hitConverted = mapArgs(hitObject);
										__gtagTracker('event', action, hitConverted);
									}
								}
								return;
							}

							function mapArgs(args) {
								var arg, hit = {};
								var gaMap = {
									'eventCategory': 'event_category',
									'eventAction': 'event_action',
									'eventLabel': 'event_label',
									'eventValue': 'event_value',
									'nonInteraction': 'non_interaction',
									'timingCategory': 'event_category',
									'timingVar': 'name',
									'timingValue': 'value',
									'timingLabel': 'event_label',
									'page': 'page_path',
									'location': 'page_location',
									'title': 'page_title',
									'referrer' : 'page_referrer',
								};
								for (arg in args) {
																		if (!(!args.hasOwnProperty(arg) || !gaMap.hasOwnProperty(arg))) {
										hit[gaMap[arg]] = args[arg];
									} else {
										hit[arg] = args[arg];
									}
								}
								return hit;
							}

							try {
								f.hitCallback();
							} catch (ex) {
							}
						};
						__gaTracker.create = newtracker;
						__gaTracker.getByName = newtracker;
						__gaTracker.getAll = function () {
							return [];
						};
						__gaTracker.remove = noopfn;
						__gaTracker.loaded = true;
						window['__gaTracker'] = __gaTracker;
					})();
									} else {
										console.log("");
					(function () {
						function __gtagTracker() {
							return null;
						}

						window['__gtagTracker'] = __gtagTracker;
						window['gtag'] = __gtagTracker;
					})();
									}
			</script>
				<!-- / Google Analytics by MonsterInsights -->
		<link rel='stylesheet' id='wp-block-library-css' href='https://tools.cep.health/wp-includes/css/dist/block-library/style.min.css?ver=6.8.2' media='all' />
<style id='classic-theme-styles-inline-css' type='text/css'>
/*! This file is auto-generated */
.wp-block-button__link{color:#fff;background-color:#32373c;border-radius:9999px;box-shadow:none;text-decoration:none;padding:calc(.667em + 2px) calc(1.333em + 2px);font-size:1.125em}.wp-block-file__button{background:#32373c;color:#fff;text-decoration:none}
</style>
<style id='global-styles-inline-css' type='text/css'>
:root{--wp--preset--aspect-ratio--square: 1;--wp--preset--aspect-ratio--4-3: 4/3;--wp--preset--aspect-ratio--3-4: 3/4;--wp--preset--aspect-ratio--3-2: 3/2;--wp--preset--aspect-ratio--2-3: 2/3;--wp--preset--aspect-ratio--16-9: 16/9;--wp--preset--aspect-ratio--9-16: 9/16;--wp--preset--color--black: #000000;--wp--preset--color--cyan-bluish-gray: #abb8c3;--wp--preset--color--white: #ffffff;--wp--preset--color--pale-pink: #f78da7;--wp--preset--color--vivid-red: #cf2e2e;--wp--preset--color--luminous-vivid-orange: #ff6900;--wp--preset--color--luminous-vivid-amber: #fcb900;--wp--preset--color--light-green-cyan: #7bdcb5;--wp--preset--color--vivid-green-cyan: #00d084;--wp--preset--color--pale-cyan-blue: #8ed1fc;--wp--preset--color--vivid-cyan-blue: #0693e3;--wp--preset--color--vivid-purple: #9b51e0;--wp--preset--gradient--vivid-cyan-blue-to-vivid-purple: linear-gradient(135deg,rgba(6,147,227,1) 0%,rgb(155,81,224) 100%);--wp--preset--gradient--light-green-cyan-to-vivid-green-cyan: linear-gradient(135deg,rgb(122,220,180) 0%,rgb(0,208,130) 100%);--wp--preset--gradient--luminous-vivid-amber-to-luminous-vivid-orange: linear-gradient(135deg,rgba(252,185,0,1) 0%,rgba(255,105,0,1) 100%);--wp--preset--gradient--luminous-vivid-orange-to-vivid-red: linear-gradient(135deg,rgba(255,105,0,1) 0%,rgb(207,46,46) 100%);--wp--preset--gradient--very-light-gray-to-cyan-bluish-gray: linear-gradient(135deg,rgb(238,238,238) 0%,rgb(169,184,195) 100%);--wp--preset--gradient--cool-to-warm-spectrum: linear-gradient(135deg,rgb(74,234,220) 0%,rgb(151,120,209) 20%,rgb(207,42,186) 40%,rgb(238,44,130) 60%,rgb(251,105,98) 80%,rgb(254,248,76) 100%);--wp--preset--gradient--blush-light-purple: linear-gradient(135deg,rgb(255,206,236) 0%,rgb(152,150,240) 100%);--wp--preset--gradient--blush-bordeaux: linear-gradient(135deg,rgb(254,205,165) 0%,rgb(254,45,45) 50%,rgb(107,0,62) 100%);--wp--preset--gradient--luminous-dusk: linear-gradient(135deg,rgb(255,203,112) 0%,rgb(199,81,192) 50%,rgb(65,88,208) 100%);--wp--preset--gradient--pale-ocean: linear-gradient(135deg,rgb(255,245,203) 0%,rgb(182,227,212) 50%,rgb(51,167,181) 100%);--wp--preset--gradient--electric-grass: linear-gradient(135deg,rgb(202,248,128) 0%,rgb(113,206,126) 100%);--wp--preset--gradient--midnight: linear-gradient(135deg,rgb(2,3,129) 0%,rgb(40,116,252) 100%);--wp--preset--font-size--small: 13px;--wp--preset--font-size--medium: 20px;--wp--preset--font-size--large: 36px;--wp--preset--font-size--x-large: 42px;--wp--preset--spacing--20: 0.44rem;--wp--preset--spacing--30: 0.67rem;--wp--preset--spacing--40: 1rem;--wp--preset--spacing--50: 1.5rem;--wp--preset--spacing--60: 2.25rem;--wp--preset--spacing--70: 3.38rem;--wp--preset--spacing--80: 5.06rem;--wp--preset--shadow--natural: 6px 6px 9px rgba(0, 0, 0, 0.2);--wp--preset--shadow--deep: 12px 12px 50px rgba(0, 0, 0, 0.4);--wp--preset--shadow--sharp: 6px 6px 0px rgba(0, 0, 0, 0.2);--wp--preset--shadow--outlined: 6px 6px 0px -3px rgba(255, 255, 255, 1), 6px 6px rgba(0, 0, 0, 1);--wp--preset--shadow--crisp: 6px 6px 0px rgba(0, 0, 0, 1);}:where(.is-layout-flex){gap: 0.5em;}:where(.is-layout-grid){gap: 0.5em;}body .is-layout-flex{display: flex;}.is-layout-flex{flex-wrap: wrap;align-items: center;}.is-layout-flex > :is(*, div){margin: 0;}body .is-layout-grid{display: grid;}.is-layout-grid > :is(*, div){margin: 0;}:where(.wp-block-columns.is-layout-flex){gap: 2em;}:where(.wp-block-columns.is-layout-grid){gap: 2em;}:where(.wp-block-post-template.is-layout-flex){gap: 1.25em;}:where(.wp-block-post-template.is-layout-grid){gap: 1.25em;}.has-black-color{color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-color{color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-color{color: var(--wp--preset--color--white) !important;}.has-pale-pink-color{color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-color{color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-color{color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-color{color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-color{color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-color{color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-color{color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-color{color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-color{color: var(--wp--preset--color--vivid-purple) !important;}.has-black-background-color{background-color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-background-color{background-color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-background-color{background-color: var(--wp--preset--color--white) !important;}.has-pale-pink-background-color{background-color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-background-color{background-color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-background-color{background-color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-background-color{background-color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-background-color{background-color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-background-color{background-color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-background-color{background-color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-background-color{background-color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-background-color{background-color: var(--wp--preset--color--vivid-purple) !important;}.has-black-border-color{border-color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-border-color{border-color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-border-color{border-color: var(--wp--preset--color--white) !important;}.has-pale-pink-border-color{border-color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-border-color{border-color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-border-color{border-color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-border-color{border-color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-border-color{border-color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-border-color{border-color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-border-color{border-color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-border-color{border-color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-border-color{border-color: var(--wp--preset--color--vivid-purple) !important;}.has-vivid-cyan-blue-to-vivid-purple-gradient-background{background: var(--wp--preset--gradient--vivid-cyan-blue-to-vivid-purple) !important;}.has-light-green-cyan-to-vivid-green-cyan-gradient-background{background: var(--wp--preset--gradient--light-green-cyan-to-vivid-green-cyan) !important;}.has-luminous-vivid-amber-to-luminous-vivid-orange-gradient-background{background: var(--wp--preset--gradient--luminous-vivid-amber-to-luminous-vivid-orange) !important;}.has-luminous-vivid-orange-to-vivid-red-gradient-background{background: var(--wp--preset--gradient--luminous-vivid-orange-to-vivid-red) !important;}.has-very-light-gray-to-cyan-bluish-gray-gradient-background{background: var(--wp--preset--gradient--very-light-gray-to-cyan-bluish-gray) !important;}.has-cool-to-warm-spectrum-gradient-background{background: var(--wp--preset--gradient--cool-to-warm-spectrum) !important;}.has-blush-light-purple-gradient-background{background: var(--wp--preset--gradient--blush-light-purple) !important;}.has-blush-bordeaux-gradient-background{background: var(--wp--preset--gradient--blush-bordeaux) !important;}.has-luminous-dusk-gradient-background{background: var(--wp--preset--gradient--luminous-dusk) !important;}.has-pale-ocean-gradient-background{background: var(--wp--preset--gradient--pale-ocean) !important;}.has-electric-grass-gradient-background{background: var(--wp--preset--gradient--electric-grass) !important;}.has-midnight-gradient-background{background: var(--wp--preset--gradient--midnight) !important;}.has-small-font-size{font-size: var(--wp--preset--font-size--small) !important;}.has-medium-font-size{font-size: var(--wp--preset--font-size--medium) !important;}.has-large-font-size{font-size: var(--wp--preset--font-size--large) !important;}.has-x-large-font-size{font-size: var(--wp--preset--font-size--x-large) !important;}
:where(.wp-block-post-template.is-layout-flex){gap: 1.25em;}:where(.wp-block-post-template.is-layout-grid){gap: 1.25em;}
:where(.wp-block-columns.is-layout-flex){gap: 2em;}:where(.wp-block-columns.is-layout-grid){gap: 2em;}
:root :where(.wp-block-pullquote){font-size: 1.5em;line-height: 1.6;}
</style>
<link rel='stylesheet' id='studio123_styles-css' href='https://tools.cep.health/wp-content/themes/cep-tools/style.min.css?ver=1743561782' media='all' />
<link rel='stylesheet' id='glossary-hint-css' href='https://tools.cep.health/wp-content/plugins/glossary-by-codeat/assets/css/tooltip-classic.css?ver=2.3.5' media='all' />
<script type="text/javascript" src="https://tools.cep.health/wp-content/plugins/google-analytics-for-wordpress/assets/js/frontend-gtag.min.js?ver=9.5.3" id="monsterinsights-frontend-script-js" async="async" data-wp-strategy="async"></script>
<script data-cfasync="false" data-wpfc-render="false" type="text/javascript" id='monsterinsights-frontend-script-js-extra'>/* <![CDATA[ */
var monsterinsights_frontend = {"js_events_tracking":"true","download_extensions":"doc,pdf,ppt,zip,xls,docx,pptx,xlsx","inbound_paths":"[{\"path\":\"\\\/go\\\/\",\"label\":\"affiliate\"},{\"path\":\"\\\/recommend\\\/\",\"label\":\"affiliate\"}]","home_url":"https:\/\/tools.cep.health","hash_tracking":"true","v4_id":"G-G1F4BDXK7E"};/* ]]> */
</script>

<!-- Google tag (gtag.js) snippet added by Site Kit -->

<!-- Google Analytics snippet added by Site Kit -->
<script type="text/javascript" src="https://www.googletagmanager.com/gtag/js?id=GT-MBGGM43" id="google_gtagjs-js" async></script>
<script type="text/javascript" id="google_gtagjs-js-after">
/* <![CDATA[ */
window.dataLayer = window.dataLayer || [];function gtag(){dataLayer.push(arguments);}
gtag("set","linker",{"domains":["tools.cep.health"]});
gtag("js", new Date());
gtag("set", "developer_id.dZTNiMT", true);
gtag("config", "GT-MBGGM43");
/* ]]> */
</script>

<!-- End Google tag (gtag.js) snippet added by Site Kit -->
<script type="text/javascript" src="https://tools.cep.health/wp-content/themes/cep-tools/js/jquery.min.js" id="jquery-js"></script>
<script type="text/javascript" src="https://tools.cep.health/wp-content/themes/cep-tools/js/jquery-migrate.min.js" id="jquery-migrate-js"></script>
<link rel="https://api.w.org/" href="https://tools.cep.health/wp-json/" /><link rel="alternate" title="JSON" type="application/json" href="https://tools.cep.health/wp-json/wp/v2/tools/56356" /><link rel="alternate" title="oEmbed (JSON)" type="application/json+oembed" href="https://tools.cep.health/wp-json/oembed/1.0/embed?url=https%3A%2F%2Ftools.cep.health%2Ftool%2Fanxiety-and-depression%2F" />
<link rel="alternate" title="oEmbed (XML)" type="text/xml+oembed" href="https://tools.cep.health/wp-json/oembed/1.0/embed?url=https%3A%2F%2Ftools.cep.health%2Ftool%2Fanxiety-and-depression%2F&#038;format=xml" />
<meta name="generator" content="Site Kit by Google 1.155.0" />
<!-- Google Tag Manager snippet added by Site Kit -->
<script type="text/javascript">
/* <![CDATA[ */

			( function( w, d, s, l, i ) {
				w[l] = w[l] || [];
				w[l].push( {'gtm.start': new Date().getTime(), event: 'gtm.js'} );
				var f = d.getElementsByTagName( s )[0],
					j = d.createElement( s ), dl = l != 'dataLayer' ? '&l=' + l : '';
				j.async = true;
				j.src = 'https://www.googletagmanager.com/gtm.js?id=' + i + dl;
				f.parentNode.insertBefore( j, f );
			} )( window, document, 'script', 'dataLayer', 'GTM-WLFDZV' );
			
/* ]]> */
</script>

<!-- End Google Tag Manager snippet added by Site Kit -->
<link rel="icon" href="https://tools.cep.health/wp-content/uploads/2019/10/cropped-Frame-36-1-32x32.png" sizes="32x32" />
<link rel="icon" href="https://tools.cep.health/wp-content/uploads/2019/10/cropped-Frame-36-1-192x192.png" sizes="192x192" />
<link rel="apple-touch-icon" href="https://tools.cep.health/wp-content/uploads/2019/10/cropped-Frame-36-1-180x180.png" />
<meta name="msapplication-TileImage" content="https://tools.cep.health/wp-content/uploads/2019/10/cropped-Frame-36-1-270x270.png" />
		<style type="text/css" id="wp-custom-css">
			.m0 {margin-top:0; margin-bottom: 0}		</style>
		<!--- Error: No Google analytics ID found. Go to Site Options > Analytics to enter your ID. ---><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({"gtm.start":new Date().getTime(),event:"gtm.js"});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!="dataLayer"?"&l="+l:"";j.async=true;j.src="https://www.googletagmanager.com/gtm.js?id="+i+dl;f.parentNode.insertBefore(j,f);})(window,document,"script","dataLayer","GTM-K6HPX8H");</script>  </head>
  <body class="wp-singular tools-template-default single single-tools postid-56356 wp-theme-cep-tools anxiety-and-depression">

      <!-- Google Tag Manager (noscript) -->
    <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-K6HPX8H"
    height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
    <!-- End Google Tag Manager (noscript) -->

    <header>
      <div class="container">
        <div class="columns is-flex is-gapless">
          <div class="column">
            <a class="logo" target="_self" href="https://cep.health/tools" data-wpel-link="external" rel="external noopener noreferrer">
              <img src="https://tools.cep.health/wp-content/themes/cep-tools/img/logo.svg" alt="Centre for Effective Practice - Digital Tools" />
            </a>
          </div>
        </div>
      </div>
    </header>

<main>
  	<section class="section--impact_area">
    <div class="container">
        <h1>Anxiety and Depression</h1>
                    <p class="last-updated"><i class="icon icon-clock-with-arrow"> </i>Last Updated: April 4, 2023</p>
                <ul class="links">
            <li>
                <button data-search-content class="button">Search Content&nbsp;&nbsp;<i class="icon icon-search"></i></a>
            </li>
                    </ul>
    </div>
</section>

		<section class="section--sections_listing" id="sections">

			
<div class="search-tool">
    <div class="search-tool-bar">
        <div class="search-wrapper">
            <div class="search-input-wrapper">
                <input data-search-tool-input type="search" autocomplete="off" placeholder="Enter search terms">
                <i class="icon icon-search"></i>
                <span class="search-no-results-found">No Results Found</span>
                <span class="search-result-count"><span class="current">0</span>/<span class="total">0</span></span>
            </div>
            <button data-search-previous disabled class="search-previous"><i class="icon icon-chevron-up"></i></button>
            <button data-search-next disabled class="search-next"><i class="icon icon-chevron-down"></i></button>
        </div>
        <button data-search-tool-close class="close"><i class="icon icon-close"></i></button>
    </div>
</div>
			<article class="block--background  core-block" data-block-name="cep/background"><div class="container">
<div class="wp-block-cep-background is-style-blue-background"><article class="block--text-with-icon ">  <div class="container">
    
        <div class="columns is-flex is-gapless">
          <div class="column is-2-mobile is-1">
            <div class="inner">
              <img decoding="async" src="https://tools.cep.health/wp-content/uploads/2019/10/Checkmark-Large.svg" />
            </div>
          </div>
          <div class="column is-10-mobile is-11">
            <h6><a href="https://cep.health/academic-detailing/" target="_blank" rel="noopener external noreferrer" data-wpel-link="external">Sign up for academic detailing (one-on-one education) with a pharmacist on this topic</a></h6>
          </div>
        </div>

      </div>
</article></div>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>This clinical tool helps family physicians and primary care nurse practitioners identify and manage anxiety and depression in adult patients. The tool was developed to help guide conversations with patients and families over a series of visits, as needed.</p>
</div></article>			<div class="container has-text-right" style="padding: 0 0 1.5rem;">
				<div class="expand-all">
					<a href="#" data-expand-text="Expand All" data-collapse-text="Collapse All">Expand All</a>
				</div>
			</div>
			<div id="top-of-sections"></div>
							<section class="main-section" id="screening-and-assessment" tabindex="-1">
					<div class="head">
						<div class="container">
							<h2 class="main-heading">
								Screening and assessment								
							</h2>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
						</div>
					</div>
					<div class="body">
						<div class="container">
							<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h4 class="wp-block-heading">Jump to:</h4>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><a href="#screenpatient" data-type="internal" data-id="#screenpatient">Screen patient</a><br><a href="#conductcompassessment" data-type="internal" data-id="#conductcompassessment">Conduct a comprehensive assessment</a></p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>Screen patients who express mood or anxiety/depression-related concerns and those who come in for unrelated concerns, but who present with risk factors for anxiety and depression. Current evidence does not indicate a recommended screening interval for anxiety and depression.</p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>Balance the use of validated screening tools with facilitating talks with patients about anxiety and depression.</p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>For patients with mild, moderate or severe symptoms, a comprehensive assessment should be conducted.</p>
</div></article>

<article class="block--background  core-block" data-block-name="cep/background"><div class="container">
<div class="wp-block-cep-background is-style-blue-background"><article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h4 class="wp-block-heading"><strong>Guiding principles for the screening and assessment of anxiety and depression:</strong></h4>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Avoid stigmatizing labels (e.g., “abnormal”, “unusual”). Ensure steps are taken to reduce stigma, discrimination and barriers for patients.</li>



<li>Talk about symptoms instead of disorders/diagnoses.</li>



<li>Ensure that patients feel comfortable establishing trust with you as their healthcare provider.</li>



<li>Ensure services are culturally appropriate or culturally adapted (e.g., language considerations/translators).&nbsp;</li>



<li>Provide various methods to engage with patients (e.g., in-person, email, telephone, online or remote consultations).&nbsp;</li>



<li>Ensure that discussions occur in settings where confidentiality, privacy and dignity are respected.</li>
</ul>
</div></article></div>
</div></article>

<article class="block--text-with-icon ">  <div class="container">
    
        <div class="columns is-flex is-gapless">
          <div class="column is-2-mobile is-1">
            <div class="inner">
              <img decoding="async" src="https://tools.cep.health/wp-content/uploads/2019/10/Checkmark-Large-2.svg" />
            </div>
          </div>
          <div class="column is-10-mobile is-11">
            <h3>Screen patient</h3>
          </div>
        </div>

      </div>
</article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h4 class="wp-block-heading" id="screenpatient">Screen for risk factors<sup>1, 3</sup></h4>
</div></article>


<div class="wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex">
<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow"><article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading"><strong>Clinical factors:</strong></h6>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Personal or family history of anxiety or depression</li>



<li>Psychosocial adversity (e.g., stressful life events, childhood trauma)</li>



<li>Chronic medical conditions (e.g., cardiovascular disease, diabetes, neurological disorders, chronic pain)</li>



<li>Other psychiatric conditions (e.g., bipolar disorder, schizophrenia, substance use disorder)</li>



<li>Perinatal/postpartum, premenstrual dysphoric disorder, menopause</li>
</ul>
</div></article></div>



<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow"><article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading"><strong>Symptom factors:</strong></h6>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Fatigue</li>



<li><a href="https://link.cep.health/ad87" data-type="URL" data-id="https://link.cep.health/ad87" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Insomnia</a></li>



<li>Unexplained physical symptoms (e.g., unexplained aches and pains)</li>



<li>Significant and repeated worry</li>



<li>Frequent healthcare use due to any of the above</li>
</ul>
</div></article></div>
</div>


<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h4 class="wp-block-heading"><strong>Complete a validated or recognized screening tool</strong><sup>3,4</sup></h4>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading">Anxiety</h6>
</div></article>


<div class="wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex">
<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow" style="flex-basis:66.66%"><article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>If anxiety is suspected, proceed with the general anxiety or specific anxiety disorder screening tool for diagnosis and measurement of progress or responses to treatment.</p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li><strong>General anxiety disorder (GAD): <a href="https://link.cep.health/ad1" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Generalized Anxiety Disorder 7 (GAD-7)</a></strong><article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Cut off points for minimal (≤4), mild (score 5-9), moderate (score 10-14) and severe anxiety (score ≥15)</li>
</ul>
</div></article></li>



<li><strong>Social anxiety disorder (SAD): <a href="https://link.cep.health/ad2" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Social Phobia Inventory (SPIN)</a> </strong><article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Cut off points for minimal (score ≤20), mild (score 21-30), moderate (score 31-40), severe (score 41-50) and very severe social phobia (score ≥51)</li>
</ul>
</div></article></li>



<li><strong>Panic disorder: <a href="https://link.cep.health/ad79" data-type="URL" data-id="https://link.cep.health/ad79" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Panic Disorder Severity Scale (PDSS)</a></strong><article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Cut off points for none (score &lt;9) and present panic disorder (score ≥9)</li>
</ul>
</div></article></li>



<li><strong>Specific phobia or agoraphobia: <a href="https://link.cep.health/ad4" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Severity Measure for Specific Phobia (SMSP)</a></strong><article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Cut off points for none (avg score of 0), mild (avg score of 1), moderate (avg score of 2), severe (avg score of 3) and extreme phobia (avg score of 4)</li>
</ul>
</div></article></li>
</ul>
</div></article></div>



<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow" style="flex-basis:33.33%"><article class="block--background  core-block" data-block-name="cep/background"><div class="container">
<div class="wp-block-cep-background is-style-blue-background"><article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading"><strong>Screening special populations</strong><sup>3-5</sup></h6>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong>Older adults</strong></p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li><a href="https://link.cep.health/ad1" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Generalized Anxiety Disorder 7 (GAD-7)</a>: Cut off points for minimal (≤4), mild (score 5-9), moderate (score 10-14) and severe anxiety (score ≥15)</li>
</ul>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong>Peri/postnatal</strong></p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li><a href="https://link.cep.health/ad88" data-type="URL" data-id="https://link.cep.health/ad88" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Perinatal Anxiety Screening Scale (PASS)</a>: Cut off points for none (score 0-20), mild (score 21-41) and severe anxiety (score 42-93)</li>
</ul>
</div></article></div>
</div></article></div>
</div>


<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading">Depression</h6>
</div></article>


<div class="wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex">
<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow" style="flex-basis:33.33%"><article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>If depression is suspected, proceed with the Patient Health Questionnaire 9 (PHQ-9) screening tool for diagnosis and measurement of progress or responses to treatment.</p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Major depression: <a href="https://link.cep.health/ad72" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Patient Health Questionnaire 9 (PHQ-9)</a><article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Cut off points for minimal (≤4), mild (score 5-9), moderate (score 10-14) and severe depression (score ≥15)</li>
</ul>
</div></article></li>
</ul>
</div></article></div>



<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow" style="flex-basis:66.66%"><article class="block--background  core-block" data-block-name="cep/background"><div class="container">
<div class="wp-block-cep-background is-style-blue-background"><article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading"><strong>Screening special populations<sup>3-5</sup></strong></h6>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong>Older adults</strong></p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li><a href="https://link.cep.health/ad8" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Geriatric Depression Scale</a>: Cut off points for does not suggest depression (score &lt; 5), suggests depression (score 5-10) and almost always indicates depression (score ≥10)</li>



<li><a href="https://link.cep.health/ad9" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Cornell Scale for Depression in Dementia</a>: Cut off points for probably major depressive episode (score &gt;10) and definite major depressive episode (score &gt;18)</li>
</ul>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong>Peri/postnatal</strong></p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li><a href="https://link.cep.health/ad10" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Edinburgh Perinatal/Postnatal Depression Scale (EPDS)</a>: Cut off points for not likely (score &lt; 8), possible (score 9-11), fairly high possibility (score 12-13), probable (score ≥ 14) and positive depression (score of 1, 2 or 3 on question 10). Pay close attention to question 10 as scores could indicate suicidality risk which requires further follow-up and intervention)</li>
</ul>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><em>Guidance for <a href="https://link.cep.health/ad89" data-type="URL" data-id="https://link.cep.health/ad89" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">screening for perinatal depression</a> by Public Health Ontario</em></p>
</div></article></div>
</div></article></div>
</div>


<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h4 class="wp-block-heading">Assess findings</h4>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>If ≥mild anxiety or depression, begin or schedule a time to conduct or complete a comprehensive assessment. Consider booking a longer appointment or schedule as the last patient of the day to ensure a less rushed and more relaxed appointment.</p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>If minimal anxiety or depression, book a follow-up appointment or create a reminder to check in at patient’s next appointment to see if their scores change. Consider reevaluating the diagnosis if necessary, as symptoms could be related to something else.</p>
</div></article>

<article class="block--text-with-icon ">  <div class="container">
    
        <div class="columns is-flex is-gapless">
          <div class="column is-2-mobile is-1">
            <div class="inner">
              <img decoding="async" src="https://tools.cep.health/wp-content/uploads/2019/10/Checkmark-Large-2.svg" />
            </div>
          </div>
          <div class="column is-10-mobile is-11">
            <h3 id="block-fddfe501-2279-4a06-bdb0-4187f53a3af7" class="block-editor-rich-text__editable block-editor-block-list__block wp-block is-selected wp-block-heading rich-text" tabindex="0" role="document" contenteditable="true" aria-multiline="true" aria-label="Block: Heading" data-block="fddfe501-2279-4a06-bdb0-4187f53a3af7" data-type="core/heading" data-title="Heading"><strong data-rich-text-format-boundary="true">Conduct a comprehensive assessment</strong><sup>2-4, 6<br />
</sup></h3>
          </div>
        </div>

      </div>
</article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h4 class="wp-block-heading" id="conductcompassessment">Collect clinical history</h4>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Onset, intensity and history of symptoms (including a snapshot of the last few weeks)</li>



<li>Past experiences of, and response(s) to, previous treatments</li>
</ul>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading">Understand individual patient-contributing factors</h6>
</div></article>


<div class="wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex">
<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow" style="flex-basis:66.66%"><article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Recent or past stressful life events (e.g., work, school,&nbsp; divorce/breakups, bereavement)</li>



<li>Traumatic life events (e.g., adverse childhood events, abuse, trauma)</li>



<li>Personal and psychosocial support (e.g., family, friends, community)</li>



<li>Lifestyle (e.g., diet, physical activity, sleep, smoking, social isolation)</li>



<li>Total screen time (e.g., work, school, excessive social media use)</li>



<li>Drug and alcohol use</li>



<li><a href="https://link.cep.health/ad84" data-type="URL" data-id="https://link.cep.health/ad84" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Social determinants of health</a> (e.g., housing access, employment, food security and nutrition, income level, racial segregation, social support networks)</li>



<li>Perspectives about mental health (e.g., stigma, comfort with management strategies)</li>



<li>Provider-patient relationship (e.g., safe space)</li>



<li>Current and history of physical health conditions (e.g., endocrine disorders, anemia, thyroid dysfunction, nutrient and vitamin deficiencies, cardiovascular disease, diabetes, neurological disorders, pregnancy and postpartum, perimenopause, menopause, oncological disorders, dementia, Alzheimer&#8217;s, Parkinson&#8217;s)</li>



<li>Refer to the latest lab / test results of the following when appropriate:<sup>5,7,8</sup><article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>CBC, HBA1c, TSH, Ferritin, B-12, Vitamin D, Electrocardiogram (ECG), Urine Drug Screen (if warranted to rule out substance use disorders) </li>
</ul>
</div></article></li>
</ul>
</div></article></div>



<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow" style="flex-basis:33.33%"><article class="block--support-materials ">

  <div class="container default">
    <div class="inner">
              <div class="columns">
                      <div class="column icon">
              <img decoding="async" src="https://tools.cep.health/wp-content/themes/cep-tools/img/support-materials.svg" />
            </div>
                                <div class="column">
              <strong class="heading">Community and social resources:</strong>
            </div>
                  </div>
                    <p><a href="https://link.cep.health/ad67" data-type="URL" data-id="https://link.cep.health/ad67" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">211Ontario</a>: Regional community and support resources.</p>
          </div>
  </div>

</article></div>
</div>


<article class="block--text-with-icon ">  <div class="container">
    
        <div class="columns is-flex is-gapless">
          <div class="column is-2-mobile is-1">
            <div class="inner">
              <img decoding="async" src="https://tools.cep.health/wp-content/uploads/2020/05/info-icon.svg" />
            </div>
          </div>
          <div class="column is-10-mobile is-11">
            <ul>
<li>If individual patient factors that affect mental health are detected or suspected, support the patient to address and manage these first.</li>
<li>If a physical condition that affects mental health is detected or suspected, screen for and treat the condition while concurrently treating and monitoring mental health symptoms as appropriate.</li>
</ul>
          </div>
        </div>

      </div>
</article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h4 class="wp-block-heading" id="suiciderisk">Screen for risk of suicide or self-harm or harm others</h4>
</div></article>


<div class="wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex">
<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow"><article class="block--text-with-icon ">  <div class="container">
    
        <div class="columns is-flex is-gapless">
          <div class="column is-2-mobile is-1">
            <div class="inner">
              <img decoding="async" src="https://tools.cep.health/wp-content/uploads/2019/10/talking-points.svg" />
            </div>
          </div>
          <div class="column is-10-mobile is-11">
            <ul>
<li><em>“Sometimes when people feel the way you do right now, they start to have thoughts about </em><em>self harm</em><em>. Has this ever happened to you?”</em></li>
<li><em>“Do you have a plan for how you would engage in self-harm?</em><em>”</em></li>
<li><em>“In the next 24-48 hours, how likely is it that you will act on your suicidal plan?”</em> (rate on scale of 1 to 10, where 1 = very unlikely and 10 = certain)</li>
<li><em>“With the way you are currently feeling, have you had any thoughts of harming yourself or others?”</em></li>
</ul>
          </div>
        </div>

    
        <div class="columns is-flex is-gapless">
          <div class="column is-2-mobile is-1">
            <div class="inner">
              <img decoding="async" src="https://tools.cep.health/wp-content/uploads/2020/05/info-icon.svg" />
            </div>
          </div>
          <div class="column is-10-mobile is-11">
            <p>Screen for risk of suicide, self-harm or harm to others</p>
<ul>
<li>When considering a patient’s mental health status consider:
<ul>
<li>Risk factors</li>
<li>Specific suicidal thoughts and methods</li>
<li>Extent of planning and action</li>
<li>Present and history</li>
<li>Obtaining input from family and caregivers</li>
</ul>
</li>
</ul>
          </div>
        </div>

    
        <div class="columns is-flex is-gapless">
          <div class="column is-2-mobile is-1">
            <div class="inner">
              <img decoding="async" src="https://tools.cep.health/wp-content/uploads/2020/05/info-icon.svg" />
            </div>
          </div>
          <div class="column is-10-mobile is-11">
            <p>If the patient is at risk, arrange appropriate help based on their level of need</p>
<ul>
<li aria-level="1">Assess for adequate social support and awareness of resources</li>
<li aria-level="1">Advise the patient to create a<a href="https://link.cep.health/ad63" data-wpel-link="external" target="_blank" rel="external noopener noreferrer"> safety plan</a> and seek further help if the situation becomes worse</li>
<li aria-level="1">Let the patient know that we have a legal obligation to report if they are in danger (document that you have mentioned this to the patient)</li>
<li aria-level="1">If the patient is identified to be at high risk of harming themselves or others (have a clear intention to act in the next 24-48 hours on a suicide plan), advise them, their family, caregivers and friends to call 911 or go to the Emergency Department (ED)</li>
<li aria-level="1">If the patient refuses further assessment and is unwilling to go to the ED:
<ol>
<li aria-level="1">Communicate with the patient the importance of going to the ED</li>
<li aria-level="1">Complete a Form 1 (if the patient meets criteria) and a brief note to accompany the patient. Consult the <a href="https://link.cep.health/ad86" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">CEP’s Keeping Your Patients Safe</a> for tips on completing a Form 1.</li>
<li aria-level="1">Arrange for EMS/police transport of the patient to the ED</li>
</ol>
</li>
</ul>
          </div>
        </div>

      </div>
</article></div>



<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow" style="flex-basis:45%"><article class="block--support-materials ">

  <div class="container default">
    <div class="inner">
              <div class="columns">
                      <div class="column icon">
              <img decoding="async" src="https://tools.cep.health/wp-content/themes/cep-tools/img/support-materials.svg" />
            </div>
                                <div class="column">
              <strong class="heading">Emergency support and suicide prevention resources</strong>
            </div>
                  </div>
                    <p><strong>For patients:</strong></p>
<ul>
<li><a href="https://link.cep.health/ad78" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Good2Talk</a>: 1-866-925-5454 (post-secondary students) open 24/7</li>
<li>Crisis Line: 1-866-996-0991 (all ages) open 24/7</li>
<li><a href="https://link.cep.health/ad74" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">9-8-8 Suicide Crisis Helpline:</a> open 24/7</li>
<li><a href="https://link.cep.health/ad62" data-type="URL" data-id="https://link.cep.health/ad62" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Distress and Crisis Ontario</a>: Provides a free, confidential chat program to support patients and offers self-management tips</li>
<li><a href="https://link.cep.health/ad75" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">My Safety Plan</a>: For patients experiencing thoughts of suicide but are not in immediate crisis</li>
</ul>
<p><strong>For family and caregivers:</strong></p>
<ul>
<li><a href="https://link.cep.health/mddweb16" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Canadian Association for Suicide Prevention</a>: Tips on identifying suicidal thoughts and suggestions for the patient’s loved ones or caregivers</li>
</ul>
<p><strong>Provider resources:</strong></p>
<ul>
<li><a href="https://link.cep.health/ad145" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Columbia-Suicide Severity Rating Scale (C-SSRS)</a></li>
</ul>
          </div>
  </div>

</article></div>
</div>


<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h4 class="wp-block-heading">Identify any comorbid mental health conditions</h4>
</div></article>


<div class="wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex">
<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow"><article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Attention deficit hyperactivity disorder (ADHD)/attention-deficit disorder (ADD)</li>



<li>Post-traumatic stress disorder (PTSD)&nbsp;</li>



<li>Bipolar disorder&nbsp;&nbsp;</li>



<li>Psychosis&nbsp;</li>



<li>Obsessive compulsive disorder (OCD)&nbsp;&nbsp;</li>



<li>Panic disorder&nbsp;&nbsp;</li>



<li>Personality disorders&nbsp;&nbsp;</li>



<li>Adverse childhood experiences</li>



<li>Substance use and addictions disorders (e.g., alcohol, drugs, gambling, gaming and problematic screen time)</li>



<li>Other</li>
</ul>
</div></article>

<article class="block--text-with-icon ">  <div class="container">
    
        <div class="columns is-flex is-gapless">
          <div class="column is-2-mobile is-1">
            <div class="inner">
              <img decoding="async" src="https://tools.cep.health/wp-content/uploads/2020/05/info-icon.svg" />
            </div>
          </div>
          <div class="column is-10-mobile is-11">
            <ul>
<li> If mental health comorbidities are suspected, consider referral to appropriate mental health services or an <a href="https://link.cep.health/ad59" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">eConsult</a> for further assessment and treatment</li>
<li>Comorbid mental health disorders significantly increase the risk of suicidal behaviour</li>
</ul>
          </div>
        </div>

      </div>
</article></div>



<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow" style="flex-basis:33.33%"><article class="block--support-materials ">

  <div class="container default">
    <div class="inner">
              <div class="columns">
                      <div class="column icon">
              <img decoding="async" src="https://tools.cep.health/wp-content/themes/cep-tools/img/support-materials.svg" />
            </div>
                                <div class="column">
              <strong class="heading">Mental health screening tools</strong>
            </div>
                  </div>
                    <p><a href="https://link.cep.health/ad61" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">List of various mental health disorder screening tools</a></p>
          </div>
  </div>

</article></div>
</div>



<div class="wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex">
<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow"><article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h4 class="wp-block-heading">Communicate diagnosis to patients </h4>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>Confirm and communicate a diagnosis to the patient as soon as possible to help with the patient&#8217;s understanding of the disorder and to start timely and effective treatment.<sup>2</sup></p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>To confirm diagnosis, use the DSM-V criteria (<a href="https://link.cep.health/ad11" data-type="URL" data-id="https://link.cep.health/ad11" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Anxiety</a> / <a href="https://link.cep.health/ad12" data-type="URL" data-id="https://link.cep.health/ad12" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Depression</a>)</li>



<li>Discuss with the patients how individual factors may affect the development, course and severity of their mental health (e.g., comorbidities, lifestyle, social determinants of health, etc.)</li>
</ul>
</div></article></div>



<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow"><article class="block--modal ">

<div class="outer">
  <div class="container">
    <div class="inner has-text-centered">
              <img decoding="async" src="https://tools.cep.health/wp-content/uploads/2019/10/talking-points.svg" alt="" />
                    <h6>Talking tips</h6>
                          <a data-modal="X84lkb" class="button open-modal" href="#" data-id="X84lkb">Click to view</a>
          </div>
  </div>
</div>

  <div data-modal="X84lkb" class="modal">
    <div class="inner text">
      <div class="close-wrapper">
                <a href="" class="close" data-wpel-link="internal">Close</a>
      </div>
      <div class="container">
                <div class="content">
          
                          <h4>Talking tips<sup>2,5,6</sup></h4>
                                      <ul>
<li aria-level="1">Being diagnosed with depression or anxiety is common. Many adults are diagnosed with it every year.</li>
<li aria-level="1">The excessive worrying and feelings of anxiousness you experience are felt by many people. There are many ways that we can improve them.</li>
<li aria-level="1">The sadness and loss of hope you are experiencing can be very difficult, and I appreciate that you have come today to talk about it. This is an important first step.</li>
<li aria-level="1"> I can share information about medications and counselling in many languages. Is there another language you or your family members prefer?</li>
</ul>
            
                  </div>
      </div>
    </div>
    <div class="overlay"></div>
</div></article></div>
</div>
						</div>
					</div>
				</section>
							<section class="main-section" id="management" tabindex="-1">
					<div class="head">
						<div class="container">
							<h2 class="main-heading">
								Management								
							</h2>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
						</div>
					</div>
					<div class="body">
						<div class="container">
							<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h4 class="wp-block-heading">Jump to:</h4>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p id="Special-populations:-peri/postnatal-patients"><a href="#psychtreatmentoptions" data-type="internal" data-id="#psychtreatmentoptions">Psychological treatment options</a><br><a href="#Non-pharma-complementary-treatment-options" data-type="internal" data-id="#Non-pharma-complementary-treatment-options">Non-pharmacological complementary treatment options</a><br><a href="#pharmatreatmentoptions" data-type="internal" data-id="#pharmatreatmentoptions">Pharmacological treatment options</a><br><a href="#side-effect-management">Side effect management</a><br><a href="#Special-populations">Special populations: peri/postnatal patients</a><br><a href="#specialpop-olderadults">Special populations: older adults</a></p>
</div></article>


<div class="wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex">
<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow" style="flex-basis:60%"><article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>Use your clinical judgement to move patients through the stepped-care approach. For the psychological and pharmacological management of anxiety and depression. Individualize therapy based on a patient’s symptom severity, concerns and preferences. This may involve skipping steps to achieve appropriate treatment for an individual patient. Routinely follow-up and monitor changes in the patient’s symptoms and quality of life. Empower patients to make decisions with you about their treatment plan.<sup>2</sup></p>
</div></article></div>



<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow"><article class="block--modal ">

<div class="outer">
  <div class="container">
    <div class="inner has-text-centered">
              <img decoding="async" src="https://tools.cep.health/wp-content/uploads/2019/10/talking-points.svg" alt="" />
                    <h6>Talking tips</h6>
                          <a data-modal="3l5gb4" class="button open-modal" href="#" data-id="3l5gb4">Click to view</a>
          </div>
  </div>
</div>

  <div data-modal="3l5gb4" class="modal">
    <div class="inner text">
      <div class="close-wrapper">
                <a href="" class="close" data-wpel-link="internal">Close</a>
      </div>
      <div class="container">
                <div class="content">
          
                          <h4>Talking tips</h4>
                                      <p>Ask the patients questions, such as:<sup>5</sup></p>
<ul>
<li aria-level="1">What is your experience with other periods of low mood/anxiety?</li>
<li aria-level="1">Is there anything that helps you feel better?</li>
<li aria-level="1">Is there anything that might be making your mood/anxiety worse?</li>
<li aria-level="1">What are you hoping to gain from your management plan?</li>
<li aria-level="1">What do you think you need to get back on track?</li>
<li aria-level="1">Do you have any ideas or preferences for treatment?</li>
</ul>
            
                  </div>
      </div>
    </div>
    <div class="overlay"></div>
</div></article></div>
</div>


<article class="block--background  core-block" data-block-name="cep/background"><div class="container">
<div class="wp-block-cep-background is-style-blue-background"><article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h4 class="wp-block-heading"><strong>Guiding principles for the management of anxiety and depression:</strong></h4>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Understand the patient’s context and life circumstances, such as:<sup>6</sup><article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Coverage options (e.g., access to extended health coverage, <a href="https://link.cep.health/ad81" data-type="URL" data-id="https://link.cep.health/ad81" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Non-insured health benefits program mental health counselling benefit</a>, and Employee Assistance Plans)</li>



<li>Potential barriers to treatment (e.g., disability, language or communication)</li>
</ul>
</div></article></li>



<li>Cost considerations<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Reach out to drug companies to inquire about their compassionate use programs</li>



<li>Connect patients with <a href="https://link.cep.health/ad34" data-type="URL" data-id="https://link.cep.health/ad34" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Ontario Works</a> and the <a href="https://link.cep.health/ad34" data-type="URL" data-id="https://link.cep.health/ad34" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Ontario Disability Support Program</a> for financial assistance with drug coverage</li>
</ul>
</div></article></li>



<li>Account for how coexisting conditions may impact treatment options.</li>
</ul>
</div></article></div>
</div></article>


<div class="wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex">
<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow"><article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h3 class="wp-block-heading" id="psychtreatmentoptions">Psychological treatment options</h3>
</div></article></div>
</div>


<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h4 class="wp-block-heading"><strong>Anxiety</strong><sup>2, 3, 9</sup></h4>
</div></article>

<article class="block--image  core-block" data-block-name="core/image"><div class="container">
<figure class="wp-block-image size-large"><img decoding="async" src="https://tools.cep.health/wp-content/uploads/2023/03/Psychological-treatment_Anxiety.png" alt=""/></figure>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h4 class="wp-block-heading" id="psychdepressionpng"><strong>Depression</strong><sup>1, 4, 5, 10</sup></h4>
</div></article>

<article class="block--image  core-block" data-block-name="core/image"><div class="container">
<figure class="wp-block-image size-large"><img decoding="async" src="https://tools.cep.health/wp-content/uploads/2023/04/CEP-Depression-chart-r10.png" alt=""/></figure>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>Refer adult patients who are experiencing mild to moderate depression, anxiety, and anxiety-related problems to publicly funded, short-term, evidence-based services that are based on the treatment principles of&nbsp;cognitive behavioural therapy (CBT) through the <a href="https://link.cep.health/ad15" data-type="URL" data-id="https://link.cep.health/ad15" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Ontario Structured Psychotherapy (OSP) Program.</a> Find your regional OSP network below. </p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>OSP services follow a stepped-care approach. They include in-person or virtual self-help resources facilitated or guided by a mental health professional and one-on-one or group CBT sessions.</p>
</div></article>

<article class="block--faq "><div class="container">
    <div class="faq-title-wrapper">
        <div class="faq-icon-wrapper">
            <img decoding="async" class="faq-icon" src="https://tools.cep.health/wp-content/uploads/2020/05/info-icon.svg" alt="" />
        </div>
        <h3 class="faq-title"><h3>OSP Networks and Referral Process</h3></h3>
    </div>
            <div class="questions">
                                                                <div class="question">
                        <button data-toggle-question class="question-title-wrapper">
                            <h6 class="question-title">Central Region</h6>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
                        </button>
                        <div class="question-answer">
                            <p><a href="https://link.cep.health/ad108" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Waypoint Centre for Mental Health Care</a></p>
<ul>
<li>Submit online: <a href="https://link.cep.health/ad109" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">referral form</a></li>
</ul>
<p><a href="https://link.cep.health/ad110" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">CarePoint Health</a> (Brampton, Halton, Mississauga)</p>
<ul>
<li>Submit online: <a href="https://link.cep.health/ad111" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">referral form</a></li>
<li><a href="https://link.cep.health/ad112" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Ocean eReferral</a></li>
<li>Fax: one-Link <a href="https://link.cep.health/ad113" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">referral form</a> (Mississauga and Halton residents)</li>
</ul>
<p><a href="https://link.cep.health/ad114" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Canadian Mental Health Association &#8211; York and South Simcoe</a></p>
<ul>
<li>Submit online: <a href="https://link.cep.health/ad115" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">referral form</a></li>
</ul>
                        </div>
                    </div>
                                                                                <div class="question">
                        <button data-toggle-question class="question-title-wrapper">
                            <h6 class="question-title">Toronto Region</h6>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
                        </button>
                        <div class="question-answer">
                            <p><a href="https://link.cep.health/ad116" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Centre for Addiction and Mental Health</a></p>
<ul>
<li>Submit online: <a href="https://link.cep.health/ad117" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">referral form</a></li>
<li>Fax: <a href="https://link.cep.health/ad118" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">referral form</a></li>
</ul>
                        </div>
                    </div>
                                                                                <div class="question">
                        <button data-toggle-question class="question-title-wrapper">
                            <h6 class="question-title">West Region</h6>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
                        </button>
                        <div class="question-answer">
                            <p><a href="https://link.cep.health/ad119" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">OSP West Region</a> (St. Joseph’s Healthcare Hamilton and St. Joseph’s Health Care London)</p>
<ul>
<li>Submit online: <a href="https://link.cep.health/ad120" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">referral form</a></li>
<li>Email: <a href="https://link.cep.health/ad121" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">referral form</a></li>
<li>Fax: <a href="https://link.cep.health/ad122" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">referral form</a></li>
</ul>
<p>&nbsp;</p>
                        </div>
                    </div>
                                                                                <div class="question">
                        <button data-toggle-question class="question-title-wrapper">
                            <h6 class="question-title">East Region</h6>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
                        </button>
                        <div class="question-answer">
                            <p><a href="https://link.cep.health/ad123" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">The Royal Ottawa Mental Health Centre</a></p>
<ul>
<li><a href="https://link.cep.health/ad124" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">AccessMHA</a> through Ocean eReferral</li>
</ul>
<p><a href="https://link.cep.health/ad125" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Ontario Shores Centre for Mental Health Services</a></p>
<ul>
<li><a href="https://link.cep.health/ad126" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Ontario Shores Centre for Mental Health Services</a> through Ocean eReferral</li>
</ul>
                        </div>
                    </div>
                                                                                <div class="question">
                        <button data-toggle-question class="question-title-wrapper">
                            <h6 class="question-title">North East Region</h6>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
                        </button>
                        <div class="question-answer">
                            <p><a href="https://link.cep.health/ad127" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Health Sciences North</a></p>
<ul>
<li>Fax/Mail: <a href="https://link.cep.health/ad128" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">referral form</a></li>
</ul>
                        </div>
                    </div>
                                                                                <div class="question">
                        <button data-toggle-question class="question-title-wrapper">
                            <h6 class="question-title">North West Region</h6>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
                        </button>
                        <div class="question-answer">
                            <p><a href="https://link.cep.health/ad129" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">St. Joseph’s Care Group</a></p>
<ul>
<li>Submit online: <a href="https://link.cep.health/ad130" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">application</a></li>
</ul>
                        </div>
                    </div>
                                    </div>
    </div></article>


<div class="wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex">
<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow"><article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h4 class="wp-block-heading"><strong><br><strong>Resources for patients and caregivers</strong><sup>9</sup></strong></h4>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>Encourage patients to consider other options for care and support while they wait for a referral, such as internet-based CBT. &nbsp;Instead of waiting for a referral, patients can also find a psychologist through the <a href="https://link.cep.health/ad82" data-type="URL" data-id="https://link.cep.health/ad82" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Ontario Psychological Association</a>, a counsellor or psychotherapist through the <a href="https://link.cep.health/ad17" data-type="URL" data-id="https://link.cep.health/ad17" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Canadian Counselling and Psychotherapy Association</a>, <a href="https://link.cep.health/ad18" data-type="URL" data-id="https://link.cep.health/ad18" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">College of Registered Psychotherapists of Ontario</a> or <a href="https://link.cep.health/ad161" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Affordable Therapy Network</a>. </p>
</div></article>

<article class="block--background  core-block" data-block-name="cep/background"><div class="container">
<div class="wp-block-cep-background is-style-blue-background"><article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h5 class="wp-block-heading">Free resources available for patients and their caregivers are listed below:</h5>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading"><strong>Community and social</strong></h6>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong><a href="https://link.cep.health/ad90" data-type="URL" data-id="https://link.cep.health/ad90" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Canadian Mental Health Association</a>:</strong> 30 branches that provide community mental health services across Ontario.</p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong><a href="https://link.cep.health/ad91" data-type="URL" data-id="https://link.cep.health/ad91" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">ConnexOntario</a>:</strong> Mental health system navigation and information. Mental health: 1-800-531-2600 | Addictions: 1-800-565-8603</p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong><a href="https://link.cep.health/ad92" data-type="URL" data-id="https://link.cep.health/ad92" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">eMentalHealth.ca</a>: </strong>Directory of publicly-funded regional service coordination and case management services.</p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong><a href="https://link.cep.health/ad93" data-type="URL" data-id="https://link.cep.health/ad93" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Hope for Wellness</a>:</strong> Mental health counselling and community-based cultural and emotional support for Indigenous people. 1-855-242-3310</p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong><a href="https://link.cep.health/ad94" data-type="URL" data-id="https://link.cep.health/ad94" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Ontario Caregiver Organization</a>:</strong> Support for caregivers to improve their caregiving experience.</p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong><a href="https://www.beendigen.com/programs/talk4healing/" data-type="URL" data-id="https://www.beendigen.com/programs/talk4healing/" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Talk4Healing</a>:</strong> 24/7 talk, text, and chat to support Indigenous women by Indigenous women. 1-888-200-9997</p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong><a href="https://link.cep.health/ad96" data-type="URL" data-id="https://link.cep.health/ad96" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">thehealthline.ca</a>:</strong> Regional mental health organizations, clinics, workshops, conferences and support groups.</p>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading"><strong>Educational supports for patients and caregivers</strong></h6>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong><a href="https://link.cep.health/ad97" data-type="URL" data-id="https://link.cep.health/ad98" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Ontario Health Anxiety Disorders Patient Guide</a></strong></p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong><a href="https://link.cep.health/ad98" data-type="URL" data-id="https://link.cep.health/ad98" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Ontario Health Depression Patient Guide</a></strong></p>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading">Online app and resources</h6>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong><a href="https://link.cep.health/ad99" data-type="URL" data-id="https://link.cep.health/ad99" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Anxiety Canada mindfulness exercises</a></strong>: Non-facilitated self-help virtual resources on mindfulness and relaxation.</p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong>Be Safe:</strong> Safety plan app. Available on <strong><a href="https://link.cep.health/ad101" data-type="URL" data-id="https://link.cep.health/ad101" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">App Store</a> </strong>and <strong><a href="https://link.cep.health/ad100" data-type="URL" data-id="https://link.cep.health/ad100" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Google Play</a>.&nbsp;</strong></p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong><a href="https://link.cep.health/mddweb6" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">BounceBack Ontario</a>: </strong>&nbsp;Available through the OSP Program. Guided self-led resources to support adults and youth manage low mood, mild to moderate <strong>depression and anxiety</strong>, stress or worry. Delivered by phone with a coach and through online videos.</p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong>MindShift CBT App</strong>: CBT-based tools for worry, <strong>panic</strong>, perfectionism, <strong>social anxiety</strong> and<strong> phobias</strong>. Available on the <a href="https://link.cep.health/ad103" data-type="URL" data-id="https://link.cep.health/ad103" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">App Store </a>and <a href="https://link.cep.health/ad104" data-type="URL" data-id="https://link.cep.health/ad104" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Google Play</a>.</p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><a href="https://link.cep.health/ad23" data-wpel-link="external" target="_blank" rel="external noopener noreferrer"><strong>My Anxiety Plan (MAP)</strong></a>: Virtual, individual non-facilitated and facilitated self-help program for adults with mild to moderate <strong>anxiety</strong>.</p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong><a href="https://link.cep.health/ad105" data-type="URL" data-id="https://link.cep.health/ad105" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Greenspace</a>: </strong>Matches patients to therapists in the GTA. Matching is free. Therapy fees apply.</p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong><a href="https://link.cep.health/ad107" data-type="URL" data-id="https://link.cep.health/ad107" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Antidepressant Skills Workbook</a>:</strong> A self-care guide for depression (to be used in combination with depression treatments).</p>
</div></article></div>
</div></article></div>
</div>


<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h3 class="wp-block-heading" id="Non-pharma-complementary-treatment-options">Non-pharmacological complementary treatment options</h3>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>Talk to patients about complementary therapies (lifestyle changes) that can help alleviate symptoms of anxiety and depression in addition to other treatment options.<sup>1,4,5</sup></p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Exercise<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>First-line monotherapy for mild to moderate depression.</li>



<li>Second-line adjunctive therapy for moderate to severe depression.</li>



<li>Typical or studied dose and duration: at least 30 minutes of moderate-intensity exercise at least 3 times weekly for a minimum of 9 weeks is considered effective.</li>
</ul>
</div></article></li>



<li><a href="https://link.cep.health/ad53" data-type="URL" data-id="https://link.cep.health/ad53" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Yoga</a><article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Second-line adjunctive therapy for mild to moderate depression.</li>



<li>Typical or studied dose and duration:&nbsp;at least 2 to 4 sessions a week over 2 to 3 months.</li>
</ul>
</div></article></li>



<li>Sleep hygiene<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Second-line adjunctive therapy.</li>



<li>Recommended habits and practices of maintaining a regular sleep schedule; avoiding excess eating, drinking, or smoking before going to sleep and establishing a proper sleep environment.</li>
</ul>
</div></article></li>



<li>Nutrition<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Third-line adjunctive therapy.</li>



<li>Maintaining a healthy, balanced diet and correcting any nutritional deficiencies.</li>
</ul>
</div></article></li>



<li>Light therapy<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>First-line therapy for depression with a seasonal pattern. </li>



<li>Second-line adjunctive therapy for moderate severity non-seasonal depression.</li>
</ul>
</div></article></li>
</ul>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h3 class="wp-block-heading" id="pharmatreatmentoptions">Pharmacological treatment options</h3>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h4 class="wp-block-heading">Factors to consider when choosing a medication<sup>1, 5</sup></h4>
</div></article>


<div class="wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex">
<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow"><article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading"><strong>Patient factors</strong>:</h6>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Previous experience with antidepressants (e.g., response, side effects). Consider a pharmacy review for information on the discontinuation of past medications.</li>



<li>Family history of a positive response to particular medication(s)</li>



<li>Clinical features/specifiers/dimensions</li>



<li>Comorbid conditions</li>



<li>Patient preference(s)</li>



<li>Other factors (e.g., age, pregnancy/breastfeeding, suicide risk)</li>
</ul>
</div></article></div>



<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow"><article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading"><a href="#firstlinemedoptions" data-type="internal" data-id="#firstlinemedoptions"><strong>Medication factors</strong>:</a></h6>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Comparative efficacy</li>



<li>Comparative tolerability, warnings, contraindications and precautions</li>



<li>Potential interactions with other medications</li>



<li>Simplicity of use</li>



<li>Cost and availability</li>
</ul>
</div></article></div>
</div>


<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong><em>Support from a pharmacist or mental health expert may be helpful in complex cases or if there is uncertainty.</em></strong></p>
</div></article>

<article class="block--modal ">

<div class="outer">
  <div class="container">
    <div class="inner has-text-centered">
              <img decoding="async" src="https://tools.cep.health/wp-content/uploads/2019/10/talking-points.svg" alt="" />
                    <h6>Talking tip<sup>5</sup></h6>
                          <a data-modal="0Kfrm5" class="button open-modal" href="#" data-id="0Kfrm5">Click to view</a>
          </div>
  </div>
</div>

  <div data-modal="0Kfrm5" class="modal">
    <div class="inner text">
      <div class="close-wrapper">
                <a href="" class="close" data-wpel-link="internal">Close</a>
      </div>
      <div class="container">
                <div class="content">
          
                          <h4>Talking tip</h4>
                                      <p>Choosing to use medications for condition, blood pressure or our mood can be difficult. Do you feel this way? What are some of your concerns?</p>
            
                  </div>
      </div>
    </div>
    <div class="overlay"></div>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading"><strong>Role of pharmacogenetic testing for medication selection<sup>1</sup></strong></h6>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>There is a paucity of large-scale randomized controlled trial (RCT) evidence for pharmacogenetic testing. Pharmacogenetic testing may be considered in specific cases, including a patient&#8217;s inability to tolerate multiple medications or repeated lack of response to high doses of medications.</p>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h3 class="wp-block-heading" id="firstlinemedoptions"><strong>First-line medication options<sup>1,3–5, 7, 9, 11–30</sup></strong><sup>, 34,35,38</sup></h3>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>The following medications are considered first-line in the CANMAT 2023 MDD Guidelines and/or 2014 Anxiety Guidelines.<sup>1,7</sup> Some international guidelines recommend all SSRIs and SNRIs broadly (+/- other agents) as first-line for MDD, anxiety or both.<sup>6,8,28</sup> Other options (e.g., amitriptyline, trazodone) are not first-line in any of the reviewed guidelines due to side effects.</p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>Available evidence for drug selection has many limitations, including limited head-to-head trials between drugs and potential for bias. If you have questions about drug selection, consult a pharmacist or specialist through <a href="https://link.cep.health/ad83" data-type="URL" data-id="https://link.cep.health/ad83" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">eConsult</a> or <a href="https://link.cep.health/ad162" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Virtual Hallway</a>.</p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><a href="https://link.cep.health/ad160" data-type="URL" data-id="https://link.cep.health/ad152" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Click to view</a> first-line medication options in table format.</p>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading"><strong>Selective Serotonin Reuptake Inhibitors (SSRIs)</strong></h6>
</div></article>

<article class="block--drug-options ">
<div class="container">
  <h5><span style="font-size: 13.5px;">Scroll (left-right) for details</h5>
          <div class="slider">
        <div class="inner-stage">
          <ul>
            
                <li>
                  <div class="inner">
                    <span class="subhead">Selective Serotonin Reuptake Inhibitors (SSRIs)</span>
                    <h6>Citalopram (Celexa®)</h6>
                    <p>10 mg, 20 mg, 40 mg tablet</p>
<p><strong>First-line for</strong></p>
<ul>
<li aria-level="1">Major depressive disorder</li>
<li aria-level="1">Panic disorder (+/- agoraphobia)</li>
</ul>
<p><strong>Coverage</strong></p>
<ul>
<li>ODB ✓</li>
<li>NIHB ✓</li>
</ul>
<p><strong>Cost for usual dose ($/100 days)</strong></p>
<ul>
<li>$24-60</li>
</ul>
<p><b>Overall tolerability*</b></p>
<ul>
<li aria-level="1">Well-tolerated</li>
</ul>
<p><b>Activating or sedating</b></p>
<ul>
<li aria-level="1">Activating/sedating</li>
</ul>
<p><strong>Interaction risk</strong></p>
<ul>
<li>+ (CYP)</li>
<li>Caution: combined QT-prolongation risk</li>
</ul>
<p><b>Features**</b></p>
<ul>
<li aria-level="1">A preferred pharmacological option in pregnancy</li>
</ul>
                                            <a class="button open-modal" href="#" data-modal="SaK7TR">View dosing, side effects, warnings and contraindications</a>
                                      </div>
                                      <div class="modal" data-modal="SaK7TR">
                      <div class="inner ">
                        <div class="close-wrapper">
                          <a href="" class="close" data-wpel-link="internal">Close</a>
                        </div>
                        <div class="container">
                          <div class="content">
                                                          <h4>Citalopram (Celexa®)</h4>
                                                                                      <h6><strong>Dosing*** </strong></h6>
<ul>
<li><b>Initial:</b> 10-20 mg daily (am/pm)</li>
<li><b>Usual:</b> 20–40 mg daily</li>
<li><b>Max:</b> 40 mg daily (20 mg in older adults, liver disease, concurrent CYP 2C19 inhibitors)</li>
</ul>
<h6><strong>Side effects</strong></h6>
<ul>
<li><b>CNS</b>: headache, sleep disturbance, drowsiness, nervousness, dizziness, somnolence, fatigue</li>
<li><b>GI</b>: nausea, vomiting, diarrhea</li>
<li><b>Anticholinergic</b>: dry mouth, constipation, blurred vision</li>
<li><b>CV</b>: orthostatic hypotension, tachycardia</li>
<li><b>Urogenital</b>: sexual dysfunction</li>
<li><strong>Other</strong>: hyperhidrosis</li>
</ul>
<h6><strong>Warnings and contraindications<br />
</strong></h6>
<ul>
<li>QTc prolongation risk</li>
<li>Contraindicated in patients with known QT prolongation or congenital long QT syndrome</li>
<li>
<p class="p1">Agitation/anxiety may worsen initially (first 1-2 weeks)</p>
</li>
<li>
<p class="p1">Discontinuation symptoms (do not discontinue abruptly)</p>
</li>
<li>
<p class="p1">Fractures (especially in first 6 weeks)</p>
</li>
<li>
<p class="p1">GI bleeding (consider gastroprotective agent if high risk)</p>
</li>
<li>
<p class="p1">Hyponatremia (especially in elderly)</p>
</li>
<li>
<p class="p1">Serotonin syndrome/Neuroleptic malignant syndrome (NMS)</p>
</li>
<li>
<p class="p1">Suicidal thinking &amp; self-harm (patients &lt;25)</p>
</li>
<li>
<p class="p1">Use with caution in narrow-angle glaucoma</p>
</li>
<li>
<p class="p1">Use with caution in patients with seizure disorders</p>
</li>
</ul>
                                                      </div>
                        </div>
                      </div>
                      <div class="overlay"></div>
                    </div>
                                  </li>

            
                <li>
                  <div class="inner">
                    <span class="subhead">Selective Serotonin Reuptake Inhibitors (SSRIs)</span>
                    <h6>Escitalopram (Cipralex®)</h6>
                    <p>10 mg, 20 mg tablet</p>
<p><strong>First-line for<br />
</strong></p>
<ul>
<li aria-level="1">Major depressive disorder</li>
<li aria-level="1">Generalized anxiety disorder</li>
<li aria-level="1">Social anxiety disorder</li>
<li aria-level="1">Panic disorder (+/- agoraphobia)</li>
</ul>
<p><strong>Coverage</strong></p>
<ul>
<li>ODB ✓</li>
<li>NIHB ✓</li>
</ul>
<p><strong>Cost for usual dose ($/100 days)</strong></p>
<ul>
<li>$26-45</li>
</ul>
<p><b>Overall tolerability*</b></p>
<ul>
<li aria-level="1">Very well-tolerated</li>
</ul>
<p><b>Activating or sedating</b></p>
<ul>
<li aria-level="1">Activating/sedating</li>
</ul>
<p><strong>Interaction risk</strong></p>
<ul>
<li>+ (CYP)</li>
<li>Caution: combined QT-prolongation risk</li>
</ul>
<p><b>Features**</b></p>
<ul>
<li aria-level="1">A preferred pharmacological option in pregnancy</li>
</ul>
                                            <a class="button open-modal" href="#" data-modal="nLCDgK">View dosing, side effects, warnings and contraindications</a>
                                      </div>
                                      <div class="modal" data-modal="nLCDgK">
                      <div class="inner ">
                        <div class="close-wrapper">
                          <a href="" class="close" data-wpel-link="internal">Close</a>
                        </div>
                        <div class="container">
                          <div class="content">
                                                          <h4>Escitalopram (Cipralex®)</h4>
                                                                                      <h6><strong>Dosing*** </strong></h6>
<ul>
<li><b>Initial:</b> 5-10 mg daily (am/pm)</li>
<li><b>Usual: </b>10-20 mg daily</li>
<li><b>Max: </b>20 mg daily (10 mg in older adults, liver disease, concurrent CYP 2C19 inhibitors)</li>
</ul>
<h6><strong>Side effects</strong></h6>
<ul>
<li><b>CNS</b>: headache, sleep disturbance, drowsiness, nervousness, dizziness, somnolence, fatigue</li>
<li><b>GI</b>: nausea, vomiting, diarrhea</li>
<li><b>Anticholinergic</b>: dry mouth, constipation, blurred vision</li>
<li><b>CV</b>: orthostatic hypotension, tachycardia</li>
<li><b>Urogenital</b>: sexual dysfunction</li>
</ul>
<h6><strong>Warnings<b> </b><b>and contraindications</b></strong></h6>
<ul>
<li>QTc prolongation risk</li>
<li>Contraindicated in patients with known QT prolongation or congenital long QT syndrome</li>
<li>
<p class="p1">Agitation/anxiety may worsen initially (first 1-2 weeks)</p>
</li>
<li>
<p class="p1">Discontinuation symptoms (do not discontinue abruptly)</p>
</li>
<li>
<p class="p1">Fractures (especially in first 6 weeks)</p>
</li>
<li>
<p class="p1">GI bleeding (consider gastroprotective agent if high risk)</p>
</li>
<li>
<p class="p1">Hyponatremia (especially in elderly)</p>
</li>
<li>
<p class="p1">Serotonin syndrome/Neuroleptic malignant syndrome (NMS)</p>
</li>
<li>
<p class="p1">Suicidal thinking &amp; self-harm (patients &lt;25)</p>
</li>
<li>
<p class="p1">Use with caution in narrow-angle glaucoma</p>
</li>
<li>
<p class="p1">Use with caution in patients with seizure disorders</p>
</li>
</ul>
                                                      </div>
                        </div>
                      </div>
                      <div class="overlay"></div>
                    </div>
                                  </li>

            
                <li>
                  <div class="inner">
                    <span class="subhead">Selective Serotonin Reuptake Inhibitors (SSRIs)</span>
                    <h6>Fluoxetine (Prozac®)</h6>
                    <p>10 mg, 20 mg, 40 mg, 60 mg capsule<br />
4 mg/mL oral solution</p>
<p><strong>First-line for</strong></p>
<ul>
<li aria-level="1">Major depressive disorder</li>
<li aria-level="1">Panic disorder (+/- agoraphobia)</li>
</ul>
<p><strong>Coverage</strong></p>
<ul>
<li>ODB ✓ (excludes 10mg tablet)<sup><br />
</sup></li>
<li>NIHB ✓</li>
</ul>
<p><strong>Cost for usual dose ($/100 days)</strong></p>
<ul>
<li>$45-152</li>
</ul>
<p><b>Overall tolerability*</b></p>
<ul>
<li aria-level="1">Well-tolerated</li>
</ul>
<p><b>Activating or sedating</b></p>
<ul>
<li aria-level="1">Activating</li>
</ul>
<p><strong>Interaction risk</strong></p>
<ul>
<li>+++</li>
</ul>
<p><b>Features**</b></p>
<ul>
<li aria-level="1">Easy to discontinue</li>
</ul>
                                            <a class="button open-modal" href="#" data-modal="cZXwj5">View dosing, side effects, warnings and contraindications</a>
                                      </div>
                                      <div class="modal" data-modal="cZXwj5">
                      <div class="inner ">
                        <div class="close-wrapper">
                          <a href="" class="close" data-wpel-link="internal">Close</a>
                        </div>
                        <div class="container">
                          <div class="content">
                                                          <h4>Fluoxetine (Prozac®)</h4>
                                                                                      <h6><strong>Dosing*** </strong></h6>
<ul>
<li><b>Initial: </b>10-20 mg daily (am)</li>
<li><b>Usual:</b> 20 mg daily</li>
<li><b>Max:</b> 80 mg daily (lower dose recommended for older adults)</li>
</ul>
<h6><strong>Side effects</strong></h6>
<ul>
<li><b>CNS</b>: insomnia, headache, sleep disturbance, drowsiness, nervousness, dizziness, somnolence, fatigue</li>
<li><b>GI</b>: nausea, vomiting, diarrhea</li>
<li><b>Anticholinergic</b>: dry mouth, constipation, blurred vision</li>
<li><b>CV</b>: orthostatic hypotension, tachycardia</li>
<li><b>Urogenital</b>: sexual dysfunction</li>
<li><strong>Other: </strong>agitation, anorexia, hyperhidrosis</li>
</ul>
<h6><strong>Warnings <b>and contraindications</b></strong></h6>
<ul>
<li aria-level="1">Higher rates of confusion</li>
<li aria-level="1">QTc prolongation risk</li>
<li>
<p class="p1">Agitation/anxiety may worsen initially (first 1-2 weeks)</p>
</li>
<li>
<p class="p1">Discontinuation symptoms (do not discontinue abruptly)</p>
</li>
<li>
<p class="p1">Fractures (especially in first 6 weeks)</p>
</li>
<li>
<p class="p1">GI bleeding (consider gastroprotective agent if high risk)</p>
</li>
<li>
<p class="p1">Hyponatremia (especially in elderly)</p>
</li>
<li>
<p class="p1">Serotonin syndrome/Neuroleptic malignant syndrome (NMS)</p>
</li>
<li>
<p class="p1">Suicidal thinking &amp; self-harm (patients &lt;25)</p>
</li>
<li>
<p class="p1">Use with caution in narrow-angle glaucoma</p>
</li>
<li>
<p class="p1">Use with caution in patients with seizure disorders</p>
</li>
</ul>
                                                      </div>
                        </div>
                      </div>
                      <div class="overlay"></div>
                    </div>
                                  </li>

            
                <li>
                  <div class="inner">
                    <span class="subhead">Selective Serotonin Reuptake Inhibitors (SSRIs)</span>
                    <h6>Fluvoxamine (Luvox®)</h6>
                    <p>50 mg, 100 mg tablet</p>
<p><strong>First-line for<br />
</strong></p>
<ul>
<li aria-level="1">Major depressive disorder</li>
<li aria-level="1">Social anxiety disorder</li>
<li aria-level="1">Panic disorder (+/- agoraphobia)</li>
</ul>
<p><strong>Coverage</strong></p>
<ul>
<li>ODB ✓<sup><br />
</sup></li>
<li>NIHB ✓</li>
</ul>
<p><strong>Cost for usual dose ($/100 days)</strong></p>
<ul>
<li>$55-132</li>
</ul>
<p><b>Overall tolerability*</b></p>
<ul>
<li aria-level="1">Poorly-tolerated</li>
</ul>
<p><b>Activating or sedating</b></p>
<ul>
<li aria-level="1">Sedating</li>
</ul>
<p><strong>Interaction risk</strong></p>
<ul>
<li>+++</li>
</ul>
<p><b>Features**</b></p>
<ul>
<li aria-level="1">No notable features</li>
</ul>
                                            <a class="button open-modal" href="#" data-modal="urfP4w">View dosing, side effects, warnings and contraindications</a>
                                      </div>
                                      <div class="modal" data-modal="urfP4w">
                      <div class="inner ">
                        <div class="close-wrapper">
                          <a href="" class="close" data-wpel-link="internal">Close</a>
                        </div>
                        <div class="container">
                          <div class="content">
                                                          <h4>Fluvoxamine (Luvox®)</h4>
                                                                                      <h6><strong>Dosing*** </strong></h6>
<ul>
<li><b>Initial:</b> 25-50 mg daily (hs)</li>
<li><b>Usual:</b> 100–200 mg daily</li>
<li><b>Max: </b>300 mg daily
<ul>
<li>Divide doses above 150 mg (max 150 mg at bedtime)</li>
<li>Hepatic/renal disease: increase dose slowly &amp; monitor carefully</li>
</ul>
</li>
</ul>
<h6><strong>Side effects</strong></h6>
<ul>
<li><b>CNS</b>: headache, sleep disturbance, drowsiness, nervousness, dizziness, somnolence, fatigue</li>
<li><b>GI</b>: severe GI upset, nausea, vomiting, diarrhea</li>
<li><b>Anticholinergic</b>: anticholinergic potential, dry mouth, constipation, blurred vision</li>
<li><b>CV</b>: orthostatic hypotension, tachycardia</li>
<li><b>Urogenital</b>: sexual dysfunction</li>
<li><strong>Other: </strong>anorexia</li>
</ul>
<h6><strong>Warnings<b> </b><b>and contraindications</b></strong></h6>
<ul>
<li>Caution when using for older adults</li>
<li>
<p class="p1">Agitation/anxiety may worsen initially (first 1-2 weeks)</p>
</li>
<li>
<p class="p1">Discontinuation symptoms (do not discontinue abruptly)</p>
</li>
<li>
<p class="p1">Fractures (especially in first 6 weeks)</p>
</li>
<li>
<p class="p1">GI bleeding (consider gastroprotective agent if high risk)</p>
</li>
<li>
<p class="p1">Hyponatremia (especially in elderly)</p>
</li>
<li>
<p class="p1">Serotonin syndrome/Neuroleptic malignant syndrome (NMS)</p>
</li>
<li>
<p class="p1">Suicidal thinking &amp; self-harm (patients &lt;25)</p>
</li>
<li>
<p class="p1">Use with caution in narrow-angle glaucoma</p>
</li>
<li>
<p class="p1">Use with caution in patients with seizure disorders</p>
</li>
</ul>
                                                      </div>
                        </div>
                      </div>
                      <div class="overlay"></div>
                    </div>
                                  </li>

            
                <li>
                  <div class="inner">
                    <span class="subhead">Selective Serotonin Reuptake Inhibitors (SSRIs)</span>
                    <h6>Paroxetine (Paxil®) </h6>
                    <p>10 mg, 20 mg, 30 mg tablet<br />
CR: 12.5 mg, 25 mg tablet</p>
<p><strong>First-line for<br />
</strong></p>
<ul>
<li aria-level="1">Major depressive disorder</li>
<li aria-level="1">Generalized anxiety disorder</li>
<li aria-level="1">Social anxiety disorder</li>
<li aria-level="1">Panic disorder (+/- agoraphobia)</li>
</ul>
<p><strong>Coverage</strong></p>
<ul>
<li>ODB ✓ (excludes 10mg and CR tablets)</li>
<li>NIHB ✓ (excludes CR tablets)</li>
</ul>
<p><strong>Cost for usual dose ($/100 days)</strong></p>
<ul>
<li>$27-125</li>
<li>CR: $252 &#8211; 790</li>
</ul>
<p><b>Overall tolerability*</b></p>
<ul>
<li aria-level="1">Poorly-tolerated</li>
</ul>
<p><b>Activating or sedating</b></p>
<ul>
<li aria-level="1">Sedating</li>
</ul>
<p><strong>Interaction risk</strong></p>
<ul>
<li>+++</li>
</ul>
<p><b>Features**</b></p>
<ul>
<li>A preferred pharmacological option for breastfeeding</li>
</ul>
                                            <a class="button open-modal" href="#" data-modal="Rja7wi">View dosing, side effects, warnings and contraindications</a>
                                      </div>
                                      <div class="modal" data-modal="Rja7wi">
                      <div class="inner ">
                        <div class="close-wrapper">
                          <a href="" class="close" data-wpel-link="internal">Close</a>
                        </div>
                        <div class="container">
                          <div class="content">
                                                          <h4>Paroxetine (Paxil®)</h4>
                                                                                      <h6><strong>Dosing*** </strong></h6>
<ul>
<li><b>Initial: </b>10-20 mg daily (hs)</li>
<li><b>Usual: </b>20 mg daily (40 mg for GAD)</li>
<li><b>Max:</b> 50 mg daily (40 mg for older adults/debilitated patients)</li>
</ul>
<h6><strong>Dosing (CR)<br />
</strong></h6>
<ul>
<li><b>Initial: </b>12.5-25 mg daily (hs)</li>
<li><b>Usual: </b>25 mg daily (50 mg for GAD)</li>
<li><b>Max:</b> 62.5 daily (50 mg for older (adults/debilitated patients)</li>
</ul>
<h6><strong>Side effects</strong></h6>
<ul>
<li><b>CNS</b>: headache, sleep disturbance, drowsiness, nervousness, dizziness, somnolence, fatigue</li>
<li><b>GI</b>: nausea, vomiting, diarrhea</li>
<li><b>Anticholinergic</b>: anticholinergic potential, dry mouth, constipation, blurred vision</li>
<li><b>CV</b>: orthostatic hypotension, tachycardia</li>
<li><b>Urogenital</b>: sexual dysfunction</li>
<li><strong>Other: </strong>weight gain, withdrawal effects, hyperhidrosis</li>
</ul>
<h6><strong>Warnings<b> </b><b>and contraindications</b></strong></h6>
<ul>
<li>Avoid in older adults and pregnancy</li>
<li>
<p class="p1">Agitation/anxiety may worsen initially (first 1-2 weeks)</p>
</li>
<li>
<p class="p1">Discontinuation symptoms (do not discontinue abruptly)</p>
</li>
<li>
<p class="p1">Fractures (especially in first 6 weeks)</p>
</li>
<li>
<p class="p1">GI bleeding (consider gastroprotective agent if high risk)</p>
</li>
<li>
<p class="p1">Hyponatremia (especially in elderly)</p>
</li>
<li>
<p class="p1">Serotonin syndrome/Neuroleptic malignant syndrome (NMS)</p>
</li>
<li>
<p class="p1">Suicidal thinking &amp; self-harm (patients &lt;25)</p>
</li>
<li>
<p class="p1">Use with caution in narrow-angle glaucoma</p>
</li>
<li>
<p class="p1">Use with caution in patients with seizure disorders</p>
</li>
</ul>
                                                      </div>
                        </div>
                      </div>
                      <div class="overlay"></div>
                    </div>
                                  </li>

            
                <li>
                  <div class="inner">
                    <span class="subhead">Selective Serotonin Reuptake Inhibitors (SSRIs)</span>
                    <h6>Sertraline (Zoloft®)</h6>
                    <p>25 mg, 50 mg, 100 mg capsule</p>
<p><strong>First-line for<br />
</strong></p>
<ul>
<li aria-level="1">Major depressive disorder</li>
<li aria-level="1">Generalized anxiety disorder</li>
<li aria-level="1">Social anxiety disorder</li>
<li aria-level="1">Panic disorder (+/- agoraphobia)</li>
</ul>
<p><strong>Coverage</strong></p>
<ul>
<li>ODB ✓<sup><br />
</sup></li>
<li>NIHB ✓</li>
</ul>
<p><strong>Cost for usual dose ($/100 days)</strong></p>
<ul>
<li>$26-81</li>
</ul>
<p><b>Overall tolerability*</b></p>
<ul>
<li aria-level="1">Very well-tolerated</li>
</ul>
<p><b>Activating or sedating</b></p>
<ul>
<li aria-level="1">Activating</li>
</ul>
<p><strong>Interaction risk</strong></p>
<ul>
<li>++</li>
</ul>
<p><b>Features**</b></p>
<ul>
<li aria-level="1">A preferred pharmacological option for older adults, pregnancy and breastfeeding</li>
<li aria-level="1">May be a preferred option in CV disease</li>
</ul>
                                            <a class="button open-modal" href="#" data-modal="NVVT2f">View dosing, side effects, warnings and contraindications</a>
                                      </div>
                                      <div class="modal" data-modal="NVVT2f">
                      <div class="inner ">
                        <div class="close-wrapper">
                          <a href="" class="close" data-wpel-link="internal">Close</a>
                        </div>
                        <div class="container">
                          <div class="content">
                                                          <h4>Sertraline (Zoloft®)</h4>
                                                                                      <h6><strong>Dosing*** </strong></h6>
<ul>
<li><b>Initial:</b> 25-50 mg daily (am/pm)</li>
<li><b>Usual:</b>
<ul>
<li><i>MDD:</i> 50-100 mg daily</li>
<li><i>GAD:</i> 50-150 mg daily</li>
<li><i>SAD &amp; panic:</i> 50-200 mg daily</li>
</ul>
</li>
<li><b>Max:</b> 200 mg daily</li>
</ul>
<h6><strong>Side effects</strong></h6>
<ul>
<li><b>CNS</b>: headache, sleep disturbance, drowsiness, nervousness, dizziness, somnolence, fatigue</li>
<li><b>GI</b>: nausea, vomiting, diarrhea</li>
<li><b>Anticholinergic</b>: dry mouth, constipation, blurred vision</li>
<li><b>CV</b>: orthostatic hypotension, tachycardia</li>
<li><b>Urogenital</b>: sexual dysfunction</li>
<li><strong>Other:</strong> hyperhidrosis</li>
</ul>
<h6><strong>Warning<b>s </b><b>and contraindications</b></strong></h6>
<ul>
<li>
<p class="p1">Agitation/anxiety may worsen initially (first 1-2 weeks)</p>
</li>
<li>
<p class="p1">Discontinuation symptoms (do not discontinue abruptly)</p>
</li>
<li>
<p class="p1">Fractures (especially in first 6 weeks)</p>
</li>
<li>
<p class="p1">GI bleeding (consider gastroprotective agent if high risk)</p>
</li>
<li>
<p class="p1">Hyponatremia (especially in elderly)</p>
</li>
<li>
<p class="p1">Serotonin syndrome/Neuroleptic malignant syndrome (NMS)</p>
</li>
<li>
<p class="p1">Suicidal thinking &amp; self-harm (patients &lt;25)</p>
</li>
<li>
<p class="p1">Use with caution in narrow-angle glaucoma</p>
</li>
<li>
<p class="p1">Use with caution in patients with seizure disorders</p>
</li>
</ul>
                                                      </div>
                        </div>
                      </div>
                      <div class="overlay"></div>
                    </div>
                                  </li>

                      </ul>
        </div>
      </div>
    </div>
</article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><sub>*Overall tolerability is based on availability of evidence that primarily evaluates drop-out rates from trials. Specific drug side effects and patient factors may influence overall tolerability in practice.<br>** Consider in addition to other patient and medication factors<br>***Titration information:<br><em>Depression: </em>for most agents &#8211; increase dose no more frequently than once a week.<em>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</em><br><em>Anxiety OR if sensitive to side effects, or has kidney disease, liver disease, advanced age, or other factors warranting caution</em>:<em> </em>start with the lowest dose and increase every 1-2 weeks</sub></p>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading"><strong>Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)</strong></h6>
</div></article>

<article class="block--drug-options ">
<div class="container">
  <h5><span style="font-size: 13.5px;">Scroll (left-right) for details</h5>
          <div class="slider">
        <div class="inner-stage">
          <ul>
            
                <li>
                  <div class="inner">
                    <span class="subhead">Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)</span>
                    <h6>Desvenlafaxine (Pristiq®)</h6>
                    <p>50 mg, 100 mg tablet</p>
<p><strong>First-line for<br />
</strong></p>
<ul>
<li>Major depressive disorder</li>
</ul>
<p><strong>Coverage</strong></p>
<ul>
<li>ODB <strong>X</strong></li>
<li>NIHB <strong>X</strong></li>
</ul>
<p><strong>Cost for usual dose ($/100 days)</strong></p>
<ul>
<li>$268</li>
</ul>
<p><b>Overall tolerability*</b></p>
<ul>
<li aria-level="1">Poorly tolerated</li>
</ul>
<p><b>Activating or sedating</b></p>
<ul>
<li aria-level="1">Activating &gt; sedating</li>
</ul>
<p><strong>Interaction risk</strong></p>
<ul>
<li>+</li>
</ul>
<p><b>Features**</b></p>
<ul>
<li>No notable features</li>
</ul>
                                            <a class="button open-modal" href="#" data-modal="SdKs9n">View dosing, side effects, warnings and contraindications</a>
                                      </div>
                                      <div class="modal" data-modal="SdKs9n">
                      <div class="inner ">
                        <div class="close-wrapper">
                          <a href="" class="close" data-wpel-link="internal">Close</a>
                        </div>
                        <div class="container">
                          <div class="content">
                                                          <h4>Desvenlafaxine (Pristiq®)</h4>
                                                                                      <h6><strong>Dosing<b>***</b> </strong></h6>
<ul>
<li><b>Initial: </b>50 mg daily</li>
<li><b>Usual: </b>50 mg daily</li>
<li><b>Max:</b> 100 mg daily</li>
</ul>
<h6><strong>Side effects</strong></h6>
<ul>
<li><b>CNS</b>: tremor, headache, sleep disturbance, drowsiness, nervousness, dizziness, somnolence, fatigue</li>
<li><b>GI</b>: nausea, vomiting, diarrhea, decreased appetite</li>
<li><b>Anticholinergic</b>: dry mouth, constipation, blurred vision, urinary retention</li>
<li><b>CV</b>: increased blood pressure, orthostatic hypotension</li>
<li><b>Urogenital</b>: sexual dysfunction</li>
<li><strong>Other:</strong> hyperhidrosis</li>
</ul>
<h6><strong>Warnings and contraindications</strong></h6>
<ul>
<li>
<p class="p1">Agitation/anxiety may worsen initially (first 1-2 weeks)</p>
</li>
<li>
<p class="p1">Discontinuation symptoms (do not discontinue abruptly)</p>
</li>
<li>
<p class="p1">Fractures (especially in first 6 weeks)</p>
</li>
<li>
<p class="p1">GI bleeding (consider gastroprotective agent if high risk)</p>
</li>
<li>
<p class="p1">Hyponatremia (especially in elderly)</p>
</li>
<li>
<p class="p1">Serotonin syndrome/Neuroleptic malignant syndrome (NMS)</p>
</li>
<li>
<p class="p1">Suicidal thinking &amp; self-harm (patients &lt;25)</p>
</li>
<li>
<p class="p1">Use with caution in narrow-angle glaucoma or elevated intraocular pressure</p>
</li>
<li>
<p class="p1">Use with caution in patients with seizure disorders, cardiovascular disease, and cerebrovascular disease</p>
</li>
</ul>
                                                      </div>
                        </div>
                      </div>
                      <div class="overlay"></div>
                    </div>
                                  </li>

            
                <li>
                  <div class="inner">
                    <span class="subhead">Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)</span>
                    <h6>Duloxetine (Cymbalta®)</h6>
                    <p>30 mg, 60 mg capsule</p>
<p><strong>First-line for<br />
</strong></p>
<ul>
<li aria-level="1">Major depressive disorder</li>
<li aria-level="1">Generalized anxiety disorder</li>
</ul>
<p><strong>Coverage</strong></p>
<ul>
<li>ODB ✓<sup><br />
</sup></li>
<li>NIHB ✓</li>
</ul>
<p><strong>Cost for usual dose ($/100 days)</strong></p>
<ul>
<li>$48-167</li>
</ul>
<p><b>Overall tolerability*</b></p>
<ul>
<li aria-level="1">Neutral</li>
</ul>
<p><b>Activating or sedating</b></p>
<ul>
<li aria-level="1">Activating &gt; sedating</li>
</ul>
<p><strong>Interaction risk</strong></p>
<ul>
<li>+ +</li>
</ul>
<p><b>Features**</b></p>
<ul>
<li aria-level="1">A preferred pharmacological option for older adults</li>
<li aria-level="1">Helpful for some types of pain</li>
</ul>
                                            <a class="button open-modal" href="#" data-modal="vlDzUm">View dosing, side effects, warnings and contraindications</a>
                                      </div>
                                      <div class="modal" data-modal="vlDzUm">
                      <div class="inner ">
                        <div class="close-wrapper">
                          <a href="" class="close" data-wpel-link="internal">Close</a>
                        </div>
                        <div class="container">
                          <div class="content">
                                                          <h4>Duloxetine (Cymbalta®)</h4>
                                                                                      <h6><strong>Dosing*** </strong></h6>
<ul>
<li><b>Initial: </b>60 mg daily (consider 30 mg daily in some patients for tolerability reasons)</li>
<li><b>Usual:</b> 60 mg daily</li>
<li><b>Max:</b> 60 mg daily (120 mg daily for GAD)</li>
</ul>
<h6><strong>Side effects</strong></h6>
<ul>
<li><b>CNS</b>: headache, sleep disturbance, drowsiness, nervousness, dizziness, somnolence, fatigue</li>
<li><b>GI</b>: nausea, vomiting, diarrhea, decreased appetite</li>
<li><b>Anticholinergic</b>: dry mouth, constipation, blurred vision, urinary retention</li>
<li><b>CV</b>: increased blood pressure, orthostatic hypotension</li>
<li><b>Urogenital</b>: sexual dysfunction</li>
<li><strong>Other:</strong> hyperhidrosis</li>
</ul>
<h6><strong>Warnings and contraindications</strong></h6>
<ul>
<li>
<p class="p1">Agitation/anxiety may worsen initially (first 1-2 weeks)</p>
</li>
<li>
<p class="p1">Discontinuation symptoms (do not discontinue abruptly)</p>
</li>
<li>
<p class="p1">Fractures (especially in first 6 weeks)</p>
</li>
<li>
<p class="p1">GI bleeding (consider gastroprotective agent if high risk)</p>
</li>
<li>
<p class="p1">Hyponatremia (especially in elderly)</p>
</li>
<li>
<p class="p1">Serotonin syndrome/Neuroleptic malignant syndrome (NMS)</p>
</li>
<li>
<p class="p1">Suicidal thinking &amp; self-harm (patients &lt;25)</p>
</li>
<li>
<p class="p1">Use with caution in narrow-angle glaucoma or elevated intraocular pressure</p>
</li>
<li>
<p class="p1">Use with caution in patients with seizure disorders, cardiovascular disease, and cerebrovascular disease</p>
</li>
</ul>
                                                      </div>
                        </div>
                      </div>
                      <div class="overlay"></div>
                    </div>
                                  </li>

            
                <li>
                  <div class="inner">
                    <span class="subhead">Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)</span>
                    <h6>Levomilnacipran (Fetzima®)</h6>
                    <p>20 mg, 40 mg, 80 mg, 120 mg capsule</p>
<p><strong>First-line for<br />
</strong></p>
<ul>
<li aria-level="1">Major depressive disorder</li>
</ul>
<p><strong>Coverage</strong></p>
<ul>
<li>ODB X<sup><br />
</sup></li>
<li>NIHB X</li>
</ul>
<p><strong>Cost for usual dose ($/100 days)</strong></p>
<ul>
<li>$481-546</li>
</ul>
<p><b>Overall tolerability*</b></p>
<ul>
<li aria-level="1">Neutral</li>
</ul>
<p><b>Activating or sedating</b></p>
<ul>
<li aria-level="1">Activating &gt; sedating</li>
</ul>
<p><strong>Interaction risk</strong></p>
<ul>
<li>++</li>
</ul>
<p><b>Features**</b></p>
<ul>
<li>No notable features</li>
</ul>
                                            <a class="button open-modal" href="#" data-modal="ZzpxZK">View dosing, side effects, warnings and contraindications</a>
                                      </div>
                                      <div class="modal" data-modal="ZzpxZK">
                      <div class="inner ">
                        <div class="close-wrapper">
                          <a href="" class="close" data-wpel-link="internal">Close</a>
                        </div>
                        <div class="container">
                          <div class="content">
                                                          <h4>Levomilnacipran (Fetzima®)</h4>
                                                                                      <h6><strong>Dosing*** </strong></h6>
<ul>
<li><b>Initial: </b>20 mg once daily</li>
<li><b>Usual:</b> 40-120 mg once daily daily</li>
<li><b>Max:</b> 120 mg once daily</li>
</ul>
<h6><strong>Side effects</strong></h6>
<ul>
<li><b>CNS</b>: headache, sleep disturbance, drowsiness, nervousness, dizziness, somnolence, fatigue</li>
<li><b>GI</b>: nausea, vomiting, diarrhea, decreased appetite</li>
<li><b>Anticholinergic</b>: dry mouth, constipation, blurred vision, urinary retention</li>
<li><b>CV</b>: increased blood pressure, orthostatic hypotension, palpitations, elevated heart rate</li>
<li><b>Urogenital</b>: testicular pain, urinary hesitancy, dysuria, sexual dysfunction</li>
<li><strong>Other</strong>: rash, hot flash, hyperhidrosis</li>
</ul>
<h6><strong>Warnings and contraindications</strong></h6>
<ul>
<li>
<p class="p1">Avoid in patients with myocardial infarction or cardiac intervention in the past 12 months, NYHA Class III or IV heart failure, uncontrolled tachyarrhythmia, uncontrolled hypertension, or a history of cerebrovascular accident</p>
</li>
<li>
<p class="p1">Agitation/anxiety may worsen initially (first 1-2 weeks)</p>
</li>
<li>
<p class="p1">Discontinuation symptoms (do not discontinue abruptly)</p>
</li>
<li>
<p class="p1">Fractures (especially in first 6 weeks)</p>
</li>
<li>
<p class="p1">GI bleeding (consider gastroprotective agent if high risk)</p>
</li>
<li>
<p class="p1">Hyponatremia (especially in elderly)</p>
</li>
<li>
<p class="p1">Serotonin syndrome/Neuroleptic malignant syndrome (NMS)</p>
</li>
<li>
<p class="p1">Suicidal thinking &amp; self-harm (patients &lt;25)</p>
</li>
<li>
<p class="p1">Use with caution in narrow-angle glaucoma or elevated intraocular pressure</p>
</li>
<li>
<p class="p1">Use with caution in patients with seizure disorders, cardiovascular disease, and cerebrovascular disease</p>
</li>
</ul>
                                                      </div>
                        </div>
                      </div>
                      <div class="overlay"></div>
                    </div>
                                  </li>

            
                <li>
                  <div class="inner">
                    <span class="subhead">Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)</span>
                    <h6>Venlafaxine (Effexor®)</h6>
                    <p>37.5 mg, 75 mg, 150 mg capsule</p>
<p><strong>First-line for<br />
</strong></p>
<ul>
<li aria-level="1">Major depressive disorder</li>
<li aria-level="1">Generalized anxiety disorder</li>
<li aria-level="1">Social anxiety disorder</li>
<li aria-level="1">Panic disorder (+/- agoraphobia)</li>
</ul>
<p><strong>Coverage</strong></p>
<ul>
<li>ODB ✓<sup><br />
</sup></li>
<li>NIHB ✓</li>
</ul>
<p><strong>Cost for usual dose ($/100 days)</strong></p>
<ul>
<li>$19-69</li>
</ul>
<p><b>Overall tolerability*</b></p>
<ul>
<li aria-level="1">Poorly tolerated</li>
</ul>
<p><b>Activating or sedating</b></p>
<ul>
<li aria-level="1">Activating &gt; sedating</li>
</ul>
<p><strong>Interaction risk</strong></p>
<ul>
<li>+</li>
</ul>
<p><b>Features**</b></p>
<ul>
<li>No notable features</li>
</ul>
                                            <a class="button open-modal" href="#" data-modal="QjkYKX">View dosing, side effects, warnings and contraindications</a>
                                      </div>
                                      <div class="modal" data-modal="QjkYKX">
                      <div class="inner ">
                        <div class="close-wrapper">
                          <a href="" class="close" data-wpel-link="internal">Close</a>
                        </div>
                        <div class="container">
                          <div class="content">
                                                          <h4>Venlafaxine (Effexor®)</h4>
                                                                                      <h6><strong>Dosing*** </strong></h6>
<ul>
<li><b>Initial:</b>
<ul>
<li><i>MDD &amp; SAD: </i>75 mg daily (37.5 mg daily may be considered for tolerability)</li>
<li><i>GAD &amp; panic:</i> 37.5 mg daily</li>
</ul>
</li>
<li><b>Usual:</b> 75 mg daily</li>
<li><b>Max:</b> 225 mg daily</li>
</ul>
<h6><strong>Side effects</strong></h6>
<ul>
<li><b>CNS</b>: paresthesia, headache, sleep disturbance, drowsiness, nervousness, dizziness, somnolence, fatigue</li>
<li><b>GI</b>: nausea, vomiting, diarrhea, decreased appetite</li>
<li><b>Anticholinergic</b>: dry mouth, constipation, blurred vision, urinary retention</li>
<li><b>CV</b>: increased blood pressure, orthostatic hypotension</li>
<li><b>Urogenital</b>: sexual dysfunction</li>
<li><strong>Other</strong>: hyperhidrosis</li>
</ul>
<h6><strong>Warnings and contraindications</strong></h6>
<ul>
<li>
<p class="p1">Agitation/anxiety may worsen initially (first 1-2 weeks)</p>
</li>
<li>
<p class="p1">Discontinuation symptoms (do not discontinue abruptly)</p>
</li>
<li>
<p class="p1">Fractures (especially in first 6 weeks)</p>
</li>
<li>
<p class="p1">GI bleeding (consider gastroprotective agent if high risk)</p>
</li>
<li>
<p class="p1">Hyponatremia (especially in elderly)</p>
</li>
<li>
<p class="p1">Serotonin syndrome/Neuroleptic malignant syndrome (NMS)</p>
</li>
<li>
<p class="p1">Suicidal thinking &amp; self-harm (patients &lt;25)</p>
</li>
<li>
<p class="p1">Use with caution in narrow-angle glaucoma or elevated intraocular pressure</p>
</li>
<li>
<p class="p1">Use with caution in patients with seizure disorders, cardiovascular disease, and cerebrovascular disease</p>
</li>
</ul>
                                                      </div>
                        </div>
                      </div>
                      <div class="overlay"></div>
                    </div>
                                  </li>

                      </ul>
        </div>
      </div>
    </div>
</article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><sub>*Overall tolerability is based on availability of evidence that primarily evaluates drop-out rates from trials. Specific drug side effects and patient factors may influence overall tolerability in practice.<br>**Consider in addition to other patient and medication factors<br>***Titration information:<br>Depression: for most agents &#8211; increase dose no more frequently than once a week.<br>Anxiety OR if sensitive to side effects, or has kidney disease, liver disease, advanced age, or other factors warranting caution: start with the lowest dose and increase every 1-2 weeks.</sub></p>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading"><strong>Other classes</strong></h6>
</div></article>

<article class="block--drug-options ">
<div class="container">
  <h5><span style="font-size: 13.5px;">Scroll (left-right) for details</h5>
          <div class="slider">
        <div class="inner-stage">
          <ul>
            
                <li>
                  <div class="inner">
                    <span class="subhead">Norepinephrine Dopamine Reuptake Inhibitor (NDRI)</span>
                    <h6>Bupropion (Wellbutrin®)</h6>
                    <p>SR: 100 mg, 150 mg tablet<br />
XL (ER): 150 mg, 300 mg capsule</p>
<p><strong>First-line for<br />
</strong></p>
<ul>
<li>Major depressive disorder</li>
</ul>
<p><strong>Coverage</strong></p>
<ul>
<li>ODB <strong>✓</strong>: <a href="https://link.cep.health/ad73" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">LU 315</a></li>
<li>NIHB <strong>✓</strong></li>
</ul>
<p><strong>Cost for usual dose ($/100 days)</strong></p>
<ul>
<li>SR: $66-207</li>
<li>XL: $41-72</li>
</ul>
<p><b>O</b><b>verall tolerability*</b></p>
<ul>
<li aria-level="1">Well tolerated</li>
</ul>
<p><b>Activating or sedating</b></p>
<ul>
<li aria-level="1">Activating</li>
</ul>
<p><strong>Interaction risk</strong></p>
<ul>
<li>++</li>
</ul>
<p><b>Features**</b></p>
<ul>
<li aria-level="1">Low risk of sexual dysfunction</li>
<li aria-level="1">Low risk of hyponatremia</li>
<li aria-level="1">Also indicated for smoking cessation</li>
</ul>
                                            <a class="button open-modal" href="#" data-modal="bApSFn">View dosing, side effects, warnings and contraindications </a>
                                      </div>
                                      <div class="modal" data-modal="bApSFn">
                      <div class="inner ">
                        <div class="close-wrapper">
                          <a href="" class="close" data-wpel-link="internal">Close</a>
                        </div>
                        <div class="container">
                          <div class="content">
                                                          <h4>Bupropion (Wellbutrin®)</h4>
                                                                                      <h6><strong>Dosing (SR)*** </strong></h6>
<ul>
<li><b>Initial:</b> 100-150 mg daily (am)</li>
<li><b>Usual: </b>100-150 mg daily</li>
<li><b>Max:</b> 300 mg daily (doses &gt; 150 mg daily should be given BID with at least 8 hours between doses. A single dose should not exceed 150 mg)</li>
</ul>
<h6><strong>Dosing (XL, given once daily)*** </strong></h6>
<ul>
<li><b>Initial:</b> 150 mg daily (am)</li>
<li><b>Usual:</b> 150–300 mg daily</li>
<li><b>Max: </b>450 mg daily</li>
</ul>
<h6><strong>Side effects</strong></h6>
<ul>
<li><b>CNS</b>: headache, sleep disturbance, nervousness, dizziness, fatigue</li>
<li><b>GI</b>: nausea, vomiting, diarrhea, decreased appetite</li>
<li><b>Anticholinergic</b>: dry mouth, constipation, blurred vision</li>
<li><b>CV</b>: Increased blood pressure, orthostatic hypotension</li>
</ul>
<h6><strong>Warnings and contraindications<br />
</strong></h6>
<ul>
<li>Contraindicated in patients with seizure disorders or at higher risk for seizures (e.g, anorexia nervosa or bulimia)</li>
<li>
<p class="p1">Discontinuation symptoms (do not discontinue abruptly)</p>
</li>
<li>
<p class="p1">Suicidal thinking &amp; self-harm (patients &lt;25)</p>
</li>
<li>
<p class="p1">Use with caution in narrow-angle glaucoma</p>
</li>
<li>
<p class="p1">Use with caution in patients with unstable heart disease</p>
</li>
</ul>
<p>&nbsp;</p>
                                                      </div>
                        </div>
                      </div>
                      <div class="overlay"></div>
                    </div>
                                  </li>

            
                <li>
                  <div class="inner">
                    <span class="subhead">Noradrenergic and Specific Serotonergic Antidepressant (NaSSA)</span>
                    <h6>Mirtazapine (Remeron®)</h6>
                    <p>15 mg, 30 mg, 45 mg tablet<br />
15 mg, 30 mg, 45 mg orally disintegrating tablet (ODT)</p>
<p><strong>First-line for<br />
</strong></p>
<ul>
<li>Major depressive disorder</li>
</ul>
<p><strong>Coverage</strong></p>
<ul>
<li>ODB ✓ (excludes 15mg and 45mg tablets)<sup><br />
</sup></li>
<li>NIHB ✓</li>
</ul>
<p><strong>Cost for usual dose ($/100 days)</strong></p>
<ul>
<li>$26-134 (tablet)</li>
<li>$54-143 (ODT)</li>
</ul>
<p><b>Overall tolerability*</b></p>
<ul>
<li aria-level="1">Neutral</li>
</ul>
<p><b>Activating or sedating</b></p>
<ul>
<li aria-level="1">Sedating</li>
</ul>
<p><strong>Interaction risk</strong></p>
<ul>
<li>+</li>
</ul>
<p><b>Features**</b></p>
<ul>
<li aria-level="1">Low risk of sexual dysfunction</li>
<li aria-level="1">Can help increase appetite and weight</li>
<li aria-level="1">May be helpful for insomnia</li>
</ul>
                                            <a class="button open-modal" href="#" data-modal="sEuvQi">View side dosing effects, warnings and contraindications</a>
                                      </div>
                                      <div class="modal" data-modal="sEuvQi">
                      <div class="inner ">
                        <div class="close-wrapper">
                          <a href="" class="close" data-wpel-link="internal">Close</a>
                        </div>
                        <div class="container">
                          <div class="content">
                                                          <h4>Mirtazapine (Remeron®)</h4>
                                                                                      <h6><strong>Dosing*** </strong></h6>
<ul>
<li><b>Initial:</b> 15 mg daily (hs)</li>
<li><b>Usual:</b> 15–45 mg daily</li>
<li><b>Maximum:</b> 45 mg daily</li>
</ul>
<h6><strong>Side effects</strong></h6>
<ul>
<li><b>CNS</b>: headache, sleep disturbance, nervousness, dizziness, fatigue</li>
<li><b>GI</b>: nausea, vomiting, diarrhea, increased appetite</li>
<li><b>Anticholinergic</b>: dry mouth, constipation, blurred vision</li>
<li><b>CV</b>: orthostatic hypotension</li>
<li><strong>Other:</strong> weight gain</li>
</ul>
<h6><strong>Warnings and contraindications<br />
</strong></h6>
<ul>
<li>
<p class="p1">Discontinuation symptoms (do not discontinue abruptly)</p>
</li>
<li>
<p class="p1">Serotonin syndrome</p>
</li>
<li>
<p class="p1">Suicidal thinking &amp; self-harm (patients &lt;25)</p>
</li>
</ul>
                                                      </div>
                        </div>
                      </div>
                      <div class="overlay"></div>
                    </div>
                                  </li>

            
                <li>
                  <div class="inner">
                    <span class="subhead">Calcium Modulator, GABA Anxiolytic</span>
                    <h6>Pregabalin (Lyrica®)</h6>
                    <p>25 mg, 50 mg, 75 mg, 150 mg, 300 mg capsule</p>
<p><strong>First-line for</strong></p>
<ul>
<li aria-level="1">Generalized anxiety disorder</li>
<li aria-level="1">Social anxiety disorder</li>
</ul>
<p><strong>Coverage</strong></p>
<ul>
<li>ODB ✓<sup><br />
</sup></li>
<li>NIHB ✓</li>
</ul>
<p><strong>Cost for usual dose ($/100 days)</strong></p>
<ul>
<li>$25-99</li>
</ul>
<p><b>Overall tolerability*</b></p>
<ul>
<li aria-level="1">Neutral</li>
</ul>
<p><b>Activating or sedating</b></p>
<ul>
<li aria-level="1">Sedating</li>
</ul>
<p><strong>Interaction risk</strong></p>
<ul>
<li>0/+</li>
</ul>
<p><b>Features**</b></p>
<ul>
<li aria-level="1">Helpful for some types of pain</li>
</ul>
                                            <a class="button open-modal" href="#" data-modal="SvvXpd">View dosing, side effects, warnings and contraindications</a>
                                      </div>
                                      <div class="modal" data-modal="SvvXpd">
                      <div class="inner ">
                        <div class="close-wrapper">
                          <a href="" class="close" data-wpel-link="internal">Close</a>
                        </div>
                        <div class="container">
                          <div class="content">
                                                          <h4>Pregabalin (Lyrica®)</h4>
                                                                                      <h6><strong>Dosing*** </strong></h6>
<ul>
<li><b>Initial:</b> 150 mg daily (75 mg BID or 50 mg TID)
<ul>
<li>Some experts recommend 50 mg daily</li>
</ul>
</li>
<li><b>Usual:</b>
<ul>
<li>GAD: 300 mg daily (150 mg BID)</li>
<li>SAD: 600 mg daily (300 mg BID)</li>
</ul>
</li>
<li><b>Max:</b> 600 mg daily (300 mg BID)</li>
</ul>
<h6><strong>Side effects</strong></h6>
<ul>
<li><b>CNS</b>: headache, sleep disturbances, memory impairment, ataxia, diplopia, dizziness, somnolence, sedation, fatigue</li>
<li><b>GI</b>: nausea, vomiting, diarrhea</li>
<li><b>Anticholinergic</b>: dry mouth, blurred vision</li>
<li><b>Other</b>: skin rash, peripheral edema, weight gain</li>
</ul>
<h6><strong>Warnings</strong></h6>
<ul>
<li>Angioedema</li>
<li>Hypersensitivity reactions</li>
<li>Caution in renal impairment</li>
<li>New-onset congestive heart failure in CV-compromised adults</li>
<li>Reduced GI motility (caution with concurrent opioid use)</li>
<li>
<p class="p1">Discontinuation symptoms (do not discontinue abruptly)</p>
</li>
<li>
<p class="p1">Suicidal thinking &amp; self-harm (patients &lt;25)</p>
</li>
</ul>
                                                      </div>
                        </div>
                      </div>
                      <div class="overlay"></div>
                    </div>
                                  </li>

            
                <li>
                  <div class="inner">
                    <span class="subhead">SSRI and partial agonist of the 5HT1A receptor</span>
                    <h6>Vilazodone (Viibryd®)</h6>
                    <p>10 mg, 20 mg, 40 mg tablets</p>
<p><strong>First-line for</strong></p>
<ul>
<li>Major depressive disorder</li>
</ul>
<p><strong>Coverage</strong></p>
<ul>
<li>ODB X<sup><br />
</sup></li>
<li>NIHB X</li>
</ul>
<p><strong>Cost for usual dose ($/100 days)</strong></p>
<ul>
<li>$404-538</li>
</ul>
<p><b>Overall tolerability*</b></p>
<ul>
<li aria-level="1">Neutral</li>
</ul>
<p><b>Activating or sedating</b></p>
<ul>
<li aria-level="1">Activating/sedating</li>
</ul>
<p><strong>Interaction risk</strong></p>
<ul>
<li>++</li>
</ul>
<p><b>Features**</b></p>
<ul>
<li aria-level="1">No notable features</li>
</ul>
                                            <a class="button open-modal" href="#" data-modal="zTSZqE">View dosing, side effects, warnings and contraindications</a>
                                      </div>
                                      <div class="modal" data-modal="zTSZqE">
                      <div class="inner ">
                        <div class="close-wrapper">
                          <a href="" class="close" data-wpel-link="internal">Close</a>
                        </div>
                        <div class="container">
                          <div class="content">
                                                          <h4>Vilazodone (Viibryd®)</h4>
                                                                                      <h6><strong>Dosing*** </strong></h6>
<ul>
<li><b>Initial: </b>10 mg once daily with food</li>
<li><b>Usual: </b>20-40 mg once daily with food</li>
<li><b>Max: </b>40 mg once daily with food</li>
</ul>
<h6><strong>Side effects</strong></h6>
<ul>
<li><b>CNS</b>: headache, dizziness, insomnia, restlessness, somnolence, fatigue</li>
<li><b>GI</b>: diarrhea, nausea, vomiting, abdominal pain, flatulence, abdominal distension</li>
<li><b>Anticholinergic</b>: dry mouth</li>
<li><b>Urogential: </b>sexual dysfunction (minimal)</li>
<li><b>Musculoskeletal: </b>muscle pain</li>
</ul>
<h6><strong>Warnings and contraindications<br />
</strong></h6>
<ul>
<li>
<p class="p1">Agitation/anxiety may worsen initially (first 1-2 weeks)</p>
</li>
<li>
<p class="p1">Discontinuation symptoms (do not discontinue abruptly)</p>
</li>
<li>
<p class="p1">Fractures (especially in first 6 weeks)</p>
</li>
<li>
<p class="p1">GI bleeding (consider gastroprotective agent if high risk)</p>
</li>
<li>
<p class="p1">Hyponatremia (especially in elderly)</p>
</li>
<li>
<p class="p1">Serotonin syndrome</p>
</li>
<li>
<p class="p1">Suicidal thinking &amp; self-harm (patients &lt;25)</p>
</li>
<li>
<p class="p1">Use with caution in narrow-angle glaucoma or elevated intraocular pressure</p>
</li>
<li>
<p class="p1">Use with caution in patients with seizure disorders</p>
</li>
</ul>
                                                      </div>
                        </div>
                      </div>
                      <div class="overlay"></div>
                    </div>
                                  </li>

            
                <li>
                  <div class="inner">
                    <span class="subhead">Serotonin Receptor Antagonist and Serotonin Reuptake Inhibitor (SARI)</span>
                    <h6>Vortioxetine (Trintellix®)</h6>
                    <p>5 mg, 10 mg, 20 mg tablet</p>
<p><strong>First-line for<br />
</strong></p>
<ul>
<li>Major depressive disorder</li>
</ul>
<p><strong>Coverage</strong></p>
<ul>
<li>ODB ✓<sup><br />
</sup></li>
<li>NIHB ✓</li>
</ul>
<p><strong>Cost for usual dose ($/100 days)</strong></p>
<ul>
<li>$320-363</li>
</ul>
<p><b>Overall tolerability*</b></p>
<ul>
<li aria-level="1">Poorly tolerated</li>
</ul>
<p><b>Activating or sedating</b></p>
<ul>
<li aria-level="1">Activating/sedating</li>
</ul>
<p><strong>Interaction risk</strong></p>
<ul>
<li>++</li>
</ul>
<p><b>Features**</b></p>
<ul>
<li aria-level="1">No notable features</li>
</ul>
                                            <a class="button open-modal" href="#" data-modal="s8Kwog">View dosing, side effects, warnings and contraindications</a>
                                      </div>
                                      <div class="modal" data-modal="s8Kwog">
                      <div class="inner ">
                        <div class="close-wrapper">
                          <a href="" class="close" data-wpel-link="internal">Close</a>
                        </div>
                        <div class="container">
                          <div class="content">
                                                          <h4>Vortioxetine (Trintellix®)</h4>
                                                                                      <h6><strong>Dosing*** </strong></h6>
<ul>
<li><b>Initial: </b>10 mg daily (5 mg daily in older adults &gt;65; consider decreasing to 5 mg if higher dose is not tolerated)</li>
<li><b>Usual: </b>10–20 mg daily</li>
<li><b>Max: </b>20 mg daily</li>
</ul>
<h6><strong>Side effects</strong></h6>
<ul>
<li><b>CNS</b>: headache, sleep disturbance, nervousness, dizziness, fatigue</li>
<li><b>GI</b>: nausea, vomiting, diarrhea, abdominal pain, bloating, decreased appetite</li>
<li><b>Anticholinergic</b>: dry mouth, constipation</li>
<li><b>CV</b>: orthostatic hypotension</li>
<li><b>Other</b>: cough, flu-like symptoms, pruritus, joint and muscle pain</li>
</ul>
<h6><strong>Warnings and contraindications<br />
</strong></h6>
<ul>
<li>
<p class="p1">Agitation/anxiety may worsen initially (first 1-2 weeks)</p>
</li>
<li>
<p class="p1">Discontinuation symptoms (do not discontinue abruptly)</p>
</li>
<li>
<p class="p1">Fractures (especially in first 6 weeks)</p>
</li>
<li>
<p class="p1">GI bleeding (consider gastroprotective agent if high risk)</p>
</li>
<li>
<p class="p1">Hyponatremia (especially in elderly)</p>
</li>
<li>
<p class="p1">Serotonin syndrome/Neuroleptic malignant syndrome (NMS)</p>
</li>
<li>
<p class="p1">Suicidal thinking &amp; self-harm (patients &lt;25)</p>
</li>
<li>
<p class="p1">Use with caution in narrow-angle glaucoma or elevated intraocular pressure</p>
</li>
<li>
<p class="p1">Use with caution in patients with seizure disorders</p>
</li>
</ul>
                                                      </div>
                        </div>
                      </div>
                      <div class="overlay"></div>
                    </div>
                                  </li>

                      </ul>
        </div>
      </div>
    </div>
</article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><sub>*Overall tolerability is based on availability of evidence that primarily evaluates drop-out rates from trials. Specific drug side effects and patient factors may influence overall tolerability in practice.<br>** Consider in addition to other patient and medication factors<br>***Titration information:<br><em>Depression: </em>for most agents &#8211; increase dose no more frequently than once a week.<em>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</em><br><em>Anxiety OR if sensitive to side effects, or has kidney disease, liver disease, advanced age, or other factors warranting caution</em>:<em> </em>start with the lowest dose and increase every 1-2 weeks</sub></p>
</div></article>


<div class="wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex">
<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow"><article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading" id="Role-of-benzodiazepines"><strong>Role of benzodiazepines for anxiety disorders<sup>3,5,7</sup></strong></h6>
</div></article>

<article class="block--text-with-icon ">  <div class="container">
    
        <div class="columns is-flex is-gapless">
          <div class="column is-2-mobile is-1">
            <div class="inner">
              <img decoding="async" src="https://tools.cep.health/wp-content/uploads/2019/10/Yellow-Notice.svg" />
            </div>
          </div>
          <div class="column is-10-mobile is-11">
            <p><strong>Benzodiazepines should not be routinely prescribed for anxiety disorders.</strong></p>
<p>Benzodiazepines may be useful as an adjunctive therapy early in treatment for acute crises. Due to concerns about tolerance, dependency, sedation, cognitive impairment, and other side effects, benzodiazepines should be restricted to short-term use. They should be used with caution, especially with patients with a history of substance use disorder. Patients should also be warned about the safety risks of driving and using benzodiazepines (i.e. drowsiness, reduced concentration). Older adults may be at increased risk of falls and fractures and memory impairment with benzodiazepines. Except for alprazolam (which may be harder to discontinue), short-acting agents are preferable to long-acting agents.</p>
          </div>
        </div>

      </div>
</article></div>



<div class="wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow" style="flex-basis:35%"><article class="block--modal ">

<div class="outer">
  <div class="container">
    <div class="inner has-text-centered">
              <img decoding="async" src="https://tools.cep.health/wp-content/uploads/2019/10/talking-points.svg" alt="" />
                    <h6>Talking tips</h6>
                          <a data-modal="WofpIl" class="button open-modal" href="#" data-id="WofpIl">Click to view</a>
          </div>
  </div>
</div>

  <div data-modal="WofpIl" class="modal">
    <div class="inner text">
      <div class="close-wrapper">
                <a href="" class="close" data-wpel-link="internal">Close</a>
      </div>
      <div class="container">
                <div class="content">
          
                          <h4>Talking tips<sup>5</sup></h4>
                                      <ul>
<li aria-level="1">If we are to start [benzodiazepine name], it would only be for a short time, until the effects of the [antidepressant/anti-anxiety medication name] are seen.</li>
<li aria-level="1">This is because [benzodiazepine name] can cause more long-term side effects, including fatigue, addiction, and difficulty with thinking clearly, learning and remembering.</li>
</ul>
            
                  </div>
      </div>
    </div>
    <div class="overlay"></div>
</div></article></div>
</div>


<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h3 class="wp-block-heading">Medication counselling</h3>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>The idea of starting a medication can cause anxiety for some patients. This can be compounded by the fact that medication side effects can make patients feel worse before there is an expected benefit.<sup>1</sup> Options to address anxiety related to medications include:<sup>5</sup></p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Provide information about the recommended treatment option(s) verbally and in writing.<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li><a href="https://link.cep.health/ad30" data-type="URL" data-id="https://link.cep.health/ad30" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Understanding antidepressant medications</a>, side effects, and managing patient expectations</li>
</ul>
</div></article></li>



<li>Probe for questions or concerns.</li>



<li>If appropriate, the patient may want time to process the information before proceeding.</li>



<li>Provide choice (e.g., treatment type, initiation timing, follow-up timing). If the patient is struggling to make decisions due to their underlying condition, consider limiting the number of options and adjusting this approach based on clinical judgement.</li>
</ul>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h4 class="wp-block-heading"><strong>Before starting a treatment, discuss the following with the patient, and if desired, their family or caregiver(s):<sup>1</sup></strong><sup>-5,9</sup></h4>
</div></article>

<article class="block--text-with-icon ">  <div class="container">
    
        <div class="columns is-flex is-gapless">
          <div class="column is-2-mobile is-1">
            <div class="inner">
              <img decoding="async" src="https://tools.cep.health/wp-content/uploads/2019/10/Checkmark-Large-2.svg" />
            </div>
          </div>
          <div class="column is-10-mobile is-11">
            <h6>Medication option(s)</h6>
          </div>
        </div>

    
        <div class="columns is-flex is-gapless">
          <div class="column is-2-mobile is-1">
            <div class="inner">
              <img decoding="async" src="https://tools.cep.health/wp-content/uploads/2019/10/Checkmark-Large-2.svg" />
            </div>
          </div>
          <div class="column is-10-mobile is-11">
            <h6>Expected benefit(s) of the particular medication</h6>
          </div>
        </div>

    
        <div class="columns is-flex is-gapless">
          <div class="column is-2-mobile is-1">
            <div class="inner">
              <img decoding="async" src="https://tools.cep.health/wp-content/uploads/2019/10/Checkmark-Large-2.svg" />
            </div>
          </div>
          <div class="column is-10-mobile is-11">
            <h6>Overall plan to “start low and go slow” to the “target” dose</h6>
          </div>
        </div>

      </div>
</article>


<div class="wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex">
<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow" style="flex-basis:100%"><article class="block--text-with-icon ">  <div class="container">
    
        <div class="columns is-flex is-gapless">
          <div class="column is-2-mobile is-1">
            <div class="inner">
              <img decoding="async" src="https://tools.cep.health/wp-content/uploads/2019/10/Checkmark-Large-2.svg" />
            </div>
          </div>
          <div class="column is-10-mobile is-11">
            <h6>Onset of action</h6>
<ul>
<li>Depression: 2-4 weeks<sup>1</sup></li>
<li>Anxiety: 2-8 weeks<sup>7</sup></li>
</ul>
          </div>
        </div>

      </div>
</article>

<article class="block--text-with-icon ">  <div class="container">
    
        <div class="columns is-flex is-gapless">
          <div class="column is-2-mobile is-1">
            <div class="inner">
              <img decoding="async" src="https://tools.cep.health/wp-content/uploads/2019/10/Checkmark-Large-2.svg" />
            </div>
          </div>
          <div class="column is-10-mobile is-11">
            <h6>Full effect(s)</h6>
<ul>
<li>Depression: 4-8 weeks<sup>4,5</sup></li>
<li>Anxiety: 6-12 weeks or more<sup>3,7</sup></li>
<li>Older adults may take longer to respond<sup>9</sup></li>
</ul>
          </div>
        </div>

      </div>
</article></div>
</div>


<article class="block--text-with-icon ">  <div class="container">
    
        <div class="columns is-flex is-gapless">
          <div class="column is-2-mobile is-1">
            <div class="inner">
              <img decoding="async" src="https://tools.cep.health/wp-content/uploads/2019/10/Checkmark-Large-2.svg" />
            </div>
          </div>
          <div class="column is-10-mobile is-11">
            <h6>Cost/coverage of the treatment</h6>
<ul>
<li>Understand your patient’s access to private health insurance</li>
<li>Reach out to drug companies to inquire about their compassionate use programs</li>
<li>Connect your patient with <a href="https://link.cep.health/ad34" target="_blank" rel="noreferrer noopener external" data-wpel-link="external">Ontario Works</a> and <a href="https://link.cep.health/ad35" target="_blank" rel="noreferrer noopener external" data-wpel-link="external">Ontario Disability Support Program</a> for financial assistance with drug coverage</li>
</ul>
          </div>
        </div>

    
        <div class="columns is-flex is-gapless">
          <div class="column is-2-mobile is-1">
            <div class="inner">
              <img decoding="async" src="https://tools.cep.health/wp-content/uploads/2019/10/Checkmark-Large-2.svg" />
            </div>
          </div>
          <div class="column is-10-mobile is-11">
            <h6>Side effects/risks of treatment and how to manage</h6>
<ul>
<li>Common side effects that are likely to go away within a week or two of each dose change (e.g., GI upset, sedation, increased anxiety, sleeping difficulties). See <a href="https://tools.cep.health/wp-admin/post.php?post=56360&amp;action=edit#sideeffectmanagement" data-wpel-link="internal">Side effect management</a>.</li>
<li>Serious side effects (e.g., serotonin syndrome, unmasking bipolar disorder, neuroleptic malignant syndrome,  hyponatremia)</li>
</ul>
          </div>
        </div>

    
        <div class="columns is-flex is-gapless">
          <div class="column is-2-mobile is-1">
            <div class="inner">
              <img decoding="async" src="https://tools.cep.health/wp-content/uploads/2019/10/Checkmark-Large-2.svg" />
            </div>
          </div>
          <div class="column is-10-mobile is-11">
            <h6>Follow-up and monitoring</h6>
<ul>
<li>Why regular monitoring is needed</li>
<li>Options for monitoring, as appropriate (i.e., phone call, virtual, in person, support staff)</li>
<li>Frequency of follow-up. See <a href="#follow-up-monitoring">Follow-up/monitoring</a> for the overall approach</li>
<li>How to self-monitor (e.g., keep track of symptoms and feelings in a mood diary)</li>
<li>Contingency plans if additional support is needed between appointments
<ul>
<li style="list-style-type: none;"></li>
</ul>
</li>
</ul>
          </div>
        </div>

    
        <div class="columns is-flex is-gapless">
          <div class="column is-2-mobile is-1">
            <div class="inner">
              <img decoding="async" src="https://tools.cep.health/wp-content/uploads/2019/10/Checkmark-Large-2.svg" />
            </div>
          </div>
          <div class="column is-10-mobile is-11">
            <h6>Treatment duration</h6>
<ul>
<li>Depression: 6-12 months after symptom remission<sup>1</sup></li>
<li>Anxiety: 12-24 months<sup>7</sup></li>
</ul>
          </div>
        </div>

    
        <div class="columns is-flex is-gapless">
          <div class="column is-2-mobile is-1">
            <div class="inner">
              <img decoding="async" src="https://tools.cep.health/wp-content/uploads/2019/10/Checkmark-Large-2.svg" />
            </div>
          </div>
          <div class="column is-10-mobile is-11">
            <h6>Precautions</h6>
<ul>
<li>Antidepressants have been associated with thoughts of suicide or self-harm early in treatment for a small number of people under the age of 25. Discuss and create a safety plan.</li>
<li>Caution with driving until impact on the central nervous system (CNS) is known (e.g., sedation, cognitive impairment).</li>
<li>Caution with other CNS-active substances: alcohol, cannabinoids, over-the-counter (OTC) products, etc.</li>
<li>Ask a pharmacist to confirm any known interactions with herbal treatments.</li>
<li>Avoid abrupt discontinuation due to risk of withdrawal symptoms.</li>
</ul>
          </div>
        </div>

      </div>
</article>


<div class="wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex">
<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow"></div>



<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow" style="flex-basis:80%"><article class="block--modal ">

<div class="outer">
  <div class="container">
    <div class="inner has-text-centered">
              <img decoding="async" src="https://tools.cep.health/wp-content/uploads/2019/10/talking-points.svg" alt="" />
                    <h6>Talking tips</h6>
                          <a data-modal="GfxYxe" class="button open-modal" href="#" data-id="GfxYxe">Click to view</a>
          </div>
  </div>
</div>

  <div data-modal="GfxYxe" class="modal">
    <div class="inner text">
      <div class="close-wrapper">
                <a href="" class="close" data-wpel-link="internal">Close</a>
      </div>
      <div class="container">
                <div class="content">
          
                          <h4>Talking tips<sup>3,5</sup></h4>
                                      <p><strong>Onset of effect</strong></p>
<ul>
<li>It may take ___ weeks [depression: 2-4; anxiety: 2-8] to notice some improvement with medication. This is partly because we are starting with a small dose of ___ mg to make sure it’s a good fit for you.</li>
<li>The full benefits will come after you’ve been taking the “target” dose or ___ mg of the medication. Because of this, it may take a total of ___ weeks [depression: 4-8 weeks; anxiety: 6-12 weeks] to notice the full effect.</li>
</ul>
<p><strong>Duration</strong></p>
<ul>
<li>Studies have shown that people do best if they continue medication for __ [depression: 6-9 months from the time they are feeling better; anxiety: 12-24 months]. After that, many people can work with their healthcare provider to reduce the dose of medication over a month or two and eventually stop taking it.</li>
<li>It is important not to stop taking the medication “cold turkey” because you may experience withdrawal symptoms. We can work together to reduce the dose over time so this is less likely to happen.</li>
</ul>
            
                  </div>
      </div>
    </div>
    <div class="overlay"></div>
</div></article></div>



<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow"></div>
</div>


<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h4 class="wp-block-heading" id="side-effect-management"><strong>Side effect management<sup>1, 5</sup></strong></h4>
</div></article>


<div class="wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex">
<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow" style="flex-basis:66.66%"><article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>Medication side effects can lead to significant distress and treatment discontinuation. In extreme cases, these negative experiences may impact a patient’s consideration of another medication or their relationship with their healthcare provider and the healthcare system. Side effects should be discussed with patients before treatment initiation. Consider booking a follow-up appointment within 2 weeks of initiation to discuss side effect management.</p>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading"><strong>Troubleshooting side effects<sup>1, 5</sup></strong></h6>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Consider whether the symptom is a side effect vs the underlying condition or improvement of the condition being treated</li>



<li>Switch the time of day taken</li>



<li>Consider taking the medication with food&nbsp;</li>



<li>Treat the side effect if short-term</li>



<li>Titrate more slowly (and do so in the future too)</li>



<li>Lower the dose</li>



<li>Consider drug interactions</li>



<li><a href="https://link.cep.health/ad32" data-type="URL" data-id="https://link.cep.health/ad32" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Switch medications</a> (see <a href="#firstlinemedoptions" data-type="internal" data-id="#firstlinemedoptions">first-line medications options table</a>)</li>



<li>Consult a pharmacist or expert as needed</li>



<li>Pharmacogenetic testing (if available) may be considered if patients have severe side effects to multiple medications.</li>
</ul>
</div></article></div>



<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow" style="flex-basis:33.33%"><article class="block--modal ">

<div class="outer">
  <div class="container">
    <div class="inner has-text-centered">
              <img decoding="async" src="https://tools.cep.health/wp-content/uploads/2019/10/talking-points.svg" alt="" />
                    <h6>Talking tips</h6>
                          <a data-modal="UGAZRS" class="button open-modal" href="#" data-id="UGAZRS">Click to view</a>
          </div>
  </div>
</div>

  <div data-modal="UGAZRS" class="modal">
    <div class="inner text">
      <div class="close-wrapper">
                <a href="" class="close" data-wpel-link="internal">Close</a>
      </div>
      <div class="container">
                <div class="content">
          
                          <h4>Talking tips<sup>5</sup></h4>
                                      <ul>
<li aria-level="1">Are there side effects that you are worried about?</li>
<li aria-level="1">Some people have side effects for the first few weeks of starting or increasing the dose of their medication. This is why we start with a low dose and increase the dose if and when you are comfortable.</li>
<li aria-level="1">The most common side effects are _____.  For many people, these will settle out as their body gets used to the medication.</li>
<li aria-level="1">I’ll give you some information to help lower the chances of side effects and some tips for how to deal with the side effects. Sometimes, it is as easy as taking with food or switching the time of day that you take the medication. Your pharmacist may have ideas to help.</li>
<li aria-level="1">We can touch base often to adjust the medication and see how it is working for you.</li>
</ul>
            
                  </div>
      </div>
    </div>
    <div class="overlay"></div>
</div></article></div>
</div>


<article class="block--faq "><div class="container">
    <div class="faq-title-wrapper">
        <div class="faq-icon-wrapper">
            <img decoding="async" class="faq-icon" src="https://tools.cep.health/wp-content/uploads/2019/10/Yellow-Notice.svg" alt="" />
        </div>
        <h3 class="faq-title">Specific side effect management for symptoms<sup>1, 5</sup></h3>
    </div>
            <div class="questions">
                                                                <div class="question">
                        <button data-toggle-question class="question-title-wrapper">
                            <h6 class="question-title">Nausea &#038; dyspepsia</h6>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
                        </button>
                        <div class="question-answer">
                            <p><b>Short-term or long-term</b>: usually short-term</p>
<p><strong>Management:</strong></p>
<ul>
<li>Take with food</li>
<li>Consider alternate dose timing</li>
<li>Eat smaller, more frequent meals</li>
<li>Drink plenty of fluids</li>
<li>Switch to another medication or use a long-acting formulation</li>
<li>Short-term use of OTC antacids or antinauseants</li>
</ul>
                        </div>
                    </div>
                                                                                <div class="question">
                        <button data-toggle-question class="question-title-wrapper">
                            <h6 class="question-title">Diarrhea</h6>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
                        </button>
                        <div class="question-answer">
                            <p><b>Short-term or long-term</b>: usually short-term</p>
<p><strong>Management:</strong></p>
<ul>
<li>Take with food</li>
<li>Ensure hydration</li>
<li>Consider alternate dose timing</li>
<li>Short-term use of loperamide</li>
</ul>
                        </div>
                    </div>
                                                                                <div class="question">
                        <button data-toggle-question class="question-title-wrapper">
                            <h6 class="question-title">Constipation</h6>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
                        </button>
                        <div class="question-answer">
                            <p><b>Short-term or long-term</b>: usually short-term</p>
<p><strong>Management:</strong></p>
<ul>
<li>Ensure hydration</li>
<li>Regular exercise</li>
<li>Dietary fibre and laxatives may be used</li>
</ul>
                        </div>
                    </div>
                                                                                <div class="question">
                        <button data-toggle-question class="question-title-wrapper">
                            <h6 class="question-title">Weight gain</h6>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
                        </button>
                        <div class="question-answer">
                            <p><b>Short-term or long-term</b>: long-term</p>
<p><strong>Management:</strong></p>
<ul>
<li>Confirm not due to increased appetite with treatment of mental health condition</li>
<li>Diet and exercise</li>
<li>Switch medication if not manageable</li>
</ul>
                        </div>
                    </div>
                                                                                <div class="question">
                        <button data-toggle-question class="question-title-wrapper">
                            <h6 class="question-title">Drowsiness/fatigue</h6>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
                        </button>
                        <div class="question-answer">
                            <p><b>Short-term or long-term</b>: Usually short-term</p>
<p><strong>Management:</strong></p>
<ul>
<li>Consider dosing at bedtime</li>
<li>Brief nap during the day</li>
<li>Dose reduction</li>
<li>Switch medication if not manageable</li>
</ul>
                        </div>
                    </div>
                                                                                <div class="question">
                        <button data-toggle-question class="question-title-wrapper">
                            <h6 class="question-title">Insomnia</h6>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
                        </button>
                        <div class="question-answer">
                            <p><b>Short-term or long-term</b>: Usually short-term</p>
<p><strong>Management:</strong></p>
<ul>
<li>Consider dosing at morning</li>
<li>Avoid caffeinated food or drinks later in the day</li>
<li>Regular exercise several hours before bedtime</li>
<li>Sleep hygiene</li>
<li>Switch medication if not manageable</li>
</ul>
                        </div>
                    </div>
                                                                                <div class="question">
                        <button data-toggle-question class="question-title-wrapper">
                            <h6 class="question-title">Nightmares</h6>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
                        </button>
                        <div class="question-answer">
                            <p><strong>Management:</strong></p>
<ul>
<li>Consider dosing at morning</li>
</ul>
                        </div>
                    </div>
                                                                                <div class="question">
                        <button data-toggle-question class="question-title-wrapper">
                            <h6 class="question-title">Agitation/anxiety</h6>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
                        </button>
                        <div class="question-answer">
                            <p><b>Short-term or long-term</b>: usually short-term</p>
<p><strong>Management:</strong></p>
<ul>
<li>Consider dosing in morning</li>
<li>If agitation/anxiety occur further dose increases should be done with caution</li>
<li>If agitation/anxiety are bothersome or not resolving, consider alternative agents</li>
<li>The risks &amp; benefits of short-term benzodiazepines may be considered for SSRI-related activation in select patients with anxiety.<sup>7</sup> See “<a href="#Role-of-benzodiazepines">role of benzodiazepines for anxiety disorders</a>”. Consider consulting an expert</li>
</ul>
                        </div>
                    </div>
                                                                                <div class="question">
                        <button data-toggle-question class="question-title-wrapper">
                            <h6 class="question-title">Sexual side effects</h6>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
                        </button>
                        <div class="question-answer">
                            <p><b>Short-term or long-term</b>: short or long-term</p>
<p><strong>Management:</strong></p>
<ul>
<li>Confirm not due to underlying condition(s)</li>
<li>Wait and watch for improvement</li>
<li>Take a once-daily dose after sexual activity</li>
<li>Lower the dose</li>
<li>Switch medication if not manageable (switch to bupropion or mirtazapine)</li>
<li>Conflicting evidence for adjunct bupropion</li>
</ul>
                        </div>
                    </div>
                                                                                <div class="question">
                        <button data-toggle-question class="question-title-wrapper">
                            <h6 class="question-title">Headache</h6>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
                        </button>
                        <div class="question-answer">
                            <p><b>Short-term or long-term</b>: usually short-term</p>
<p><strong>Management:</strong></p>
<ul>
<li>Consider switching dose timing</li>
</ul>
                        </div>
                    </div>
                                                                                <div class="question">
                        <button data-toggle-question class="question-title-wrapper">
                            <h6 class="question-title">Other anticholinergic side effects (urinary retention, dry eyes, cognitive changes, etc.)
</h6>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
                        </button>
                        <div class="question-answer">
                            <p><b>Short-term or long-term</b>: long-term</p>
<p><strong>Management:</strong></p>
<ul>
<li>Ensure hydration</li>
<li>Reduce dose or consider switching medications</li>
</ul>
                        </div>
                    </div>
                                                                                <div class="question">
                        <button data-toggle-question class="question-title-wrapper">
                            <h6 class="question-title">Emotional blunting</h6>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
                        </button>
                        <div class="question-answer">
                            <p><b>Short-term or long-term</b>: short or long-term</p>
<p><strong>Management:</strong></p>
<ul>
<li>Exercise and outdoor activities</li>
<li>Diet and exercise</li>
<li>Work with a therapist</li>
<li>Reduce dose or consider switching medications</li>
</ul>
                        </div>
                    </div>
                                                                                <div class="question">
                        <button data-toggle-question class="question-title-wrapper">
                            <h6 class="question-title">Orthostatic hypotension</h6>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
                        </button>
                        <div class="question-answer">
                            <p><b>Short-term or long-term</b>: short or long-term</p>
<p><strong>Management:</strong></p>
<ul>
<li>Provide education on how to identify and manage</li>
<li>Keep a glass of water at the bedside to drink when waking</li>
<li>Get up gradually from sitting or lying down</li>
<li>Perform leg pumps before getting up</li>
<li>Reduce dose or consider switching medications<sup>31</sup></li>
</ul>
                        </div>
                    </div>
                                                                                <div class="question">
                        <button data-toggle-question class="question-title-wrapper">
                            <h6 class="question-title">Dry mouth</h6>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
                        </button>
                        <div class="question-answer">
                            <p><b>Short-term or long-term</b>: short-term</p>
<p><strong>Management:</strong></p>
<ul>
<li>Sip water regularly</li>
<li>Chew sugarless gum or suck on sugarless candy/ice</li>
<li>Avoid tobacco, alcohol and caffeinated beverages</li>
<li>Breathe through nose</li>
<li>Dental hygiene</li>
<li>Reduce dose or switch medication if not manageable</li>
<li>Use an OTC artificial saliva product</li>
</ul>
                        </div>
                    </div>
                                    </div>
    </div></article>

<article class="block--faq "><div class="container">
    <div class="faq-title-wrapper">
        <div class="faq-icon-wrapper">
            <img decoding="async" class="faq-icon" src="https://tools.cep.health/wp-content/uploads/2020/05/stop.svg" alt="" />
        </div>
        <h3 class="faq-title">Warnings and precautions</h3>
    </div>
            <div class="questions">
                                                                <div class="question">
                        <button data-toggle-question class="question-title-wrapper">
                            <h6 class="question-title">Falls and fractures</h6>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
                        </button>
                        <div class="question-answer">
                            <p>An association with falls and fractures has been noted for patients taking SSRIs long-term. The risk of fractures has been noted to be elevated in the first 6 weeks of treatment.<sup>1</sup></p>
<p>Management: Provide education and strategies to lower the general risk as relevant for the patient.<sup>5</sup></p>
                        </div>
                    </div>
                                                                                <div class="question">
                        <button data-toggle-question class="question-title-wrapper">
                            <h6 class="question-title">GI Bleeding</h6>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
                        </button>
                        <div class="question-answer">
                            <p>SSRIs have been associated with an increased risk of upper GI bleeding, especially in older adults, patients with a history of GI bleeding and patients taking other agents that may increase risk (e.g., non-steroidal anti-inflammatory drugs, steroids).</p>
<p>Management: Educate regarding this potential side effect and consider a gastroprotective agent if an SSRI is chosen for these patients.<sup>1, 2</sup></p>
<p>&nbsp;</p>
                        </div>
                    </div>
                                                                                <div class="question">
                        <button data-toggle-question class="question-title-wrapper">
                            <h6 class="question-title">Hyponatremia</h6>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
                        </button>
                        <div class="question-answer">
                            <p>Older adults may be at a higher risk of hyponatremia with SSRIs.<sup>1</sup></p>
<p>Management: Caution when using with older adults and in patients taking other agents that lower sodium. Consider baseline serum sodium levels and repeat at 2-4 weeks. Thereafter repeat yearly or as appropriate.<sup>5</sup></p>
                        </div>
                    </div>
                                                                                <div class="question">
                        <button data-toggle-question class="question-title-wrapper">
                            <h6 class="question-title">QTc prolongation</h6>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
                        </button>
                        <div class="question-answer">
                            <p>In the absence of known risk factors, the risk of Torsades de Pointes (TdP) is very low.<sup>1</sup> However, when other risk factors exist, the risk of TdP may occur at even low therapeutic doses of antidepressants and has even occurred with QTc intervals within the normal range.<sup>1</sup></p>
<p>Management: For QT-prolonging antidepressants, request an ECG if the patient has risk factors, such as a history of Tdp, arrhythmias, chronic kidney disease and age.<sup>5</sup></p>
                        </div>
                    </div>
                                                                                <div class="question">
                        <button data-toggle-question class="question-title-wrapper">
                            <h6 class="question-title">Serotonin syndrome</h6>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
                        </button>
                        <div class="question-answer">
                            <p>While serotonin syndrome is rare, it can occur in cases of overdose or when multiple serotonergic agents are used (e.g., SSRIs, SNRIs, TCAs, tramadol, OTC products).<sup>1</sup></p>
<p><a href="https://link.cep.health/ad33" data-type="URL" data-id="https://link.cep.health/ad33" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Serotonin Syndrome Patient handout from UWaterloo Pharmacy 5-in5</a></p>
<p>Management: Particular caution should be taken when changing or adding another serotonergic agent, especially if the agent being discontinued has a long half-life (e.g., fluoxetine).<sup>8</sup> Educate the patient and monitor for signs and symptoms.<sup>5</sup></p>
                        </div>
                    </div>
                                                                                <div class="question">
                        <button data-toggle-question class="question-title-wrapper">
                            <h6 class="question-title">Suicide risk</h6>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
                        </button>
                        <div class="question-answer">
                            <p><span class="TextRun SCXW114549792 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="none"><span class="NormalTextRun SCXW114549792 BCX0">Antidepressants have been associated with thoughts of suicide or self-harm early in treatment or a small number of people under the age of 25</span></span>. Weekly monitoring should be employed with treatment initiation until the condition has stabilized. Discuss and create a safety plan.<sup>1</sup> <em>See <a href="#suiciderisk"><strong>Emergency Support and Suicide Prevention</strong></a>.</em></p>
                        </div>
                    </div>
                                    </div>
    </div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h3 class="wp-block-heading" id="Special-populations">Special populations</h3>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h4 class="wp-block-heading" id="specialpop-peri/postnatal">Peri/post natal</h4>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>This section pertains to patients who develop depression or anxiety while trying to conceive or who are pregnant or breastfeeding. This section excludes patients who have postpartum depression. At the time of pregnancy, all medications should be reviewed (i.e., by a peripartum psychiatrist). Patients who are already receiving SSRI treatment should not be taken off of their treatment medication(s) when they become pregnant.<sup>5</sup> &nbsp;A shared decision-making approach should consider the risks and benefits of pharmacological management, including the risks of not treating. In cases of high risk or uncertainty, there should be a low threshold for referral to an expert for support (<a href="https://link.cep.health/ad65" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">OTN eConsult</a>).</p>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading">Psychological management</h6>
</div></article>


<div class="wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex">
<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow"><article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong>Anxiety</strong> </p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Despite the lack of data on the efficacy of psychological interventions in perinatal patients with anxiety disorders, CBT or behavioural therapy are considered safe alternatives during pregnancy.<sup>7</sup></li>
</ul>
</div></article></div>



<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow"><article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong>Depression</strong> (excluding postpartum depression)</p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>For patients who wish to become pregnant, are pregnant, or are breastfeeding, depression-focused psychological interventions alone are recommended. Depending on the severity of symptoms, depression-focused psychological interventions should be considered the first-line treatment.</li>



<li>First-line treatment for mild to moderate antenatal depression: CBT or IPT.<sup>1</sup></li>
</ul>
</div></article></div>
</div>


<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading">Pharmacological management</h6>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong>Anxiety and Depression (excluding postpartum depression)</strong></p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>Before prescribing medication, weigh the risks of pharmacological treatment to the fetus and newborn against the potential risks of untreated anxiety and depression.<sup>1,7</sup> Refer to the <a href="https://link.cep.health/ad66" data-type="URL" data-id="https://link.cep.health/ad66" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">LactMed®</a> database for information on exposure to medications and during lactation.&nbsp;Refer to <a href="https://link.cep.health/ad85" data-type="URL" data-id="https://link.cep.health/ad85" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Medicines in Pregnancy</a> for information on exposure to medications during pregnancy.</p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>Special considerations:</p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>In pregnant patients, if pharmacological treatment is indicated, citalopram, escitalopram, and sertraline are preferred second-line treatments after CBT or IPT.<sup>1</sup> Valproate and paroxetine must not be used.<sup>7,10</sup></li>



<li>Empower patients and encourage them to think about their treatment as an important element of their health and wellness and their child&#8217;s.<sup>5</sup></li>



<li>In breastfeeding patients, if pharmacological treatment is indicated, sertraline or paroxetine are preferred. Despite the limited evidence, the excretion of such prescription medication in breast milk results in very low amounts being transferred to the baby and few isolated instances of adverse events.<sup>7</sup></li>



<li>Refer to the pharmacy with a prescription, noting that the patient is breastfeeding and request that they be counselled.<sup>5</sup>&nbsp;</li>



<li>St. John’s Wort must not be used in pregnant and breastfeeding women.<sup>10</sup></li>
</ul>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong>Depression</strong> <strong>(excluding postpartum depression)</strong></p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>First-line treatment for severe antenatal depression: pharmacological treatment, either alone or in combination with CBT or IPT.<sup>1</sup></li>
</ul>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h4 class="wp-block-heading" id="specialpop-olderadults">Older adults</h4>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>Depression and anxiety disorders are commonly present simultaneously present among patients aged 65 or older.<sup>7</sup> Determine the onset of depression. Late-onset depression is more chronic with a higher relapse rate and higher levels of medical comorbidity, cognitive impairment and mortality.<sup>1</sup> Monitor cognition at the initial assessment and over time. Late-onset depression might be an early symptom of dementia.<sup>1</sup></p>
</div></article>

<article class="block--background  core-block" data-block-name="cep/background"><div class="container">
<div class="wp-block-cep-background is-style-red-background"><article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p class="is-style-default"><strong>Medications and risks</strong><br>Before prescribing medication, weigh the risks associated with antidepressant use against their potential benefits.</p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p class="is-style-default">Consider pharmacokinetic changes with aging and patient factors such as hepatic and renal function and body mass. Also consider comorbidities and the use of other medications which could increase the risk of side effects (e.g., anticholinergic, sedation, orthostatic hypotension, and neurological effects).<sup>1, 7, 30</sup></p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p class="is-style-default">Due to these pharmacokinetic changes, including an increased risk of&nbsp; impaired balance and falls early in treatment, initiate older adults at a low dose and increase doses slowly with regular follow-up.<sup>30</sup></p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p class="is-style-default">When prescribing an SSRI or SNRI, patients should be screened for hyponatremia. A serum level should be obtained before starting medication if there is a positive history. In general, a serum sodium level should be done within 2-4 weeks of initiating an SSRI or SNRI.<sup>32</sup></p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p class="is-style-default">Risks:&nbsp;</p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Increased susceptibility to adverse drug events and drug-drug interactions<sup>7</sup></li>



<li>Increased risk of&nbsp; impaired balance and falls early in treatment<sup>30</sup></li>



<li>Increased risk of fractures<sup>7</sup></li>



<li>Increased risk of mortality in older patients with dementia<sup>7</sup></li>



<li>Increased risk of rare side effects such as bone loss, serotonin syndrome, extrapyramidal side effects, and neuroleptic malignant syndrome<sup>1</sup></li>
</ul>
</div></article></div>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading">Psychological management</h6>
</div></article>


<div class="wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex">
<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow"><article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong>Anxiety</strong> (the efficacy of psychological and pharmacological treatments is similar)<sup>7</sup></p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Relaxation training</li>



<li>CBT (with learning- and memory-aids)</li>



<li>Supportive therapy</li>



<li>Cognitive therapy</li>



<li>Exercise for prevention<sup>7</sup></li>
</ul>
</div></article></div>



<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow"><article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong>Depression</strong> </p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Problem-solving therapy: discrete, time-limited, structured psychological intervention that focuses on learning to cope with specific problem areas and where therapist and patient work collaboratively to identify and prioritize key problem areas.<sup>10</sup></li>



<li>Interventions that reduce social isolation and loneliness (e.g., reminiscence therapy, physical exercise programs, video conferences with family, horticultural therapy and gender-based social groups)<sup>32</sup></li>



<li>Social prescribing (referring patients with social, emotional and practical needs to local, non-clinical services typically from the voluntary or community sectors)<sup>32</sup></li>



<li>Increased physical activity (e.g., Fountain of Health)<sup>32</sup></li>
</ul>
</div></article></div>
</div>


<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading" id="pharmamanagement">Pharmacological management</h6>
</div></article>


<div class="wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex">
<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow"><article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong>Anxiety</strong> (the efficacy of psychological and pharmacological treatments is similar).<sup>7</sup></p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>Medication has similar effectiveness as in younger adults.<sup>7</sup></p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>First-line: escitalopram, citalopram, sertraline, or venlafaxine.<sup>40</sup></li>



<li>Second-line: duloxetine or buspirone.<sup>40</sup></li>
</ul>
</div></article></div>



<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow"><article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong>Depression</strong> </p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>First-line: sertraline or duloxetine.<sup>32</sup></li>



<li>Second-line: escitalopram or citalopram (must be balanced with concerns around QTc prolongation). Other appropriate options may include venlafaxine, bupropion, and mirtazapine.<sup>32</sup></li>
</ul>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>Note: A serum sodium level should be done within 2–4 weeks of initiating SSRI or SNRI antidepressants.<sup>32</sup></p>
</div></article></div>
</div>
						</div>
					</div>
				</section>
							<section class="main-section" id="follow-up-monitoring" tabindex="-1">
					<div class="head">
						<div class="container">
							<h2 class="main-heading">
								Follow-up/monitoring								
							</h2>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
						</div>
					</div>
					<div class="body">
						<div class="container">
							<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h4 class="wp-block-heading">Jump to:</h4>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><a href="#depression" data-type="internal" data-id="#depression">Depression</a><br><a href="#anxiety" data-type="internal" data-id="#anxiety">Anxiety</a><br><a href="#discontinuationandwithdrawal" data-type="internal" data-id="#discontinuationandwithdrawal">Discontinuation &amp; withdrawal symptoms for anxiety and depression</a></p>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h3 class="wp-block-heading" id="depression">Depression</h3>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h5 class="wp-block-heading"><strong>Overall approach</strong><sup>4,5</sup></h5>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>Follow-up frequency for patients using pharmacological treatment:<sup>4</sup>&nbsp;</p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>First 6 weeks OR until response and tolerability are established: at least every 2 weeks</li>



<li>After 6 weeks OR after response and tolerability are confirmed: every 4 weeks</li>
</ul>
</div></article>

<article class="block--image  core-block" data-block-name="core/image"><div class="container">
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="2560" height="1649" src="https://tools.cep.health/wp-content/uploads/2024/12/Follow-up-monitoring_Depression.jpg" alt="" class="wp-image-67235" style="width:1450px;height:auto" srcset="https://tools.cep.health/wp-content/uploads/2024/12/Follow-up-monitoring_Depression.jpg 2560w, https://tools.cep.health/wp-content/uploads/2024/12/Follow-up-monitoring_Depression-300x193.jpg 300w, https://tools.cep.health/wp-content/uploads/2024/12/Follow-up-monitoring_Depression-1024x660.jpg 1024w, https://tools.cep.health/wp-content/uploads/2024/12/Follow-up-monitoring_Depression-768x495.jpg 768w, https://tools.cep.health/wp-content/uploads/2024/12/Follow-up-monitoring_Depression-1536x989.jpg 1536w, https://tools.cep.health/wp-content/uploads/2024/12/Follow-up-monitoring_Depression-2048x1319.jpg 2048w, https://tools.cep.health/wp-content/uploads/2024/12/Follow-up-monitoring_Depression-1677x1080.jpg 1677w, https://tools.cep.health/wp-content/uploads/2024/12/Follow-up-monitoring_Depression-1118x720.jpg 1118w, https://tools.cep.health/wp-content/uploads/2024/12/Follow-up-monitoring_Depression-640x412.jpg 640w" sizes="auto, (max-width: 2560px) 100vw, 2560px" /></figure>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading"><strong>Ongoing treatment options&nbsp;</strong></h6>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong>Treatment response:</strong><br>At least a 50% reduction in the patient’s baseline score on a validated depression rating scale indicates early improvement/response to antidepressant treatment. The evidence is mixed regarding the benefits of switching at 2-4 weeks for non-response to the first antidepressant tried.<sup>1</sup>&nbsp;Whereas symptom remission is when the patient’s score is in the nondepressed range.<sup>1</sup></p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong>Partial or non-response:<sup>1, 5, 28</sup></strong><br>Ask: Is the treatment being taken as prescribed?</p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li><em>No:</em> explore reasons why not and provide support. Adjust treatment plan if needed</li>



<li><em>Yes:&nbsp;</em><article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Consider:<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Is the diagnosis correct?</li>



<li>Factors that may complicate response (e.g., social factors, comorbid conditions, drug interactions)</li>
</ul>
</div></article></li>



<li>Consider increasing the dose of medication if:<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>The target dose has not been reached</li>



<li>The medication is being tolerated well</li>



<li>This is not the first medication tried</li>



<li>Functional deficit and symptoms are mild (no urgency for effect)</li>



<li>The patient is comfortable with increasing the dose</li>
</ul>
</div></article></li>



<li>Note: less frequent dose increases may be preferable for patients who are anxious or medically compromised&nbsp;</li>



<li>Review opportunities to switch to, intensify, or add non-pharmacological treatment, including psychological interventions, exercise and light therapy. See <a href="#psychdepressionpng" data-type="internal" data-id="#psychdepressionpng">Psychological treatment options</a> for depression.</li>



<li>If the above options not preferred, an adjunctive medication or medication switch can be considered as follows:<sup>1,5</sup></li>
</ul>
</div></article></li>
</ul>
</div></article>


<div class="wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex">
<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow"><article class="block--background  core-block" data-block-name="cep/background"><div class="container">
<div class="wp-block-cep-background is-style-blue-background"><article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading is-style-blue-background" id="adjunt-switch">Adjunct</h6>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong>When to consider:</strong></p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Not the first antidepressant tried</li>



<li>Tolerated well</li>



<li>&gt;25% improvement on symptom scale</li>



<li>Urgency for efficacy (severe symptoms)</li>



<li>Additional symptoms that could be addressed by an additional drug</li>



<li>The patient prefers to add-on</li>
</ul>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong>Advantages</strong></p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Fast onset for effectiveness</li>



<li>More convenient to start</li>



<li>Easier for a provider to implement</li>



<li>Able to target symptoms not fully addressed</li>
</ul>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong>Disadvantages</strong></p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Higher CNS load</li>



<li>Risk of additive side effects</li>



<li>High interaction risk</li>



<li>Likely less convenient overall (2 drugs)</li>



<li>Possibly higher cost</li>



<li>Less certainty of effect</li>



<li>Harder to discontinue (2 drugs)</li>
</ul>
</div></article></div>
</div></article></div>



<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow"><article class="block--background  core-block" data-block-name="cep/background"><div class="container">
<div class="wp-block-cep-background is-style-blue-background"><article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading">Switch</h6>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong>When to consider:</strong></p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>First antidepressant tried</li>



<li>Bothersome side effects</li>



<li>&lt;25% improvement on symptom scale</li>



<li>No urgency for efficacy</li>



<li>No additional symptoms being targeted</li>



<li>The patient prefers to switch</li>
</ul>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong>Advantages</strong></p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Lower overall CNS load</li>



<li>Low interaction risk (high to start)</li>



<li>Likely more convenient overall (1 drug)</li>



<li>Possibly lower cost</li>



<li>More certainty of effect</li>



<li>Easier to discontinue (1 drug)</li>
</ul>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong>Disadvantages</strong></p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Slow onset for effectiveness</li>



<li>Risk of additive side effects</li>



<li>Risk of withdrawal&nbsp;</li>



<li>Less convenient to start</li>



<li>Harder for a provider to implement</li>
</ul>
</div></article></div>
</div></article></div>
</div>


<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><sub>*For the initial antidepressant trial. In subsequent trials, lack of response (&lt;25% improvement) may not be a factor for choosing between switch and adjunctive strategies</sub></p>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading" id="adjunctivemeds"><strong>First-line adjunctive medication options for depression</strong><sup>1,27,29,33,39</sup></h6>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>The evidence and recommendations for adjunctive treatment strategies are mixed and must be balanced with the risk of adding an additional medication.<sup>1,28</sup> The following medications are considered first-line adjunctive agents in the CANMAT 2023 MDD Guidelines.<sup>1</sup> Other options include an alternative class of antidepressant.<sup>6,28</sup> Consider patient and medication factors in the approach to adjunct medication selection. If you have questions about adjunctive medications, consult a pharmacist or specialist through <a href="https://link.cep.health/ad83" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">eConsult</a>.</p>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading" id="atypical-antipsychotics">Atypical antipsychotics<strong><sup>1,5,33</sup></strong><sup>,39</sup></h6>
</div></article>

<article class="block--drug-options ">
<div class="container">
  <h5><span style="font-size: 13.5px;">Scroll (left-right) for details</h5>
          <div class="slider">
        <div class="inner-stage">
          <ul>
            
                <li>
                  <div class="inner">
                    <span class="subhead">Atypical antipsychotics</span>
                    <h6>Aripiprazole (Abilify®)</h6>
                    <p>2 mg, 5 mg, 10 mg, 15 mg, 20 mg, 30 mg tablet</p>
<p><strong>Coverage </strong></p>
<ul>
<li>ODB ✓</li>
<li>NIHB ✓</li>
</ul>
<p><b>Cost for usual dose ($/100 days)</b></p>
<ul>
<li>$96-146</li>
</ul>
<p><b>Overall tolerability*</b></p>
<ul>
<li aria-level="1">Neutral</li>
</ul>
<p><b>Activating or sedating</b></p>
<ul>
<li aria-level="1">Activating &gt; sedating</li>
</ul>
<p><b>Interaction risk</b></p>
<ul>
<li>++</li>
</ul>
<p><b>Features**</b></p>
<ul>
<li aria-level="1">Useful if there is comorbid psychosis</li>
</ul>
                                            <a class="button open-modal" href="#" data-modal="1LJJCk">View dosing, side effects and warnings</a>
                                      </div>
                                      <div class="modal" data-modal="1LJJCk">
                      <div class="inner ">
                        <div class="close-wrapper">
                          <a href="" class="close" data-wpel-link="internal">Close</a>
                        </div>
                        <div class="container">
                          <div class="content">
                                                          <h4>Aripiprazole (Abilify®)</h4>
                                                                                      <h6><strong>Dosing</strong></h6>
<ul>
<li>Initial: 2-5 mg daily</li>
<li>Titration: Increase gradually by ≤ 5 mg daily, at intervals of ≥ 1 week</li>
<li>Usual: 5-15 mg daily</li>
<li>Max: 15 mg daily</li>
</ul>
<h6><strong>Common side effects</strong></h6>
<ul>
<li aria-level="1"><b>CNS:</b> akathisia, restlessness, fatigue, insomnia, somnolence</li>
<li aria-level="1"><b>Anticholinergic:</b> blurred vision, constipation</li>
</ul>
<h6><strong>Warnings</strong></h6>
<ul>
<li aria-level="1">Increased mortality, cerebrovascular events, dysphagia and other treatment-emergent side effects in older adults with dementia.</li>
<li aria-level="1">Caution in older adults due to changes in pharmacodynamic response.</li>
<li aria-level="1">Caution in patients who have Parkinson’s disease or dementia with Lewy Bodies.</li>
<li aria-level="1"><b>General: </b>disruption of body temperature regulation, falls, carcinogenicity (animal models), fertility impairment (animal models), dependence/tolerance</li>
<li aria-level="1"><b>Cardiovascular: </b>orthostatic hypotension (especially in elderly), tachycardia, syncope, arrhythmias including 1st-degree AV block, hypotension, QT prolongation</li>
<li aria-level="1"><b>Endocrine and metabolism:</b> hyperglycemia and Diabetes Mellitus, dyslipidemia, weight gain (lower risk than quetiapine and risperidone)</li>
<li aria-level="1"><b>Genitourinary:</b> priapism</li>
<li aria-level="1"><b>Hematologic: </b>leukopenia, neutropenia and agranulocytosis, venous thromboembolism</li>
<li aria-level="1"><b>Neurologic:</b> Extrapyramidal symptoms, Neuroleptic Malignant Syndrome, potential effect on cognitive and motor performance, seizures, tardive dyskinesia</li>
<li aria-level="1"><b>Psychiatric:</b> suicide, pathological gambling and other impulse-control disorders</li>
<li aria-level="1"><b>Skin:</b> Severe cutaneous adverse events</li>
</ul>
                                                      </div>
                        </div>
                      </div>
                      <div class="overlay"></div>
                    </div>
                                  </li>

            
                <li>
                  <div class="inner">
                    <span class="subhead">Atypical antipsychotics</span>
                    <h6>Brexpiprazole (Rexulti®)</h6>
                    <p>0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg tablet</p>
<p><strong>Coverage </strong></p>
<ul>
<li>ODB ✓</li>
<li>NIHB ✓</li>
</ul>
<p><b>Cost for usual dose ($/100 days)</b></p>
<ul>
<li>$398</li>
</ul>
<p><b>Overall tolerability*</b></p>
<ul>
<li aria-level="1">Neutral</li>
</ul>
<p><b>Activating or sedating</b></p>
<ul>
<li aria-level="1">Activating&gt; sedating</li>
</ul>
<p><b>Interaction risk</b></p>
<ul>
<li>++</li>
</ul>
<p><b>Features**</b></p>
<ul>
<li aria-level="1">Useful if there is comorbid psychosis</li>
</ul>
                                            <a class="button open-modal" href="#" data-modal="o6OIpt">View dosing, side effects and warnings</a>
                                      </div>
                                      <div class="modal" data-modal="o6OIpt">
                      <div class="inner ">
                        <div class="close-wrapper">
                          <a href="" class="close" data-wpel-link="internal">Close</a>
                        </div>
                        <div class="container">
                          <div class="content">
                                                          <h4>Brexpiprazole (Rexulti®)</h4>
                                                                                      <h6><strong>Dosing</strong></h6>
<ul>
<li>Initial: 0.5 mg or 1 mg once daily</li>
<li>Titration: Increase gradually at weekly intervals based on clinical response and tolerability to 1 mg once daily, then 2 mg once daily</li>
<li>Usual: 2 mg daily</li>
<li>Max: 2 mg daily</li>
</ul>
<h6><strong>Common side effects</strong></h6>
<ul>
<li><b>CNS:</b> akathisia, restlessness, fatigue, insomnia, somnolence</li>
<li><b>GI:</b> diarrhea, dyspepsia, dry mouth, abdominal pain</li>
<li><strong>Musculoskeletal:</strong> back pain, pain in extremity, muscle pain</li>
</ul>
<h6><strong>Warnings</strong></h6>
<ul>
<li aria-level="1">Increased mortality, cerebrovascular events, dysphagia and other treatment-emergent side effects in older adults with dementia</li>
<li aria-level="1">Caution in older adults due to changes in pharmacodynamic response</li>
<li aria-level="1">Caution in patients who have Parkinson’s disease or dementia with Lewy Bodies</li>
<li aria-level="1"><b>General: </b>disruption of body temperature regulation, falls, carcinogenicity (animal models), fertility impairment (animal models), dependence/tolerance</li>
<li aria-level="1"><b>Cardiovascular: </b>orthostatic hypotension (especially in elderly), tachycardia, dizziness, syncope, hypotension, QT prolongation</li>
<li aria-level="1"><b>Endocrine &amp; metabolism:</b> hyperglycemia and Diabetes Mellitus, dyslipidemia, weight gain (lower risk than quetiapine and risperidone), hyperprolactinemia</li>
<li aria-level="1"><b>Genitourinary:</b> priapism</li>
<li aria-level="1"><b>Hematologic: </b>leukopenia, neutropenia and agranulocytosis, venous thromboembolism</li>
<li aria-level="1"><b>Neurologic:</b> Extrapyramidal symptoms, Neuroleptic Malignant Syndrome, potential effect on cognitive and motor performance, seizures, tardive dyskinesia</li>
<li aria-level="1"><b>Psychiatric:</b> suicide, pathological gambling and other impulse-control disorders</li>
<li aria-level="1"><strong>Skin:</strong> severe cutaneous adverse events</li>
<li aria-level="1"><strong>Other:</strong> tablets contain lactose</li>
</ul>
                                                      </div>
                        </div>
                      </div>
                      <div class="overlay"></div>
                    </div>
                                  </li>

                      </ul>
        </div>
      </div>
    </div>
</article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><sub>*Overall tolerability is based on availability of evidence that primarily evaluates drop-out rates from trials. Specific drug side effects and patient factors may influence overall tolerability in practice.<br>**Consider in addition to other patient and medication factors</sub></p>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading"><strong>Guidance for switching medications</strong></h6>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong>Drug selection: </strong></p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>There is a paucity of evidence to guide whether to switch to an alternate first-line drug within the same class versus switching to a different class of first-line medication after the first medication is tried.<sup>1</sup></p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong>Consider:</strong></p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Reasons for switching (e.g., tolerability or lack of effect)</li>



<li>Specific features of alternate options as they pertain to your patient’s clinical picture</li>
</ul>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong>Cross-tapering:</strong></p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>Due to the risk of additive side effects, serotonin syndrome, withdrawal effects and drug interactions, consider asking a pharmacist or clinical expert for support with cross-tapers.<sup>5</sup></p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>The <a href="https://link.cep.health/ad32" data-type="URL" data-id="https://link.cep.health/ad32" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Switchrx.com</a> website offers some general medication-related guidance.&nbsp;See <a href="#firstlinemedoptions" data-type="internal" data-id="#firstlinemedoptions">first-line medications</a> table. </p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>Cross-tapers may occur over weeks or months depending on several factors, including:<sup>5</sup></p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>How long has the patient been taking the medication?</li>



<li>Urgency of completing the cross taper (e.g., severity of mental health condition and side effects)?</li>



<li>What is the risk of destabilizing the mental health condition with changes based on the patient’s clinical factors?</li>



<li>What is the half-life of the drug involved?</li>



<li>What is the propensity for withdrawal effects with the medications involved?</li>



<li>What is the risk of side effects with the new medication?</li>



<li>What drug interactions may impact the taper?</li>



<li>What is the patient’s preference?</li>
</ul>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong>Putting it into practice:<sup>5</sup></strong></p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Develop a plan with the patient. Consider including an expert in pharmacological treatment options (e.g., pharmacist, mental health expert).</li>



<li>Discuss the risks and benefits of the plan with the patient&nbsp;</li>



<li>Provide the cross-taper plan in writing.&nbsp;</li>



<li>Provide guidance for side effect management of the new medication and any potential withdrawal effects of the medication being stopped (<a href="#discontinuationandwithdrawal" data-type="internal" data-id="#discontinuationandwithdrawal">see discontinuation and withdrawal symptoms</a>) if relevant.</li>



<li>Discuss serotonin syndrome symptoms if multiple serotonergic medications are involved in the cross-taper (see <a href="#sideeffectmanagement" data-type="internal" data-id="#sideeffectmanagement">warnings and precautions: serotonin syndrome under side effect management</a>).</li>



<li>Follow-up within 1 week of each dose change to review side effects and symptoms.</li>
</ul>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h3 class="wp-block-heading" id="anxiety">Anxiety</h3>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h5 class="wp-block-heading"><strong>Overall approach</strong><sup>1,3,5,7,8,11</sup></h5>
</div></article>

<article class="block--image  core-block" data-block-name="core/image"><div class="container">
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="619" src="https://tools.cep.health/wp-content/uploads/2024/12/Follow-up-monitoring_Anxiety-1-1024x619.png" alt="" class="wp-image-67234" srcset="https://tools.cep.health/wp-content/uploads/2024/12/Follow-up-monitoring_Anxiety-1-1024x619.png 1024w, https://tools.cep.health/wp-content/uploads/2024/12/Follow-up-monitoring_Anxiety-1-300x181.png 300w, https://tools.cep.health/wp-content/uploads/2024/12/Follow-up-monitoring_Anxiety-1-768x465.png 768w, https://tools.cep.health/wp-content/uploads/2024/12/Follow-up-monitoring_Anxiety-1-1536x929.png 1536w, https://tools.cep.health/wp-content/uploads/2024/12/Follow-up-monitoring_Anxiety-1-1190x720.png 1190w, https://tools.cep.health/wp-content/uploads/2024/12/Follow-up-monitoring_Anxiety-1-640x387.png 640w, https://tools.cep.health/wp-content/uploads/2024/12/Follow-up-monitoring_Anxiety-1.png 1698w" sizes="auto, (max-width: 1024px) 100vw, 1024px" /></figure>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading"><strong>Ongoing treatment options</strong></h6>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong>Treatment response: </strong></p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>A 25-50% reduction in the patient’s score on a validated disorder-specific rating scale indicates response to treatment. Whereas symptom remission is when the patient loses diagnostic status and has no functional impairment.<sup>7</sup></p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong>Partial or non-response:<sup>3, 5, 7</sup></strong></p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>Ask: Is the treatment being taken as prescribed?</p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li><em>No:</em> explore reasons why not and provide support. Adjust treatment plan if needed</li>



<li><em>Yes:&nbsp;</em><article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Review options for intensifying psychological treatment&nbsp;</li>



<li>Consider increasing the dose of medication to condition-related target* if:<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>The target dose has not been reached</li>



<li>The medication is being tolerated well</li>



<li>This is not the first medication tried</li>



<li>Functional deficit and symptoms are mild (no urgency for effect)</li>



<li>The patient is comfortable with increasing the dose</li>
</ul>
</div></article></li>



<li>If increasing is not preferred, switching to an alternate medication is recommended (see guidance for switching medications).</li>
</ul>
</div></article></li>
</ul>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>*While initial medication dosing for anxiety is often lower than dosing for depression, the usual and maximum doses for anxiety are sometimes higher than those used for depression (<a href="#atypical-antipsychotics" data-type="internal" data-id="#atypical-antipsychotics">see drug cards</a>).</p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>Adjunctive treatment is generally reserved for second-line management after multiple first-line agents have been tried.<sup>7</sup> A clinical expert should be consulted in cases where second-line treatment or second-line adjunctive therapy is being considered.<sup>3</sup></p>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading"><strong>Duration of <strong>pharmacological treatment</strong></strong></h6>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong>Anxiety<sup>7</sup></strong></p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>Treatment should be continued for at least 12 to 24 months to maintain symptom remission and prevent relapse.</p>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading"><strong>Discontinuation guidance</strong></h6>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>Due to the risk of withdrawal symptoms, the dose of medication should generally be gradually reduced over an extended period. This may be weeks or months, depending on the duration of treatment, the medication involved, and patient factors.<sup>5</sup></p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>If a medication is being stopped to switch to another antidepressant due to lack of effectiveness or side effects, dose reductions may be done more quickly (e.g., over days). Symptoms emerging during the transition period may be due to either discontinuation/withdrawal effects OR side effects to the new medication.</p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>A pharmacist or mental health expert can be helpful in providing guidance as it relates to the individual drug and patient.&nbsp;</p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>The website <a href="https://link.cep.health/ad36" data-type="URL" data-id="https://link.cep.health/ad36" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Medstopper.com</a> offers advice regarding tapering plans and possible withdrawal symptoms.&nbsp;</p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>Putting it into practice:<sup>5</sup></p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Develop a plan with the patient. Consider including an expert in pharmacological treatment options (e.g., pharmacist, mental health expert).</li>



<li>Discuss the risks and benefits of the plan with the patient.&nbsp;</li>



<li>Provide the plan and withdrawal symptom management information in writing.</li>



<li>Follow-up within 1-2 weeks of each dose change to review withdrawal effects and emerging mental health symptoms.</li>
</ul>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h3 class="wp-block-heading" id="discontinuationandwithdrawal">Discontinuation &amp; withdrawal symptoms for anxiety and depression</h3>
</div></article>

<article class="block--faq "><div class="container">
    <div class="faq-title-wrapper">
        <div class="faq-icon-wrapper">
            <img decoding="async" class="faq-icon" src="https://tools.cep.health/wp-content/uploads/2020/04/Stop-Updated-1.png" alt="" />
        </div>
        <h3 class="faq-title"><h6>Discontinuation &#038; withdrawal symptoms<sup>8</sup></h6></h3>
    </div>
            <div class="questions">
                                                                <div class="question">
                        <button data-toggle-question class="question-title-wrapper">
                            <h6 class="question-title">General </h6>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
                        </button>
                        <div class="question-answer">
                            <p><strong>Symptoms<sup>29</sup></strong></p>
<ul>
<li>Flu-like symptoms (e.g., malaise, headache, fatigue, chills, sweating, tremor, loss of appetite)</li>
</ul>
<p><strong>Management<sup>5</sup></strong></p>
<p>Provide reassurance and support to patients, including but not limited to:</p>
<ul>
<li aria-level="1">Symptom management</li>
<li aria-level="1">Additional follow-up</li>
<li aria-level="1">Pause, adjust, or stop the tapering plan according to patient preference</li>
<li aria-level="1">Arranging contingency plans for subsequent dose reductions</li>
</ul>
<p>In some cases, it may be helpful to:</p>
<ul>
<li aria-level="1">Increase the dose of the medication</li>
<li aria-level="1">Consult an expert for further advice  (e.g., cross-taper, managing discontinuation symptoms, etc.)</li>
</ul>
                        </div>
                    </div>
                                                                                <div class="question">
                        <button data-toggle-question class="question-title-wrapper">
                            <h6 class="question-title">Sensory</h6>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
                        </button>
                        <div class="question-answer">
                            <p><strong>Symptoms<sup>29</sup></strong></p>
<ul>
<li>“Electric shock sensations” (especially with SNRIs), paresthesias, numbness, blurred vision, palinopsia, auditory disturbances</li>
</ul>
<p><strong>Management<sup>5</sup></strong></p>
<p>Provide reassurance and support to patients, including but not limited to:</p>
<ul>
<li aria-level="1">Symptom management</li>
<li aria-level="1">Additional follow-up</li>
<li aria-level="1">Pause, adjust, or stop the tapering plan according to patient preference</li>
<li aria-level="1">Arranging contingency plans for subsequent dose reductions</li>
</ul>
<p>In some cases, it may be helpful to:</p>
<ul>
<li aria-level="1">Increase the dose of the medication</li>
<li aria-level="1">Consult an expert for further advice  (i.e., cross-taper, managing discontinuation symptoms, etc.)</li>
</ul>
                        </div>
                    </div>
                                                                                <div class="question">
                        <button data-toggle-question class="question-title-wrapper">
                            <h6 class="question-title">Vestibular</h6>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
                        </button>
                        <div class="question-answer">
                            <p><strong>Symptoms<sup>29</sup></strong></p>
<ul>
<li>Light-headedness, dizziness, vertigo</li>
</ul>
<p><strong>Management<sup>5</sup></strong></p>
<p>Provide reassurance and support to patients, including but not limited to:</p>
<ul>
<li aria-level="1">Symptom management</li>
<li aria-level="1">Additional follow-up</li>
<li aria-level="1">Pause, adjust, or stop the tapering plan according to patient preference</li>
<li aria-level="1">Arranging contingency plans for subsequent dose reductions</li>
</ul>
<p>In some cases, it may be helpful to:</p>
<ul>
<li aria-level="1">Increase the dose of the medication</li>
<li aria-level="1">Consult an expert for further advice  (i.e., cross-taper, managing discontinuation symptoms, etc.)</li>
</ul>
                        </div>
                    </div>
                                                                                <div class="question">
                        <button data-toggle-question class="question-title-wrapper">
                            <h6 class="question-title">Gastrointestinal</h6>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
                        </button>
                        <div class="question-answer">
                            <p><strong>Symptoms<sup>29</sup></strong></p>
<ul>
<li>Nausea, vomiting, diarrhea</li>
</ul>
<p><strong>Management<sup>5</sup></strong></p>
<p>Provide reassurance and support to patients, including but not limited to:</p>
<ul>
<li aria-level="1">Symptom management</li>
<li aria-level="1">Additional follow-up</li>
<li aria-level="1">Pause, adjust, or stop the tapering plan according to patient preference</li>
<li aria-level="1">Arranging contingency plans for subsequent dose reductions</li>
</ul>
<p>In some cases, it may be helpful to:</p>
<ul>
<li aria-level="1">Increase the dose of the medication</li>
<li aria-level="1">Consult an expert for further advice  (i.e., cross-taper, managing discontinuation symptoms, etc.)</li>
</ul>
                        </div>
                    </div>
                                                                                <div class="question">
                        <button data-toggle-question class="question-title-wrapper">
                            <h6 class="question-title">Sleep</h6>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
                        </button>
                        <div class="question-answer">
                            <p><strong>Symptoms<sup>29</sup></strong></p>
<ul>
<li>Insomnia, nightmares, excessive dreaming</li>
</ul>
<p><strong>Management<sup>5</sup></strong></p>
<p>Provide reassurance and support to patients, including but not limited to:</p>
<ul>
<li aria-level="1">Symptom management</li>
<li aria-level="1">Additional follow-up</li>
<li aria-level="1">Pause, adjust, or stop the tapering plan according to patient preference</li>
<li aria-level="1">Arranging contingency plans for subsequent dose reductions</li>
</ul>
<p>In some cases, it may be helpful to:</p>
<ul>
<li aria-level="1">Increase the dose of the medication</li>
<li aria-level="1">Consult an expert for further advice  (i.e., cross-taper, managing discontinuation symptoms, etc.)</li>
</ul>
                        </div>
                    </div>
                                    </div>
    </div></article>						</div>
					</div>
				</section>
							<section class="main-section" id="appendix-alternative-therapies-and-natural-health-products" tabindex="-1">
					<div class="head">
						<div class="container">
							<h2 class="main-heading">
								Appendix: alternative therapies and natural health products								
							</h2>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
						</div>
					</div>
					<div class="body">
						<div class="container">
							<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h4 class="wp-block-heading">Jump to:</h4>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><a href="#Alternative-therapies" data-type="internal" data-id="#Alternative-therapies">Alternative therapies</a><br><a href="#NHPs" data-type="internal" data-id="#NHPs">Natural health products</a></p>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h6 class="wp-block-heading" id="CAM"><strong>Considerations for alternative therapies and natural health products:<sup>5</sup></strong></h6>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>Patient values and wishes are a priority in treatment selection. While there is evidence for some types of alternative therapies and natural health products (NHPs), as with any treatment, the potential for harm must be considered.</p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>Consider the advantages:</p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Patient places high value on treatment</li>



<li>Likelihood of the treatment addressing factors related to the patient’s symptoms</li>



<li>Evidence for treatment</li>
</ul>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>Consider the disadvantages:</p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Cost</li>



<li>Risk of negative impact </li>
</ul>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h3 class="wp-block-heading" id="Alternative-therapies">Alternative therapies</h3>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li><a href="https://link.cep.health/ad144" data-type="URL" data-id="https://link.cep.health/ad144" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Light Therapy</a><article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>First-line monotherapy for seasonal depression</li>



<li>Second-line adjunctive therapy or monotherapy for moderate to severe depression</li>



<li>Typical or studied dose and<s> </s>duration: standard protocol is 10,000 lux (light intensity) for 30 minutes per day during the early morning for up to 6 weeks. A response is usually seen within 1 to 3 weeks</li>
</ul>
</div></article></li>



<li>Acupuncture<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Third-line adjunctive therapy for mild to moderate depression</li>



<li>Typical or studied dose and duration:&nbsp;typically 20 to 30 minutes in session duration, and ranging from 10 to 30 sessions, decreasing in frequency over time from daily to weekly intervals</li>
</ul>
</div></article></li>
</ul>
</div></article>

<article class="block--heading  core-block" data-block-name="core/heading"><div class="container">
<h3 class="wp-block-heading" id="NHPs">Natural health products (NHPs)<sup> 1, 36</sup></h3>
</div></article>


<div class="wp-block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 wp-block-columns-is-layout-flex">
<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow"><article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><strong>Considerations for</strong> <strong>NHPs:</strong><br>A pharmacist can support you and patients in navigating herbal treatments. Some general considerations include the following:</p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Is it a quality product?<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Does it have an <a href="https://link.cep.health/ad54" data-type="URL" data-id="https://link.cep.health/ad54" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">NPN (Natural Product Number)</a>?</li>
</ul>
</div></article></li>



<li>Is there a potential for harm?<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Risk of bleeding and liver damage are the most common warnings for herbal products.</li>
</ul>
</div></article></li>



<li>Is there a potential for drug interactions? (e.g., St. John’s Wort)</li>



<li>How many ingredients are listed?<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Products with more than one ingredient have a higher risk of interactions and side effects.</li>
</ul>
</div></article></li>



<li>How much does the product cost?</li>



<li>Is there evidence of the product&#8217;s efficacy?</li>
</ul>
</div></article></div>



<div class="wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow" style="flex-basis:35%"><article class="block--modal ">

<div class="outer">
  <div class="container">
    <div class="inner has-text-centered">
              <img decoding="async" src="https://tools.cep.health/wp-content/uploads/2019/10/talking-points.svg" alt="" />
                    <h6>Talking tips</h6>
                          <a data-modal="Lq6ClK" class="button open-modal" href="#" data-id="Lq6ClK">Click to view</a>
          </div>
  </div>
</div>

  <div data-modal="Lq6ClK" class="modal">
    <div class="inner text">
      <div class="close-wrapper">
                <a href="" class="close" data-wpel-link="internal">Close</a>
      </div>
      <div class="container">
                <div class="content">
          
                          <h4>Talk tips</h4>
                                      <p><strong>Herbal Products<sup>5</sup></strong></p>
<ul>
<li aria-level="1">There are many products that are safe, and some have been studied for mental health.</li>
<li aria-level="1">Even though herbal products are natural, they may have side effects, interfere with your medications and may not be safe for you.</li>
<li aria-level="1">A rule of thumb is to find a product with only one ingredient and “NPN” or Natural Product Number. Having one ingredient makes the product less likely to interfere with other medications or include things that are not safe for you. The Natural Product Number means that the company has proven to Health Canada that the product has passed safety standards and is what it claims to be.</li>
<li aria-level="1">Talk to your pharmacist to confirm that the natural product is a good fit for you.</li>
</ul>
            
                  </div>
      </div>
    </div>
    <div class="overlay"></div>
</div></article></div>
</div>


<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>The <a href="https://link.cep.health/ad55" data-type="URL" data-id="https://link.cep.health/ad55" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">National Institute for Health (NIH) National Center for Complementary and Integrative Health</a> has information about evidence, potential harms and drug interaction risks for various modalities.</p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p><a href="https://link.cep.health/ad147" data-type="URL" data-id="https://link.cep.health/ad147" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Click to view</a> natural health products in table format.</p>
</div></article>

<article class="block--paragraph  core-block" data-block-name="core/paragraph"><div class="container">
<p>NHPs not recommended:<sup>1</sup></p>
</div></article>

<article class="block--list  core-block" data-block-name="core/list"><div class="container">
<ul class="wp-block-list">
<li>Inositol</li>



<li>Tryptophan&nbsp;</li>



<li>Rhodiola rosea (roseroot)</li>
</ul>
</div></article>						</div>
					</div>
				</section>
							<section class="main-section" id="references" tabindex="-1">
					<div class="head">
						<div class="container">
							<h2 class="main-heading">
								References								
							</h2>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
						</div>
					</div>
					<div class="body">
						<div class="container">
							<article class="block--references ">
<div class="container">

                        <ul>
               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [1]
                    </div>

                    <div class="column">
                      <p><span class="TextRun SCXW109566185 BCX0" lang="FR-FR" xml:lang="FR-FR" data-contrast="none"><span class="NormalTextRun SCXW109566185 BCX0">Lam</span><span class="NormalTextRun SCXW109566185 BCX0"> RW, Kennedy SH, Adams C, </span><span class="NormalTextRun SCXW109566185 BCX0">Bahji</span><span class="NormalTextRun SCXW109566185 BCX0"> A, Beaulieu S, Bhat V, et </span><span class="NormalTextRun SCXW109566185 BCX0">al. Canadian</span><span class="NormalTextRun SCXW109566185 BCX0"> Network for </span><span class="NormalTextRun SCXW109566185 BCX0">Mood</span><span class="NormalTextRun SCXW109566185 BCX0"> and </span><span class="NormalTextRun SCXW109566185 BCX0">Anxiety</span> <span class="NormalTextRun SCXW109566185 BCX0">Treatments</span><span class="NormalTextRun SCXW109566185 BCX0"> (CANMAT) 2023 Update on </span><span class="NormalTextRun SCXW109566185 BCX0">Clinical</span><span class="NormalTextRun SCXW109566185 BCX0"> Guidelines for Management of Major </span><span class="NormalTextRun SCXW109566185 BCX0">Depressive</span> <span class="NormalTextRun SCXW109566185 BCX0">Disorder</span><span class="NormalTextRun SCXW109566185 BCX0"> in </span><span class="NormalTextRun SCXW109566185 BCX0">Adults</span><span class="NormalTextRun SCXW109566185 BCX0">: </span><span class="NormalTextRun SCXW109566185 BCX0">Réseau</span> <span class="NormalTextRun SCXW109566185 BCX0">canadien</span><span class="NormalTextRun SCXW109566185 BCX0"> pour les </span><span class="NormalTextRun SCXW109566185 BCX0">traitements</span><span class="NormalTextRun SCXW109566185 BCX0"> de </span><span class="NormalTextRun SCXW109566185 BCX0">l&#8217;humeur</span><span class="NormalTextRun SCXW109566185 BCX0"> et de </span><span class="NormalTextRun SCXW109566185 BCX0">l&#8217;anxiété</span><span class="NormalTextRun SCXW109566185 BCX0"> (CANMAT) 2023: Mise à jour des </span><span class="NormalTextRun SCXW109566185 BCX0">lignes</span><span class="NormalTextRun SCXW109566185 BCX0"> directrices </span><span class="NormalTextRun SCXW109566185 BCX0">cliniques</span><span class="NormalTextRun SCXW109566185 BCX0"> pour la </span><span class="NormalTextRun SCXW109566185 BCX0">prise</span> <span class="NormalTextRun SCXW109566185 BCX0">en</span><span class="NormalTextRun SCXW109566185 BCX0"> charge du trouble </span><span class="NormalTextRun SCXW109566185 BCX0">dépressif</span> <span class="NormalTextRun SCXW109566185 BCX0">majeur</span><span class="NormalTextRun SCXW109566185 BCX0"> chez les </span><span class="NormalTextRun SCXW109566185 BCX0">adultes</span><span class="NormalTextRun SCXW109566185 BCX0">. Can J </span><span class="NormalTextRun SCXW109566185 BCX0">Psychiatry</span><span class="NormalTextRun SCXW109566185 BCX0">. 2024 May </span><span class="NormalTextRun SCXW109566185 BCX0">6:</span><span class="NormalTextRun SCXW109566185 BCX0">7067437241245384.</span></span><span class="EOP SCXW109566185 BCX0" data-ccp-props="{&quot;335551550&quot;:1,&quot;335551620&quot;:1}"> </span></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [2]
                    </div>

                    <div class="column">
                      <p>NICE. Generalised anxiety disorder and panic disorder in adults: management | Guidance | NICE [Internet]. NICE; 2011 [cited 2023 Feb 10]. Available from: <a href="https://link.cep.health/ad131" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">https://www.nice.org.uk/guidance/cg113</a></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [3]
                    </div>

                    <div class="column">
                      <p>Anxiety Disorders &#8211; Health Quality Ontario (HQO) [Internet]. [cited 2022 Nov 16]. Available from: <a href="https://link.cep.health/ad132" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">https://www.hqontario.ca/evidence-to-improve-care/quality-standards/view-all-quality-standards/anxiety-disorders</a></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [4]
                    </div>

                    <div class="column">
                      <p>Major Depression &#8211; Health Quality Ontario (HQO) [Internet]. [cited 2022 Nov 16]. Available from: <a href="https://link.cep.health/ad133" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">https://www.hqontario.ca/evidence-to-improve-care/quality-standards/view-all-quality-standards/major-depression</a></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [5]
                    </div>

                    <div class="column">
                      <p><a href="https://link.cep.health/expertopinionrationale" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Expert opinion</a>.</p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [6]
                    </div>

                    <div class="column">
                      <p>NICE. Depression in adults: treatment and management | Guidance | NICE [Internet]. NICE; 2022 [cited 2023 Feb 10]. Available from: <a href="https://link.cep.health/ad134" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">https://www.nice.org.uk/guidance/ng222</a></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [7]
                    </div>

                    <div class="column">
                      <p>Katzman MA, Bleau P, Blier P, Chokka P, Kjernisted K, Van Ameringen M, et al. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry. 2014 Jul 2;14(1):S1.</p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [8]
                    </div>

                    <div class="column">
                      <p>Andrews G. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of panic disorder, social anxiety disorder and generalised anxiety disorder. Aust N Z J Psychiatry. 2018;52(12):1109–72.</p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [9]
                    </div>

                    <div class="column">
                      <p>Bandelow B, Allgulander C, Baldwin DS, Costa DL da C, Denys D, Dilbaz N, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders &#8211; Version 3. Part I: Anxiety disorders. World J Biol Psychiatry Off J World Fed Soc Biol Psychiatry. 2023 Feb;24(2):79–117.</p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [10]
                    </div>

                    <div class="column">
                      <p>Management of Major Depressive Disorder (MDD) (2022) &#8211; VA/DoD Clinical Practice Guidelines [Internet]. [cited 2022 Sep 23]. Available from: <a href="https://link.cep.health/ad135" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">https://www.healthquality.va.gov/guidelines/MH/mdd/</a></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [11]
                    </div>

                    <div class="column">
                      <p>Bandelow B, Werner AM, Kopp I, Rudolf S, Wiltink J, Beutel ME. The German Guidelines for the treatment of anxiety disorders: first revision. Eur Arch Psychiatry Clin Neurosci. 2022 Jun 1;272(4):571–82.</p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [12]
                    </div>

                    <div class="column">
                      <p>CPS [Internet]. Ottawa (ON): Canadian Pharmacists Association. SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) [product monograph] [Internet]. 2019 [cited 2022 Nov 10]. Available from: <a href="https://link.cep.health/ad136" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">http://www.e-therapeutics.ca</a></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [13]
                    </div>

                    <div class="column">
                      <p>CPS [Internet]. Ottawa (ON): Canadian Pharmacists Association. ESCITALOPRAM  [product monograph] [Internet]. 2018 [cited 2022 Nov 10]. Available from: <a href="https://link.cep.health/ad136" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">http://www.e-therapeutics.ca</a></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [14]
                    </div>

                    <div class="column">
                      <p>CPS [Internet]. Ottawa (ON): Canadian Pharmacists Association. Paroxetine  [product monograph] [Internet]. 2017 [cited 2022 Nov 10]. Available from: <a href="https://link.cep.health/ad136" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">http://www.e-therapeutics.ca</a></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [15]
                    </div>

                    <div class="column">
                      <p>CPS [Internet]. Ottawa (ON): Canadian Pharmacists Association. CYMBALTA: Duloxetine [product monograph] [Internet]. 2021 [cited 2022 Nov 10]. Available from: <a href="https://link.cep.health/ad136" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">http://www.e-therapeutics.ca</a></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [16]
                    </div>

                    <div class="column">
                      <p>CPS [Internet]. Ottawa (ON): Canadian Pharmacists Association. EFFEXOR XR: Venlafaxine [product monograph] [Internet]. 2020 [cited 2022 Nov 10]. Available from: <a href="https://link.cep.health/ad136" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">http://www.e-therapeutics.ca</a></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [17]
                    </div>

                    <div class="column">
                      <p>CPS [Internet]. Ottawa (ON): Canadian Pharmacists Association. PREGABALIN  [product monograph] [Internet]. 2017 [cited 2022 Nov 10]. Available from: <a href="https://link.cep.health/ad136" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">http://www.e-therapeutics.ca</a></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [18]
                    </div>

                    <div class="column">
                      <p>CPS [Internet]. Ottawa (ON): Canadian Pharmacists Association. BUSPIRONE  [product monograph] [Internet]. 2018 [cited 2022 Nov 10]. Available from: <a href="https://link.cep.health/ad136" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">http://www.e-therapeutics.ca</a></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [19]
                    </div>

                    <div class="column">
                      <p>CPS [Internet]. Ottawa (ON): Canadian Pharmacists Association. ZOLOFT: Sertraline [product monograph] [Internet]. 2020 [cited 2022 Nov 10]. Available from: <a href="https://link.cep.health/ad136" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">http://www.e-therapeutics.ca</a></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [20]
                    </div>

                    <div class="column">
                      <p>CPS [Internet]. Ottawa (ON): Canadian Pharmacists Association. CITALOPRAM [product monograph [Internet]. 2018 [cited 2022 Nov 10]. Available from: <a href="https://link.cep.health/ad136" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">http://www.e-therapeutics.ca</a></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [21]
                    </div>

                    <div class="column">
                      <p>CPS [Internet]. Ottawa (ON): Canadian Pharmacists Association. WELLBUTRIN XL: Buproprion [product monograph] [Internet]. 2017 [cited 2022 Nov 10]. Available from: <a href="https://link.cep.health/ad136" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">http://www.e-therapeutics.ca</a></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [22]
                    </div>

                    <div class="column">
                      <p>CPS [Internet]. Ottawa (ON): Canadian Pharmacists Association. TRINTELLIX: Vortioxetine [product monograph] [Internet]. 2021 [cited 2022 Nov 10]. Available from: <a href="https://link.cep.health/ad136" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">http://www.e-therapeutics.ca</a></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [23]
                    </div>

                    <div class="column">
                      <p>CPS [Internet]. Ottawa (ON): Canadian Pharmacists Association. PRISTIQ: Desvenlafaxine Succinate [product monograph] [Internet]. 2018 [cited 2022 Nov 10]. Available from: <a href="https://link.cep.health/ad136" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">http://www.e-therapeutics.ca</a></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [24]
                    </div>

                    <div class="column">
                      <p>CPS [Internet]. Ottawa (ON): Canadian Pharmacists Association. PROZAC: Fluoxetine [product monograph] [Internet]. 2021 [cited 2022 Nov 10]. Available from: <a href="https://link.cep.health/ad136" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">http://www.e-therapeutics.ca</a></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [25]
                    </div>

                    <div class="column">
                      <p>CPS [Internet]. Ottawa (ON): Canadian Pharmacists Association. LUVOX:  Fluvoxamine Maleate [product monograph] [Internet]. 2021 [cited 2022 Nov 10]. Available from: <a href="https://link.cep.health/ad136" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">http://www.e-therapeutics.ca</a></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [26]
                    </div>

                    <div class="column">
                      <p>CPS [Internet]. Ottawa (ON): Canadian Pharmacists Association. MIRTAZAPINE [product monograph] [Internet]. 2018 [cited 2022 Nov 10]. Available from:<a href="https://link.cep.health/ad136" data-wpel-link="external" target="_blank" rel="external noopener noreferrer"> http://www.e-therapeutics.ca</a></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [27]
                    </div>

                    <div class="column">
                      <p>Government of Ontario M of H. Formulary Search [Internet]. Ontario Drug Benefit Formulary/Comparative Drug Index. 2023 [cited 2023 Feb 10]. Available from: <a href="https://link.cep.health/ad137" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">https://www.formulary.health.gov.on.ca/formulary/</a></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [28]
                    </div>

                    <div class="column">
                      <p>Qaseem A, Owens DK, Etxeandia-Ikobaltzeta I, Tufte J, Cross JT, Wilt TJ. Nonpharmacologic and Pharmacologic Treatments of Adults in the Acute Phase of Major Depressive Disorder: A Living Clinical Guideline From the American College of Physicians. Ann Intern Med [Internet]. 2023 Jan 24 [cited 2023 Feb 10]; Available from: <a href="https://link.cep.health/ad138" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">https://www.acpjournals.org/doi/10.7326/M22-2056</a></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [29]
                    </div>

                    <div class="column">
                      <p>Indigenous Services Canada. Non-insured health benefits, First Nations and Inuit Health Branch: Drug benefit list [Internet]. 2020. Available from: <a href="https://link.cep.health/ad141" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">https://nihb-ssna.express-scripts.ca/en/0205140506092019/16/160407</a></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [30]
                    </div>

                    <div class="column">
                      <p>American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2019 Apr;67(4):674–94.</p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [31]
                    </div>

                    <div class="column">
                      <p>Centre for Effective Practice. Falls Prevention [Internet]. 2021 [cited 2023 Mar 17]. Available from: <a href="https://link.cep.health/ad139" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">https://cep.health/clinical-products/falls-prevention/</a></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [32]
                    </div>

                    <div class="column">
                      <p>Canadian Coalition for Senior’s Mental Health. Canadian Guidelines on Prevention, Assessment and Treatment of Depression Among Older Adults [Internet]. 2021. Available from: <a href="https://link.cep.health/ad140" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">https://ccsmh.ca/wp-content/uploads/2021/06/CCSMH_Depression_Guidelines_FINAL_EN.pdf</a></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [33]
                    </div>

                    <div class="column">
                      <p>CPS [Internet]. Ottawa (ON): Canadian Pharmacists Association. Aripiprazole [product monograph]. 2021.</p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [34]
                    </div>

                    <div class="column">
                      <p><span class="TextRun SCXW210156483 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="none"><span class="NormalTextRun SCXW210156483 BCX0">Actavis </span><span class="NormalTextRun SCXW210156483 BCX0">Speciality</span><span class="NormalTextRun SCXW210156483 BCX0"> Pharmaceuticals Co. Product monograph: Fetzima [Internet]. 2015 [cited </span><span class="NormalTextRun SCXW210156483 BCX0">18</span> <span class="NormalTextRun SCXW210156483 BCX0">July</span><span class="NormalTextRun SCXW210156483 BCX0"> </span><span class="NormalTextRun SCXW210156483 BCX0">2024]. Available from: </span><a href="https://link.cep.health/ad156" data-wpel-link="external" target="_blank" rel="external noopener noreferrer"><span class="NormalTextRun SCXW210156483 BCX0">https://www.cda-amc.ca/sites/default/files/cdr/monograph/fetzima-monograph.pdf</span></a></span><span class="EOP SCXW210156483 BCX0" data-ccp-props="{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:0,&quot;335559739&quot;:0}"> </span></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [35]
                    </div>

                    <div class="column">
                      <p><span class="TextRun SCXW113660842 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="none"><span class="NormalTextRun SCXW113660842 BCX0">Forest Laboratories Canada Inc. Product monograph: </span><span class="NormalTextRun SCXW113660842 BCX0">Viibryd</span><span class="NormalTextRun SCXW113660842 BCX0"> [Internet]. 2015 [cited </span><span class="NormalTextRun SCXW113660842 BCX0">1</span><span class="NormalTextRun SCXW113660842 BCX0">8</span><span class="NormalTextRun SCXW113660842 BCX0"> </span><span class="NormalTextRun SCXW113660842 BCX0">July</span><span class="NormalTextRun SCXW113660842 BCX0"> 2024]. Available from: </span><a href="https://link.cep.health/ad157" data-wpel-link="external" target="_blank" rel="external noopener noreferrer"><span class="NormalTextRun SCXW113660842 BCX0">https://pdf.hres.ca/dpd_pm/00031333.PDF</span></a></span><span class="EOP SCXW113660842 BCX0" data-ccp-props="{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:0,&quot;335559739&quot;:0}"> </span></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [36]
                    </div>

                    <div class="column">
                      <p>Canada H. About Natural Health Products [Internet]. 2016 [cited 2023 Feb 10]. Available from: <a href="https://link.cep.health/ad142" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">https://www.canada.ca/en/health-canada/services/drugs-health-products/natural-non-prescription/regulation/about-products.html</a></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [37]
                    </div>

                    <div class="column">
                      <p>Office of Dietary Supplements &#8211; Folate [Internet]. [cited 2023 Feb 1]. Available from: <a href="https://link.cep.health/ad143" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">https://ods.od.nih.gov/factsheets/Folate-Consumer/</a></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [38]
                    </div>

                    <div class="column">
                      <p><span class="TextRun SCXW150648000 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="none"><span class="NormalTextRun SCXW150648000 BCX0">Ottawa Depression Algorithm. Table of antidepressant medications (adult) [Internet]. 2024 [cited 18 July</span> <span class="NormalTextRun SCXW150648000 BCX0">2024]. Available from: </span></span><a class="Hyperlink SCXW150648000 BCX0" href="https://link.cep.health/ad158" target="_blank" rel="noreferrer noopener external" data-wpel-link="external"><span class="TextRun Underlined SCXW150648000 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="none"><span class="NormalTextRun SCXW150648000 BCX0" data-ccp-charstyle="Hyperlink">https://ottawadepressionalgorithm.ca/en/content?id=38</span></span></a><span class="EOP SCXW150648000 BCX0" data-ccp-props="{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:0,&quot;335559739&quot;:0}"> </span></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [39]
                    </div>

                    <div class="column">
                      <p><span class="TextRun SCXW256293283 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="none"><span class="NormalTextRun SCXW256293283 BCX0">Otsuka Pharmaceutical Co. Ltd. Product monograph: </span><span class="NormalTextRun SCXW256293283 BCX0">Rexulti</span><span class="NormalTextRun SCXW256293283 BCX0"> [Internet]. 2017 [cited </span><span class="NormalTextRun SCXW256293283 BCX0">18</span> <span class="NormalTextRun SCXW256293283 BCX0">July</span><span class="NormalTextRun SCXW256293283 BCX0"> </span><span class="NormalTextRun SCXW256293283 BCX0">2024]. Available from: </span><a href="https://link.cep.health/ad159" data-wpel-link="external" target="_blank" rel="external noopener noreferrer"><span class="NormalTextRun SCXW256293283 BCX0">https://otsukacanada.com/wp-content/uploads/2018/09/REXULTI-PM_16Feb2017.pdf</span></a></span><span class="EOP SCXW256293283 BCX0" data-ccp-props="{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:0,&quot;335559739&quot;:0}"> </span></p>
                    </div>
                  </li>

               
                  <li class="columns is-flex is-gapless">
                    <div class="column is-1 is-1-mobile number">
                      [40]
                    </div>

                    <div class="column">
                      <p><span class="TextRun SCXW119571457 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="auto"><span class="NormalTextRun SCXW119571457 BCX0">Canadian Coalition for Seniors&#8217; Mental Health. Canadian Guidelines for the Assessment and Treatment of Anxiety in Older Adults [Internet]. 2024 [cited </span><span class="NormalTextRun SCXW119571457 BCX0">25</span> <span class="NormalTextRun SCXW119571457 BCX0">July</span><span class="NormalTextRun SCXW119571457 BCX0"> 2024]. Available from: </span></span><a class="Hyperlink SCXW119571457 BCX0" href="https://link.cep.health/ad155" target="_blank" rel="noreferrer noopener external" data-wpel-link="external"><span class="TextRun Underlined SCXW119571457 BCX0" lang="EN-US" xml:lang="EN-US" data-contrast="none"><span class="NormalTextRun CommentStart CommentHighlightPipeRestV2 CommentHighlightRest SCXW119571457 BCX0" data-ccp-charstyle="Hyperlink">https://ccsmh.ca/wp-content/uploads/2024/01/Anxiety-Clinical-Guidelines_ENG_digital_final.pdf</span></span></a><span class="EOP CommentHighlightPipeRestV2 SCXW119571457 BCX0" data-ccp-props="{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:0,&quot;335559739&quot;:0}"> </span></p>
                    </div>
                  </li>

                            </ul>
           
</div>
</article>						</div>
					</div>
				</section>
							<section class="main-section" id="acknowledgment-and-legal" tabindex="-1">
					<div class="head">
						<div class="container">
							<h2 class="main-heading">
								Acknowledgment and legal								
    <span class="badge new" data-last-modified="Feb 22, 2024" data-hide-on-click>New</span>
							</h2>
							<div class="icon">
								<svg width="22" height="22" viewBox="0 0 22 22" fill="none" xmlns="http:/ /www.w3.org/2000/svg">
									<path fill-rule="evenodd" clip-rule="evenodd" d="M16 12H6V10H16V12Z" class="horizontal-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M10 16V6H12V16H10Z" class="vertical-stroke" />
									<path fill-rule="evenodd" clip-rule="evenodd" d="M11 20C15.9706 20 20 15.9706 20 11C20 6.02944 15.9706 2 11 2C6.02944 2 2 6.02944 2 11C2 15.9706 6.02944 20 11 20ZM11 22C17.0751 22 22 17.0751 22 11C22 4.92487 17.0751 0 11 0C4.92487 0 0 4.92487 0 11C0 17.0751 4.92487 22 11 22Z" class="outline" />
								</svg>
							</div>
						</div>
					</div>
					<div class="body">
						<div class="container">
							<article class="block--legal-text ">
<div class="container">
  <div class="columns is-gapless">
    <div class="column is-8 text">
      <div class="inner">
        <p>The Managing Patients with Anxiety and Depression in Primary Care Tool was developed using the Centre for Effective Practice’s (CEP’s) integrated knowledge translation approach as part of the Knowledge Translation in Primary Care (KTinPC) Initiative. This approach ensures that clinicians are engaged throughout the development processes through the application of user-centered design methodology. Clinical leadership of the resource was provided by Dr. Sharon Bal. End users and clinical experts were also engaged to provide feedback. This tool&#8217;s development was completed in collaboration with <a href="https://link.cep.health/ad149" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Ontario College of Family Physicians (OCFP)</a> and <a href="https://link.cep.health/ad150" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">Nurse Practitioners’ Association of Ontario (NPAO)</a>. Funded by the Ministry of Health, the KTinPC Initiative supports primary care clinicians with a series of clinical tools and health information resources. Learn more about the <a href="https://link.cep.health/ad151" data-wpel-link="external" target="_blank" rel="external noopener noreferrer">KTinPC Initiative</a>.</p>
<p>This Tool was developed for licensed health care professionals in Ontario as a guide only and does not constitute medical or other professional advice. Health care professionals are required to exercise their own clinical judgement in using this tool. Neither the CEP, Government of Ontario, collaborating partner(s), nor any of their respective agents, appointees, directors, officers, employees, contractors, members or volunteers: (i) are providing medical, diagnostic or treatment services through this Tool; (ii) to the extent permitted by applicable law, accept any responsibility for the use or misuse of this Tool by any individual including, but not limited to, primary care providers or entity, including for any loss, damage or injury (including death) arising from or in connection with the use of this Tool, in whole or in part; or (iii) give or make any representation, warranty or endorsement of any external sources referenced in this Tool (whether specifically named or not) that are owned or operated by their parties, including any information or advice contained therein.</p>
<p><i>This Tool is a product of the CEP. Permission to use, copy, and distribute this material is for all noncommercial and research purposes is granted, provided the above disclaimer, this paragraph and the following paragraphs, and appropriate citations appear in all copies, modifications, and distributions. Use of this Tool for commercial purposes or any modifications of the Tool are subject to charge and must be negotiated with the CEP (</i><i>info@cep.health</i><i>).</i></p>
<p><i>For statistical and bibliographic purposes, please notify the CEP (</i><i>info@cep.health</i><i>) of any use or reprinting of the Tool. Please use the following citation when referencing the Tool: Reprinted with Permission from Centre for Effective Practice. (March 2023). Managing Patients with Anxiety and Depression in Primary Care: Ontario. Toronto: Centre for Effective Practice.</i></p>
<p><img decoding="async" class="alignnone size-medium wp-image-327" src="https://tools.cep.health/wp-content/uploads/2019/10/CCLicense.svg" alt="" /></p>
      </div>
    </div>
    <div class="column is-4 logos">
      <div class="inner">
                  <div>
            
                <p>
                  Developed by:                </p>

                
                  <img decoding="async" src="https://tools.cep.health/wp-content/uploads/2019/10/CEP-Logo-Color.svg" />

                
            
                <p>
                  In collaboration with                </p>

                
                  <img decoding="async" src="https://tools.cep.health/wp-content/uploads/2019/10/NPAO-Logo.svg" />

                
            
                <p>
                  and                </p>

                
                  <img decoding="async" src="https://tools.cep.health/wp-content/uploads/2020/04/OCFP_Logo_UPDATED.png" />

                
                      </div>
              </div>
    </div>
  </div>
</div>
</article>						</div>
					</div>
				</section>
			
		</section>
  </main>

<div class="utility-bar">
    <button data-search-tool-open class="utility-button search-button"><i class="icon icon-search"></i></button>
    <a href="#top-of-sections" class="utility-button back-to-top"><i class="icon icon-arrow-up"></i></a>
</div>
<div class="global-modal"></div>

<script type="speculationrules">
{"prefetch":[{"source":"document","where":{"and":[{"href_matches":"\/*"},{"not":{"href_matches":["\/wp-*.php","\/wp-admin\/*","\/wp-content\/uploads\/*","\/wp-content\/*","\/wp-content\/plugins\/*","\/wp-content\/themes\/cep-tools\/*","\/*\\?(.+)"]}},{"not":{"selector_matches":"a[rel~=\"nofollow\"]"}},{"not":{"selector_matches":".no-prefetch, .no-prefetch a"}}]},"eagerness":"conservative"}]}
</script>
<!-- This site is converting visitors into subscribers and customers with OptinMonster - https://optinmonster.com :: Campaign Title: Obesity management HTML - enhance confidence -->
<script>(function(d,u,ac){var s=d.createElement('script');s.type='text/javascript';s.src='https://a.omappapi.com/app/js/api.min.js';s.async=true;s.dataset.user=u;s.dataset.campaign=ac;d.getElementsByTagName('head')[0].appendChild(s);})(document,75076,'hhgajtyemrlknjsvrsd5');</script>
<!-- / OptinMonster --><!-- This site is converting visitors into subscribers and customers with OptinMonster - https://optinmonster.com :: Campaign Title: RSV HTML - change in patient care -->
<script>(function(d,u,ac){var s=d.createElement('script');s.type='text/javascript';s.src='https://a.omappapi.com/app/js/api.min.js';s.async=true;s.dataset.user=u;s.dataset.campaign=ac;d.getElementsByTagName('head')[0].appendChild(s);})(document,75076,'tkia37pcyyahx6opqim2');</script>
<!-- / OptinMonster --><!-- This site is converting visitors into subscribers and customers with OptinMonster - https://optinmonster.com :: Campaign Title: 2024.07 HTML Secure Messaging -->
<script>(function(d,u,ac){var s=d.createElement('script');s.type='text/javascript';s.src='https://a.omappapi.com/app/js/api.min.js';s.async=true;s.dataset.user=u;s.dataset.campaign=ac;d.getElementsByTagName('head')[0].appendChild(s);})(document,75076,'ngtztpck7tvpbcvakl7d');</script>
<!-- / OptinMonster --><!-- This site is converting visitors into subscribers and customers with OptinMonster - https://optinmonster.com :: Campaign Title: 2024.07 AI LC - fill knowledge gaps -->
<script>(function(d,u,ac){var s=d.createElement('script');s.type='text/javascript';s.src='https://a.omappapi.com/app/js/api.min.js';s.async=true;s.dataset.user=u;s.dataset.campaign=ac;d.getElementsByTagName('head')[0].appendChild(s);})(document,75076,'f2bzjhvjmeyfqkxxjggz');</script>
<!-- / OptinMonster --><!-- This site is converting visitors into subscribers and customers with OptinMonster - https://optinmonster.com :: Campaign Title: 2024.07 HTML Social Rxing -->
<script>(function(d,u,ac){var s=d.createElement('script');s.type='text/javascript';s.src='https://a.omappapi.com/app/js/api.min.js';s.async=true;s.dataset.user=u;s.dataset.campaign=ac;d.getElementsByTagName('head')[0].appendChild(s);})(document,75076,'qgchslypk4toxdtgsfsf');</script>
<!-- / OptinMonster --><!-- This site is converting visitors into subscribers and customers with OptinMonster - https://optinmonster.com :: Campaign Title: 2024.07 HTML COPD -->
<script>(function(d,u,ac){var s=d.createElement('script');s.type='text/javascript';s.src='https://a.omappapi.com/app/js/api.min.js';s.async=true;s.dataset.user=u;s.dataset.campaign=ac;d.getElementsByTagName('head')[0].appendChild(s);})(document,75076,'cfontzigzdapzyxtbhg4');</script>
<!-- / OptinMonster --><!-- This site is converting visitors into subscribers and customers with OptinMonster - https://optinmonster.com :: Campaign Title: 2024.07 HTML Type 2 DM Insulin -->
<script>(function(d,u,ac){var s=d.createElement('script');s.type='text/javascript';s.src='https://a.omappapi.com/app/js/api.min.js';s.async=true;s.dataset.user=u;s.dataset.campaign=ac;d.getElementsByTagName('head')[0].appendChild(s);})(document,75076,'nflzw9az1mcray2ltc4m');</script>
<!-- / OptinMonster --><!-- This site is converting visitors into subscribers and customers with OptinMonster - https://optinmonster.com :: Campaign Title: 2024.07 HTML Type 2 DM Non-Insulin -->
<script>(function(d,u,ac){var s=d.createElement('script');s.type='text/javascript';s.src='https://a.omappapi.com/app/js/api.min.js';s.async=true;s.dataset.user=u;s.dataset.campaign=ac;d.getElementsByTagName('head')[0].appendChild(s);})(document,75076,'edlo1w0s0lujgciyjgf9');</script>
<!-- / OptinMonster --><!-- This site is converting visitors into subscribers and customers with OptinMonster - https://optinmonster.com :: Campaign Title: 2024.07 HTML ME/CFS -->
<script>(function(d,u,ac){var s=d.createElement('script');s.type='text/javascript';s.src='https://a.omappapi.com/app/js/api.min.js';s.async=true;s.dataset.user=u;s.dataset.campaign=ac;d.getElementsByTagName('head')[0].appendChild(s);})(document,75076,'ybbyul2ujyofvsznkiti');</script>
<!-- / OptinMonster --><!-- This site is converting visitors into subscribers and customers with OptinMonster - https://optinmonster.com :: Campaign Title: 2024.07 HTML FM -->
<script>(function(d,u,ac){var s=d.createElement('script');s.type='text/javascript';s.src='https://a.omappapi.com/app/js/api.min.js';s.async=true;s.dataset.user=u;s.dataset.campaign=ac;d.getElementsByTagName('head')[0].appendChild(s);})(document,75076,'doewskxay35gb860nodl');</script>
<!-- / OptinMonster --><!-- This site is converting visitors into subscribers and customers with OptinMonster - https://optinmonster.com :: Campaign Title: 2024.07 HTML Role Q -->
<script>(function(d,u,ac){var s=d.createElement('script');s.type='text/javascript';s.src='https://a.omappapi.com/app/js/api.min.js';s.async=true;s.dataset.user=u;s.dataset.campaign=ac;d.getElementsByTagName('head')[0].appendChild(s);})(document,75076,'wm0xaeyycxvhthxjz76n');</script>
<!-- / OptinMonster --><!-- This site is converting visitors into subscribers and customers with OptinMonster - https://optinmonster.com :: Campaign Title: 2024.07 HTML POTS -->
<script>(function(d,u,ac){var s=d.createElement('script');s.type='text/javascript';s.src='https://a.omappapi.com/app/js/api.min.js';s.async=true;s.dataset.user=u;s.dataset.campaign=ac;d.getElementsByTagName('head')[0].appendChild(s);})(document,75076,'iqff27bs0pszfabitkgw');</script>
<!-- / OptinMonster --><!-- This site is converting visitors into subscribers and customers with OptinMonster - https://optinmonster.com :: Campaign Title: 2024.07 HTML HF -->
<script>(function(d,u,ac){var s=d.createElement('script');s.type='text/javascript';s.src='https://a.omappapi.com/app/js/api.min.js';s.async=true;s.dataset.user=u;s.dataset.campaign=ac;d.getElementsByTagName('head')[0].appendChild(s);})(document,75076,'xfup8pda84l5bd0udyje');</script>
<!-- / OptinMonster --><!-- This site is converting visitors into subscribers and customers with OptinMonster - https://optinmonster.com :: Campaign Title: 2024.07 HTML A&D -->
<script>(function(d,u,ac){var s=d.createElement('script');s.type='text/javascript';s.src='https://a.omappapi.com/app/js/api.min.js';s.async=true;s.dataset.user=u;s.dataset.campaign=ac;d.getElementsByTagName('head')[0].appendChild(s);})(document,75076,'xokl1h6esysgo5wdkq9d');</script>
<!-- / OptinMonster --><!-- This site is converting visitors into subscribers and customers with OptinMonster - https://optinmonster.com :: Campaign Title: 2022.11 E2P Patient Resource Page -->
<script>(function(d,u,ac){var s=d.createElement('script');s.type='text/javascript';s.src='https://a.omappapi.com/app/js/api.min.js';s.async=true;s.dataset.user=u;s.dataset.campaign=ac;d.getElementsByTagName('head')[0].appendChild(s);})(document,75076,'jaxkt0icjnuu0z43iuik');</script>
<!-- / OptinMonster --><!-- This site is converting visitors into subscribers and customers with OptinMonster - https://optinmonster.com :: Campaign Title: 2021.11 MAID - Measuring knowledge -->
<script>(function(d,u,ac){var s=d.createElement('script');s.type='text/javascript';s.src='https://a.omappapi.com/app/js/api.min.js';s.async=true;s.dataset.user=u;s.dataset.campaign=ac;d.getElementsByTagName('head')[0].appendChild(s);})(document,75076,'vso3vlstnsfjgeuogzry');</script>
<!-- / OptinMonster --><!-- This site is converting visitors into subscribers and customers with OptinMonster - https://optinmonster.com :: Campaign Title: 2021.11 Fall Prevention & MGMT Resource - Fill knowledge gaps -->
<script>(function(d,u,ac){var s=d.createElement('script');s.type='text/javascript';s.src='https://a.omappapi.com/app/js/api.min.js';s.async=true;s.dataset.user=u;s.dataset.campaign=ac;d.getElementsByTagName('head')[0].appendChild(s);})(document,75076,'awihu5noxqqj5s7iasv8');</script>
<!-- / OptinMonster --><!-- This site is converting visitors into subscribers and customers with OptinMonster - https://optinmonster.com :: Campaign Title: 2021.08 PPIs - Change prescribing -->
<script>(function(d,u,ac){var s=d.createElement('script');s.type='text/javascript';s.src='https://a.omappapi.com/app/js/api.min.js';s.async=true;s.dataset.user=u;s.dataset.campaign=ac;d.getElementsByTagName('head')[0].appendChild(s);})(document,75076,'cdikvvptidch9oj1o56k');</script>
<!-- / OptinMonster --><!-- This site is converting visitors into subscribers and customers with OptinMonster - https://optinmonster.com :: Campaign Title: 2021.08 Chronic Insomnia HTML - Increase Confidence -->
<script>(function(d,u,ac){var s=d.createElement('script');s.type='text/javascript';s.src='https://a.omappapi.com/app/js/api.min.js';s.async=true;s.dataset.user=u;s.dataset.campaign=ac;d.getElementsByTagName('head')[0].appendChild(s);})(document,75076,'qeu7gqedkzjnotzskhln');</script>
<!-- / OptinMonster --><!-- This site is converting visitors into subscribers and customers with OptinMonster - https://optinmonster.com :: Campaign Title: 2021.08 Non-Medical Cannabis Resource - Fill knowledge gaps -->
<script>(function(d,u,ac){var s=d.createElement('script');s.type='text/javascript';s.src='https://a.omappapi.com/app/js/api.min.js';s.async=true;s.dataset.user=u;s.dataset.campaign=ac;d.getElementsByTagName('head')[0].appendChild(s);})(document,75076,'okkbvdzprjjylm7wjkhe');</script>
<!-- / OptinMonster --><!-- This site is converting visitors into subscribers and customers with OptinMonster - https://optinmonster.com :: Campaign Title: 2021.07 ADHD Resource - Fill knowledge gaps -->
<script>(function(d,u,ac){var s=d.createElement('script');s.type='text/javascript';s.src='https://a.omappapi.com/app/js/api.min.js';s.async=true;s.dataset.user=u;s.dataset.campaign=ac;d.getElementsByTagName('head')[0].appendChild(s);})(document,75076,'rxekv8i4pwnmp4zvclcm');</script>
<!-- / OptinMonster --><!-- This site is converting visitors into subscribers and customers with OptinMonster - https://optinmonster.com :: Campaign Title: 2020.05 COVID-19 - Change the way you will provide care for your patients? -->
<script>(function(d,u,ac){var s=d.createElement('script');s.type='text/javascript';s.src='https://a.omappapi.com/app/js/api.min.js';s.async=true;s.dataset.user=u;s.dataset.campaign=ac;d.getElementsByTagName('head')[0].appendChild(s);})(document,75076,'koz3ranojk5yi8c5wmpe');</script>
<!-- / OptinMonster --><!-- This site is converting visitors into subscribers and customers with OptinMonster - https://optinmonster.com :: Campaign Title: 2020.07 CNCP - change in patient care -->
<script>(function(d,u,ac){var s=d.createElement('script');s.type='text/javascript';s.src='https://a.omappapi.com/app/js/api.min.js';s.async=true;s.dataset.user=u;s.dataset.campaign=ac;d.getElementsByTagName('head')[0].appendChild(s);})(document,75076,'e6m4njfonyv93sqcttlx');</script>
<!-- / OptinMonster -->		<!-- Google Tag Manager (noscript) snippet added by Site Kit -->
		<noscript>
			<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-WLFDZV" height="0" width="0" style="display:none;visibility:hidden"></iframe>
		</noscript>
		<!-- End Google Tag Manager (noscript) snippet added by Site Kit -->
				<script type="text/javascript">
		var hhgajtyemrlknjsvrsd5_shortcode = true;var tkia37pcyyahx6opqim2_shortcode = true;var ngtztpck7tvpbcvakl7d_shortcode = true;var f2bzjhvjmeyfqkxxjggz_shortcode = true;var qgchslypk4toxdtgsfsf_shortcode = true;var cfontzigzdapzyxtbhg4_shortcode = true;var nflzw9az1mcray2ltc4m_shortcode = true;var edlo1w0s0lujgciyjgf9_shortcode = true;var ybbyul2ujyofvsznkiti_shortcode = true;var doewskxay35gb860nodl_shortcode = true;var wm0xaeyycxvhthxjz76n_shortcode = true;var iqff27bs0pszfabitkgw_shortcode = true;var xfup8pda84l5bd0udyje_shortcode = true;var xokl1h6esysgo5wdkq9d_shortcode = true;var jaxkt0icjnuu0z43iuik_shortcode = true;var vso3vlstnsfjgeuogzry_shortcode = true;var awihu5noxqqj5s7iasv8_shortcode = true;var cdikvvptidch9oj1o56k_shortcode = true;var qeu7gqedkzjnotzskhln_shortcode = true;var okkbvdzprjjylm7wjkhe_shortcode = true;var rxekv8i4pwnmp4zvclcm_shortcode = true;var koz3ranojk5yi8c5wmpe_shortcode = true;var e6m4njfonyv93sqcttlx_shortcode = true;		</script>
		<style id='core-block-supports-inline-css' type='text/css'>
.wp-container-core-columns-is-layout-9d6595d7{flex-wrap:nowrap;}
</style>
<script>(function(d){var s=d.createElement("script");s.type="text/javascript";s.src="https://a.omappapi.com/app/js/api.min.js";s.async=true;s.id="omapi-script";d.getElementsByTagName("head")[0].appendChild(s);})(document);</script><script type="text/javascript" src="https://tools.cep.health/wp-content/themes/cep-tools/js/vendor.min.js" id="vendor-js"></script>
<script type="text/javascript" src="https://tools.cep.health/wp-content/themes/cep-tools/js/app.min.js?ver=1674670088" id="app-js"></script>
<script type="text/javascript" src="https://tools.cep.health/wp-content/plugins/glossary-by-codeat/assets/js/off-screen.js?ver=2.3.5" id="glossary-off-screen-js"></script>
<script type="text/javascript" src="https://tools.cep.health/wp-content/themes/cep-tools/assets/js/app/modules/slider.js?ver=6.4.2" id="block-acf-drug-options-js"></script>
<script type="text/javascript" src="https://tools.cep.health/wp-content/plugins/optinmonster/assets/dist/js/helper.min.js?ver=2.16.20" id="optinmonster-wp-helper-js"></script>
		<script type="text/javascript">var omapi_localized = {
			ajax: 'https://tools.cep.health/wp-admin/admin-ajax.php?optin-monster-ajax-route=1',
			nonce: '54d7109d0e',
			slugs:
			{"hhgajtyemrlknjsvrsd5":{"slug":"hhgajtyemrlknjsvrsd5","mailpoet":false},"tkia37pcyyahx6opqim2":{"slug":"tkia37pcyyahx6opqim2","mailpoet":false},"ngtztpck7tvpbcvakl7d":{"slug":"ngtztpck7tvpbcvakl7d","mailpoet":false},"f2bzjhvjmeyfqkxxjggz":{"slug":"f2bzjhvjmeyfqkxxjggz","mailpoet":false},"qgchslypk4toxdtgsfsf":{"slug":"qgchslypk4toxdtgsfsf","mailpoet":false},"cfontzigzdapzyxtbhg4":{"slug":"cfontzigzdapzyxtbhg4","mailpoet":false},"nflzw9az1mcray2ltc4m":{"slug":"nflzw9az1mcray2ltc4m","mailpoet":false},"edlo1w0s0lujgciyjgf9":{"slug":"edlo1w0s0lujgciyjgf9","mailpoet":false},"ybbyul2ujyofvsznkiti":{"slug":"ybbyul2ujyofvsznkiti","mailpoet":false},"doewskxay35gb860nodl":{"slug":"doewskxay35gb860nodl","mailpoet":false},"wm0xaeyycxvhthxjz76n":{"slug":"wm0xaeyycxvhthxjz76n","mailpoet":false},"iqff27bs0pszfabitkgw":{"slug":"iqff27bs0pszfabitkgw","mailpoet":false},"xfup8pda84l5bd0udyje":{"slug":"xfup8pda84l5bd0udyje","mailpoet":false},"xokl1h6esysgo5wdkq9d":{"slug":"xokl1h6esysgo5wdkq9d","mailpoet":false},"jaxkt0icjnuu0z43iuik":{"slug":"jaxkt0icjnuu0z43iuik","mailpoet":false},"vso3vlstnsfjgeuogzry":{"slug":"vso3vlstnsfjgeuogzry","mailpoet":false},"awihu5noxqqj5s7iasv8":{"slug":"awihu5noxqqj5s7iasv8","mailpoet":false},"cdikvvptidch9oj1o56k":{"slug":"cdikvvptidch9oj1o56k","mailpoet":false},"qeu7gqedkzjnotzskhln":{"slug":"qeu7gqedkzjnotzskhln","mailpoet":false},"okkbvdzprjjylm7wjkhe":{"slug":"okkbvdzprjjylm7wjkhe","mailpoet":false},"rxekv8i4pwnmp4zvclcm":{"slug":"rxekv8i4pwnmp4zvclcm","mailpoet":false},"koz3ranojk5yi8c5wmpe":{"slug":"koz3ranojk5yi8c5wmpe","mailpoet":false},"e6m4njfonyv93sqcttlx":{"slug":"e6m4njfonyv93sqcttlx","mailpoet":false}}		};</script>
				<script type="text/javascript">var omapi_data = {"object_id":56356,"object_key":"tools","object_type":"post","term_ids":[],"wp_json":"https:\/\/tools.cep.health\/wp-json","wc_active":false,"edd_active":false,"nonce":"9051981ff5"};</script>
		
  </body>
</html>
